True Cell Type,Predicted Main Cell Type,Predicted Sub Cell Types,Possible Mixed Cell Types,Marker Number,Marker List,Iterations,Model,Provider,Tissue,Species,Additional Info,Conversation History
cluster_10,Endothelial Cells,"Inflammatory Endothelial Cells, Angiogenic Endothelial Cells, Activated Endothelial Cells",,50,"PCAT19, SELE, CSF3, ADAMTS9, ECSCR, IL6, AKAP12, ANGPT2, ADGRL4, SERPINE1, HMOX1, S1PR1, FABP4, CD93, CXCL8, CALCRL, TFPI2, GNG11, PLVAP, CCL2, IGFBP7, CXCL2, MT2A, TFPI, SPARCL1, TM4SF1, CXCL3, ADAMTS4, UPP1, CXCL1, PNP, SPRY1, TUBB6, PKIG, STC1, SOD2, FOSL1, CAV1, PLPP3, EMP1, NFKBIA, ICAM1, CD59, ID3, PHLDA1, TXNRD1, TCF4, FAM241A, ETS2, IFI27",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **IL6 (Interleukin 6):** A cytokine involved in inflammation and the maturation of B cells. It plays a role in immune response and is often associated with inflammatory processes.
- **CSF3 (Colony Stimulating Factor 3):** Also known as G-CSF, it is involved in the production, differentiation, and function of granulocytes.
- **ANGPT2 (Angiopoietin 2):** Involved in angiogenesis and endothelial cell function.
- **SERPINE1 (PAI-1):** A serine protease inhibitor that plays a role in fibrinolysis and is involved in tissue remodeling and inflammation.
- **HMOX1 (Heme Oxygenase 1):** An enzyme that provides protection against oxidative stress.
- **CXCL8 (IL-8):** A chemokine involved in the recruitment of neutrophils and other immune cells to sites of inflammation.
- **CCL2 (MCP-1):** A chemokine that recruits monocytes, memory T cells, and dendritic cells to sites of tissue injury and infection.
- **CXCL2, CXCL3, CXCL1:** Chemokines involved in the recruitment of immune cells, particularly neutrophils.
- **NFKBIA (IκBα):** An inhibitor of NF-κB, a key transcription factor in inflammatory responses.

### Step 2: List the Key Cell Type Markers
- **SELE (E-Selectin):** Expressed on endothelial cells activated by cytokines, involved in leukocyte adhesion and migration.
- **ECSCR (Endothelial Cell Specific Chemotaxis Regulator):** Specific to endothelial cells, involved in chemotaxis.
- **CD93:** A marker associated with endothelial cells and involved in cell adhesion and angiogenesis.
- **PLVAP (Plasmalemma Vesicle Associated Protein):** An endothelial cell marker involved in the formation of diaphragms in fenestrated endothelia.
- **ICAM1 (Intercellular Adhesion Molecule 1):** Expressed on endothelial cells and immune cells, involved in leukocyte endothelial transmigration.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, PanglaoDB, and literature on scRNA-seq datasets, the markers listed are predominantly associated with endothelial cells, particularly those involved in angiogenesis, inflammation, and immune cell recruitment.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of markers such as SELE, ECSCR, CD93, PLVAP, and ICAM1, the most probable general cell type is **endothelial cells**. These markers are characteristic of endothelial cells, especially in the context of inflammation and angiogenesis, which are relevant in breast cancer tissue.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Inflammatory Endothelial Cells:** Given the high expression of inflammatory cytokines and chemokines (IL6, CXCL8, CCL2), these endothelial cells are likely involved in inflammatory responses.
2. **Angiogenic Endothelial Cells:** The presence of ANGPT2 and other angiogenesis-related markers suggests a role in new blood vessel formation.
3. **Activated Endothelial Cells:** The expression of adhesion molecules like SELE and ICAM1 indicates an activated state, often seen in response to cytokines in the tumor microenvironment.

**Most Likely Subtype:** Inflammatory Endothelial Cells, due to the prominent expression of inflammatory cytokines and chemokines.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of endothelial cells. These cells are characterized by markers associated with inflammation, angiogenesis, and immune cell recruitment. The top probable subtypes are inflammatory endothelial cells, angiogenic endothelial cells, and activated endothelial cells, with inflammatory endothelial cells being the most likely subtype due to the high expression of inflammatory markers.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency:**
   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. 
   - The markers such as SELE, ECSCR, CD93, PLVAP, and ICAM1 are indeed associated with endothelial cells, supporting the annotation of the cell type as endothelial cells.
   - The presence of inflammatory markers like IL6, CXCL8, and CCL2 aligns with the identification of inflammatory endothelial cells as a probable subtype.

2. **Mixed Cell Type Consideration:**
   - The annotation considers the possibility of mixed subtypes within the endothelial cell category, such as inflammatory, angiogenic, and activated endothelial cells. This is appropriate given the expression of markers related to inflammation, angiogenesis, and activation.
   - There is no strong evidence of distinct, non-endothelial cell types based on the high-ranking markers provided, so the annotation does not need to be flagged for mixed cell types beyond the subtypes already considered.

Overall, the annotation is well-supported by the marker list and the context of breast cancer tissue, and the analysis appropriately identifies the most likely cell type and subtypes. | Formatting Agent: {
  ""main_cell_type"": ""Endothelial Cells"",
  ""sub_cell_types"": [
    ""Inflammatory Endothelial Cells"",
    ""Angiogenic Endothelial Cells"",
    ""Activated Endothelial Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_1,macrophages,"Tumor-associated macrophages (TAMs), Classical macrophages (M1), Non-classical macrophages (M2)",,50,"LYZ, TYROBP, OLR1, AIF1, C1QA, FCER1G, C1QB, HLA-DRA, FCGR3A, C1QC, MNDA, MS4A6A, FPR3, IGSF6, APOC1, LST1, HLA-DPA1, CYBB, HLA-DQA1, HLA-DPB1, FCGR2A, SPP1, FGL2, HLA-DRB1, CD14, SPI1, C1orf162, CCL3, CD68, CD74, PLEK, HLA-DQB1, CTSS, APOE, LAPTM5, RNASE6, HLA-DMB, GPR183, SRGN, CLEC7A, RGS1, ITGB2, TNFSF13B, KCTD12, HLA-DRB5, CD83, HLA-DMA, CTSZ, ZEB2, SGK1",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell RNA sequencing dataset of breast cancer tissue, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **LYZ (Lysozyme):** An enzyme that breaks down bacterial cell walls, commonly associated with myeloid cells, particularly macrophages and neutrophils.
- **TYROBP (DAP12):** An adaptor protein involved in immune signaling, often found in myeloid cells.
- **AIF1 (Allograft Inflammatory Factor 1):** Involved in inflammatory responses, typically expressed in macrophages and microglia.
- **HLA-DRA, HLA-DPA1, HLA-DQA1, HLA-DPB1, HLA-DRB1, HLA-DQB1, HLA-DRB5, HLA-DMA, HLA-DMB:** These are major histocompatibility complex (MHC) class II molecules, crucial for antigen presentation, predominantly expressed in antigen-presenting cells like dendritic cells, macrophages, and B cells.
- **FCER1G, FCGR3A, FCGR2A:** Fc receptors involved in binding antibodies, typically found in myeloid cells.
- **C1QA, C1QB, C1QC:** Components of the complement system, often associated with macrophages.
- **CD14, CD68:** Classical markers for monocytes and macrophages.
- **APOE (Apolipoprotein E):** Involved in lipid metabolism, expressed in macrophages and other cell types.
- **SPI1 (PU.1):** A transcription factor critical for myeloid and lymphoid lineage development.

### Step 2: List the Key Cell Type Markers
- **CD14, CD68:** Strongly indicative of monocytes and macrophages.
- **HLA-DRA, HLA-DPA1, HLA-DQA1, HLA-DPB1, HLA-DRB1, HLA-DQB1, HLA-DRB5, HLA-DMA, HLA-DMB:** Indicate antigen-presenting cells, such as macrophages and dendritic cells.
- **LYZ, TYROBP, AIF1:** Commonly associated with myeloid lineage, particularly macrophages.
- **C1QA, C1QB, C1QC:** Suggestive of macrophage activity.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Cell Atlas and literature on breast cancer tissue, the expression of these markers is consistent with myeloid lineage cells, particularly macrophages. The presence of MHC class II molecules and complement components further supports this.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of these markers, the most likely general cell type is **macrophages**. These cells are known for their role in immune response, antigen presentation, and tissue homeostasis.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Tumor-associated macrophages (TAMs):** Given the breast cancer tissue context, TAMs are highly probable. They are known to express many of the markers listed, including CD68, CD14, and MHC class II molecules.
2. **Classical macrophages (M1):** Characterized by high expression of MHC class II molecules and pro-inflammatory markers.
3. **Non-classical macrophages (M2):** Often involved in tissue repair and express markers like CD68 and MHC class II, but with a different cytokine profile.

The most likely subtype, considering the tumor environment, is **Tumor-associated macrophages (TAMs)**, as they are prevalent in cancer tissues and express a wide range of the provided markers.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of macrophages, specifically tumor-associated macrophages (TAMs). This conclusion is based on the high expression of myeloid and macrophage-specific markers, including CD14, CD68, and MHC class II molecules, which are characteristic of TAMs in the tumor microenvironment.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency:**
   - The markers used in the annotation (e.g., LYZ, TYROBP, AIF1, HLA-DRA, CD14, CD68, etc.) are present in the provided marker list.
   - The markers are consistent with the identification of myeloid lineage cells, particularly macrophages. The presence of MHC class II molecules and complement components further supports this.

2. **Mixed Cell Type Consideration:**
   - The analysis does not strongly suggest the presence of multiple distinct cell types. The markers predominantly indicate macrophages, specifically tumor-associated macrophages (TAMs), which are common in breast cancer tissue.
   - There is no strong evidence of mixed cell types that would require further investigation.

The annotation of the cell cluster as macrophages, particularly tumor-associated macrophages (TAMs), is well-supported by the marker list and the context of breast cancer tissue. | Formatting Agent: {
  ""main_cell_type"": ""macrophages"",
  ""sub_cell_types"": [
    ""Tumor-associated macrophages (TAMs)"",
    ""Classical macrophages (M1)"",
    ""Non-classical macrophages (M2)""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_0,Epithelial Cells,"Basal-like Epithelial Cells, Luminal Progenitor Cells, Cancer Stem-like Cells",,50,"KRT6A, FDCSP, KRT14, KRT17, KRT6B, SLPI, SERPINB5, DDIT4, SAA1, RHOV, NDUFA4L2, ID1, RARRES1, S100P, SFRP1, RPL39L, TACSTD2, CDKN2A, PDZK1IP1, MT1X, MFGE8, DMKN, CSTB, LY6K, TMEM45A, KRT5, TFDP1, S100A9, WFDC2, PERP, GADD45A, PMAIP1, SOX9, MAL2, TPM2, GIPC1, CLDN4, ANXA2, SLC25A37, LSR, LAMP1, RHEB, LGALS3, SNRPA1, GSTP1, STMN1, EMP2, BRI3, ATP1B3, YBX3",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **KRT6A, KRT14, KRT17, KRT6B, KRT5**: These are keratins, which are structural proteins typically expressed in epithelial cells. They play a role in the structural integrity and function of epithelial tissues.
- **SERPINB5 (Maspin)**: A serine protease inhibitor involved in tumor suppression and regulation of cell adhesion.
- **SAA1 (Serum Amyloid A1)**: An acute-phase protein involved in inflammation and immune response.
- **S100P, S100A9**: Members of the S100 family of proteins, involved in calcium binding and regulation of a variety of cellular processes including cell cycle progression and differentiation.
- **SOX9**: A transcription factor involved in the regulation of developmental processes and differentiation, particularly in chondrogenesis and stem cell maintenance.
- **CLDN4 (Claudin 4)**: A component of tight junction strands, important for maintaining cell polarity and barrier function in epithelial cells.
- **ANXA2 (Annexin A2)**: Involved in membrane organization and dynamics, and plays a role in cellular processes such as endocytosis and exocytosis.
- **LGALS3 (Galectin-3)**: Involved in cell-cell and cell-matrix interactions, apoptosis, and immune response modulation.

### Step 2: List the Key Cell Type Markers
- **KRT5, KRT14, KRT17**: These keratins are typically associated with basal epithelial cells, particularly basal-like cells in the breast.
- **FDCSP (Follicular Dendritic Cell Secreted Protein)**: Although primarily associated with follicular dendritic cells, its expression in this context may indicate a role in the tumor microenvironment.
- **SLPI (Secretory Leukocyte Peptidase Inhibitor)**: Expressed in epithelial tissues, particularly in the respiratory and reproductive tracts, and has roles in immune response and inflammation.
- **TACSTD2 (TROP2)**: A cell surface glycoprotein expressed in various epithelial tissues and often upregulated in cancers, including breast cancer.
- **LY6K**: Overexpressed in various cancers, including breast cancer, and associated with tumor progression.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer scRNA-seq, we can cross-reference these markers:
- **Basal-like breast cancer cells**: Known to express high levels of KRT5, KRT14, and KRT17.
- **Epithelial cells**: Express keratins and markers like CLDN4, TACSTD2, and SLPI.
- **Cancer-associated markers**: SERPINB5, SAA1, and LY6K are often upregulated in breast cancer tissues.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of keratins (KRT5, KRT14, KRT17) and other epithelial markers (CLDN4, TACSTD2), the most probable general cell type is **epithelial cells**, specifically those associated with the basal layer.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Basal-like Epithelial Cells**: High expression of KRT5, KRT14, and KRT17 strongly suggests basal-like epithelial cells, common in basal-like breast cancer.
2. **Luminal Progenitor Cells**: While less likely, some markers like TACSTD2 and S100P can also be expressed in luminal progenitor cells.
3. **Cancer Stem-like Cells**: The presence of markers like SOX9 and LY6K may indicate a stem-like or progenitor state within the cancerous tissue.

The most likely subtype based on the markers is **Basal-like Epithelial Cells**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of basal-like epithelial cells. This is supported by the high expression of basal keratins (KRT5, KRT14, KRT17) and other epithelial markers. These cells are characteristic of basal-like breast cancer, a subtype known for its aggressive nature and distinct molecular profile.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**: 
   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. 
   - The markers KRT5, KRT14, and KRT17 are indeed associated with basal epithelial cells, particularly in the context of basal-like breast cancer, which aligns with the annotation of basal-like epithelial cells.
   - Other markers such as CLDN4, TACSTD2, and SLPI support the epithelial nature of the cells, while markers like LY6K and SOX9 suggest a cancerous or stem-like state, which is consistent with the context of breast cancer.

2. **Mixed Cell Type Consideration**:
   - The annotation considers the possibility of mixed cell types by identifying potential subtypes such as luminal progenitor cells and cancer stem-like cells. However, the strongest evidence supports the basal-like epithelial cell type, which is appropriate given the marker expression profile.

Overall, the annotation is well-supported by the marker list and the context provided, leading to a valid conclusion of basal-like epithelial cells as the primary cell type in the cluster. | Formatting Agent: {
  ""main_cell_type"": ""Epithelial Cells"",
  ""sub_cell_types"": [
    ""Basal-like Epithelial Cells"",
    ""Luminal Progenitor Cells"",
    ""Cancer Stem-like Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_11,Epithelial Cells,"Luminal Epithelial Cells, Luminal Progenitor Cells, Basal Epithelial Cells",,50,"MTCO2P12, CPB1, GSTM1, KCNC2, H3-3A, H1-0, GRIA2, H3-3B, H2AJ, PHGR1, LRP2, PLAAT3, ANKRD50, WBP1, MTRNR2L12, H2AZ1, FAM3B, GABARAP, TPRG1, CA2, PRKACB, RBIS, PTPRT, ATP6V0C, CXCL14, FSIP1, AKR7A3, ASAH1, TFF3, NAT1, ABHD2, GPX1, MICOS13, PSD3, KAT6B, PKIB, NGRN, ALDOA, AFF3, BCAM, LDLRAD4, MAST4, PLAT, ESR1, COX6C, QDPR, GATA3, SLC39A6, IGF1R, MRPS30",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **MTCO2P12**: Mitochondrial gene, often involved in energy metabolism.
- **GSTM1**: Glutathione S-transferase, involved in detoxification.
- **H3-3A, H3-3B, H2AJ, H2AZ1**: Histone proteins, involved in chromatin structure and gene regulation.
- **GABARAP**: Involved in autophagy and intracellular trafficking.
- **CA2**: Carbonic anhydrase, involved in pH regulation and ion transport.
- **PRKACB**: Protein kinase, involved in signal transduction.
- **CXCL14**: Chemokine, involved in immune cell recruitment.
- **ESR1**: Estrogen receptor, involved in hormone signaling.
- **GATA3**: Transcription factor, involved in cell differentiation and development.
- **IGF1R**: Insulin-like growth factor receptor, involved in growth and survival signaling.

### Step 2: List the Key Cell Type Markers
- **ESR1**: Estrogen receptor, a key marker for breast epithelial cells, particularly luminal cells.
- **GATA3**: Often associated with luminal epithelial cells in the breast.
- **CXCL14**: Expressed in various epithelial cells and involved in immune interactions.
- **IGF1R**: Expressed in epithelial cells, involved in growth signaling.
- **CA2**: Expressed in epithelial cells, involved in ion transport and pH regulation.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer scRNA-seq datasets, the following observations can be made:
- **ESR1** and **GATA3** are well-known markers for luminal epithelial cells in the breast.
- **CXCL14** and **IGF1R** are also expressed in epithelial cells, supporting the epithelial nature of the cluster.
- **CA2** is expressed in various epithelial tissues, including breast tissue.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of **ESR1**, **GATA3**, and other epithelial markers, the most probable general cell type is **epithelial cells**, specifically luminal epithelial cells in the breast.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal Epithelial Cells**: High expression of **ESR1** and **GATA3** strongly suggests luminal epithelial cells, which are hormone-responsive and a major component of breast tissue.
2. **Luminal Progenitor Cells**: These cells also express **GATA3** and may have some overlap with luminal epithelial markers.
3. **Basal Epithelial Cells**: Although less likely due to the lack of specific basal markers, some overlap in epithelial markers could suggest a minor presence.

The most likely subtype based on the markers is **Luminal Epithelial Cells**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of luminal epithelial cells. This conclusion is supported by the high expression of key markers such as **ESR1** and **GATA3**, which are characteristic of luminal epithelial cells in the breast. These cells play a crucial role in hormone response and are a significant component of breast tissue architecture.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**: 
   - The key markers used in the annotation, such as **ESR1**, **GATA3**, **CXCL14**, **IGF1R**, and **CA2**, are present in the provided marker list.
   - These markers are well-known for their association with epithelial cells, particularly luminal epithelial cells in breast tissue.

2. **Mixed Cell Type Consideration**:
   - The analysis correctly identifies the potential presence of luminal progenitor cells and basal epithelial cells, although the evidence strongly supports luminal epithelial cells as the predominant type.
   - The presence of markers like **ESR1** and **GATA3** strongly supports the annotation of luminal epithelial cells, and there is no strong evidence of a mixed cell type population that would require further investigation.

The annotation is well-supported by the marker list and aligns with known biological roles and literature, making the validation successful. | Formatting Agent: {
  ""main_cell_type"": ""Epithelial Cells"",
  ""sub_cell_types"": [
    ""Luminal Epithelial Cells"",
    ""Luminal Progenitor Cells"",
    ""Basal Epithelial Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_12,epithelial cells,"Luminal A Breast Cancer Cells, Luminal B Breast Cancer Cells, Normal Luminal Epithelial Cells",,50,"CLIC6, SIM2, STC2, FASN, SLC7A2, MS4A7, TMC5, COL1A1, MUC1, PGR, CA12, PGGHG, MAPT, COL1A2, POLR2J3.1, SLC40A1, ZNF552, FKBP5, GJA1, COL3A1, BATF, C1orf21, SEMA3C, DLG5, KRT19, CRIP1, KDM4B, ZNF652, SLC38A1, ANKRD30A, KRT7, RUNX1, PRLR, S100A14, SREBF1, EVL, RAB11FIP1, DEGS2, CRACR2B, ZG16B, SMIM22, ADIRF, TBC1D9, NPDC1, STOM, FN1, IL6ST, SPARC, UGDH, AZGP1",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell RNA sequencing dataset of breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **FASN (Fatty Acid Synthase):** Involved in lipogenesis, often upregulated in cancer cells for membrane synthesis.
- **SLC7A2 (Solute Carrier Family 7 Member 2):** Amino acid transporter, important for cellular metabolism.
- **CA12 (Carbonic Anhydrase 12):** Involved in pH regulation, often expressed in cancer cells.
- **MAPT (Microtubule Associated Protein Tau):** Stabilizes microtubules, associated with cell structure.
- **SREBF1 (Sterol Regulatory Element Binding Transcription Factor 1):** Regulates lipid homeostasis.
- **IL6ST (Interleukin 6 Signal Transducer):** Part of the IL-6 receptor complex, involved in immune signaling.

### Step 2: List the Key Cell Type Markers
- **MUC1 (Mucin 1):** A glycoprotein expressed on the apical surface of epithelial cells, often overexpressed in breast cancer.
- **PGR (Progesterone Receptor):** A nuclear receptor, indicative of hormone-responsive breast cancer cells.
- **KRT19 (Keratin 19):** An epithelial marker, often used to identify epithelial cells in breast tissue.
- **KRT7 (Keratin 7):** Another epithelial marker, common in glandular and transitional epithelium.
- **PRLR (Prolactin Receptor):** Involved in mammary gland development, often expressed in breast tissue.
- **ANKRD30A (Ankyrin Repeat Domain 30A):** Known to be expressed in breast tissue, particularly in luminal cells.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer, the markers MUC1, PGR, KRT19, KRT7, and PRLR are strongly associated with epithelial cells, particularly luminal epithelial cells in the breast. These markers are often used to identify luminal subtypes of breast cancer.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of epithelial markers (MUC1, KRT19, KRT7) and hormone receptors (PGR, PRLR), the most probable general cell type is **epithelial cells**. Given the context of breast cancer tissue, these are likely to be **luminal epithelial cells**.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal A Breast Cancer Cells:** Characterized by the expression of hormone receptors (PGR, PRLR) and low proliferation markers.
2. **Luminal B Breast Cancer Cells:** Similar to Luminal A but with higher proliferation and possibly higher expression of genes like FASN and SREBF1.
3. **Normal Luminal Epithelial Cells:** Express markers like KRT19 and KRT7 but may have lower expression of cancer-associated markers like MUC1.

The most likely subtype, given the presence of PGR, PRLR, and epithelial markers, is **Luminal A Breast Cancer Cells**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of luminal epithelial cells. The expression of hormone receptors and epithelial markers strongly indicates a luminal subtype of breast cancer, with Luminal A being the most probable due to the presence of PGR and PRLR. This subtype is characterized by hormone receptor positivity and lower proliferation compared to Luminal B.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency:**
   - The key functional markers (FASN, SLC7A2, CA12, MAPT, SREBF1, IL6ST) and key cell type markers (MUC1, PGR, KRT19, KRT7, PRLR, ANKRD30A) are all present in the provided marker list.
   - The markers used to identify the cell type as luminal epithelial cells, particularly Luminal A Breast Cancer Cells, are consistent with known literature and databases for breast cancer tissue.

2. **Mixed Cell Type Consideration:**
   - The analysis does not strongly suggest the presence of multiple distinct cell types within the cluster. The markers predominantly support the identification of luminal epithelial cells, specifically Luminal A Breast Cancer Cells.
   - There is no indication of a mixed cell population that would require further investigation.

The annotation is well-supported by the marker list and aligns with the known characteristics of luminal epithelial cells in breast cancer tissue. | Formatting Agent: {
  ""main_cell_type"": ""epithelial cells"",
  ""sub_cell_types"": [
    ""Luminal A Breast Cancer Cells"",
    ""Luminal B Breast Cancer Cells"",
    ""Normal Luminal Epithelial Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_13,breast epithelial cells,"Luminal Epithelial Cells, HER2-positive Breast Cancer Cells, Basal-like Breast Cancer Cells",,50,"MUCL1, SCGB2A2, AC109826.1, AC025154.2, ERBB2, CALML5, CNTNAP2, AQP5, AL354707.1, KRT10, CEACAM6, TEX9, PPP1R1A, CISD3, NUDT8, DUSP6, FADS2, PSMB3, IGHG1, IGHM, SOCS7, PIP4K2B, GRB7, FAM84B, PGAP3, SCD, MRPL45, MLLT6, LASP1, CWC25, S100A9, RPL23, MIEN1, PCGF2, CXCL17, SQLE, IGKC, G6PD, HMGCS1, MPHOSPH6, CRIP1, LAPTM4B, IGLC2, QPRT, SMARCE1, GALNT7, TMEM99, MGST1, PLGRKT, CBR3",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **ERBB2 (HER2)**: A receptor tyrosine kinase involved in the growth and differentiation of cells. Overexpression is commonly associated with certain types of breast cancer.
- **CALML5**: Calmodulin-like protein involved in calcium signaling, which can play a role in cell proliferation and differentiation.
- **AQP5**: Aquaporin 5, a water channel protein, often associated with glandular tissues and involved in fluid transport.
- **CEACAM6**: A cell adhesion molecule that can be involved in cancer progression and metastasis.
- **S100A9**: A calcium-binding protein involved in inflammatory processes and often associated with myeloid cells.
- **CXCL17**: A chemokine involved in immune cell recruitment, often expressed in epithelial tissues.
- **SQLE**: Squalene epoxidase, involved in cholesterol biosynthesis, often upregulated in cancer cells.

### Step 2: List the Key Cell Type Markers
- **MUCL1**: Mucin-like protein 1, highly expressed in breast tissue and often used as a marker for breast cancer cells.
- **SCGB2A2 (Mammaglobin)**: A secretoglobin family member, highly specific to breast tissue and often used as a marker for breast cancer.
- **KRT10**: Keratin 10, typically expressed in epithelial cells, particularly in the skin.
- **IGHG1, IGHM, IGKC, IGLC2**: Immunoglobulin genes, typically associated with B cells and plasma cells.
- **S100A9**: As mentioned, often associated with myeloid cells but can also be expressed in epithelial cells in certain contexts.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer, we can confirm that markers like MUCL1, SCGB2A2, and ERBB2 are highly indicative of breast epithelial cells, particularly those involved in breast cancer.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of MUCL1, SCGB2A2, and ERBB2, the most probable general cell type is **breast epithelial cells**, specifically those associated with breast cancer.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal Epithelial Cells**: Characterized by the expression of SCGB2A2 and ERBB2, these cells are often involved in breast cancer, particularly luminal subtypes.
2. **HER2-positive Breast Cancer Cells**: Given the high expression of ERBB2, these cells are likely to be HER2-positive, a subtype of breast cancer.
3. **Basal-like Breast Cancer Cells**: While less likely due to the lack of specific basal markers, the presence of certain epithelial markers could suggest a basal-like phenotype.

The most likely subtype based on the markers is **Luminal Epithelial Cells** due to the strong expression of SCGB2A2 and ERBB2.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of breast epithelial cells, specifically luminal epithelial cells associated with breast cancer. The presence of markers such as MUCL1, SCGB2A2, and ERBB2 strongly supports this annotation, with a high probability of these cells being involved in luminal subtype breast cancer.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**:
   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. 
   - The markers MUCL1, SCGB2A2, and ERBB2 are well-known markers for breast epithelial cells, particularly those associated with breast cancer, which aligns with the annotation of luminal epithelial cells.
   - The presence of ERBB2 supports the identification of HER2-positive breast cancer cells, which is consistent with the annotation.

2. **Mixed Cell Type Consideration**:
   - While there are markers like S100A9 and immunoglobulin genes (IGHG1, IGHM, IGKC, IGLC2) that could suggest the presence of myeloid cells or B cells, the annotation primarily focuses on the epithelial markers, which are more strongly represented and relevant to the context of breast cancer tissue.
   - The annotation acknowledges the potential for basal-like breast cancer cells but correctly prioritizes the luminal epithelial cell type based on the stronger expression of luminal markers.

Overall, the annotation is well-supported by the marker list and the context of breast cancer tissue, and no significant evidence suggests a mixed cell type population that would require further investigation. | Formatting Agent: {
  ""main_cell_type"": ""breast epithelial cells"",
  ""sub_cell_types"": [
    ""Luminal Epithelial Cells"",
    ""HER2-positive Breast Cancer Cells"",
    ""Basal-like Breast Cancer Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_14,Epithelial Cells,"Luminal Epithelial Cells, Basal/Myoepithelial Cells, Cancer Stem-like Cells",,50,"PIGR, PI3, ALDH1A3, SAA1, CXCL1, SAA2, CCL20, MMP7, CXCL3, LTF, SOD2, CXCL8, MT2A, S100A9, SNORC, ANXA3, KRT23, LCN2, CCL2, HMGA1, MT1X, CXCL2, BIRC3, S100A6, CD59, KRT7, GLIPR1, SVIL, WFDC2, PDZK1IP1, SLC25A37, TNFRSF12A, SLPI, RPS17, MT-ND6, SDC4, ANXA1, TACSTD2, S100A16, MGST1, CARHSP1, DDX21, PRELID1, SMS, RPL17, TUBA1C, TXN, YBX1, RPL31, RPL34",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **PIGR (Polymeric Immunoglobulin Receptor):** Involved in the transcytosis of polymeric immunoglobulin across epithelial cells.
- **ALDH1A3 (Aldehyde Dehydrogenase 1 Family Member A3):** Plays a role in the oxidation of aldehydes and is often associated with stem cell properties and cancer stem cells.
- **SAA1/SAA2 (Serum Amyloid A1/A2):** Acute-phase proteins involved in inflammation.
- **CXCL1/CXCL2/CXCL3/CXCL8 (Chemokine Ligands):** Involved in chemotaxis and inflammatory responses.
- **MMP7 (Matrix Metallopeptidase 7):** Involved in the breakdown of extracellular matrix, important in tissue remodeling and cancer metastasis.
- **SOD2 (Superoxide Dismutase 2):** Mitochondrial enzyme that protects against oxidative stress.
- **MT2A/MT1X (Metallothioneins):** Involved in metal ion homeostasis and protection against oxidative damage.
- **S100A9/S100A6/S100A16 (S100 Calcium Binding Proteins):** Involved in regulation of a variety of cellular processes such as cell cycle progression and differentiation.
- **CCL20 (C-C Motif Chemokine Ligand 20):** Involved in immune responses and inflammation.
- **BIRC3 (Baculoviral IAP Repeat Containing 3):** Involved in inhibiting apoptosis.
- **TNFRSF12A (Tumor Necrosis Factor Receptor Superfamily Member 12A):** Involved in cell survival and inflammation.

### Step 2: List the Key Cell Type Markers
- **KRT7 (Keratin 7):** Typically expressed in epithelial cells, including ductal and glandular epithelia.
- **KRT23 (Keratin 23):** Associated with epithelial cells.
- **LCN2 (Lipocalin 2):** Often expressed in epithelial cells and involved in innate immunity.
- **SLPI (Secretory Leukocyte Peptidase Inhibitor):** Expressed in epithelial cells, involved in protecting epithelial tissues from proteolytic damage.
- **WFDC2 (WAP Four-Disulfide Core Domain 2):** Also known as HE4, expressed in epithelial cells, particularly in reproductive tissues.
- **ANXA1/ANXA3 (Annexins):** Involved in membrane-related events along exocytotic and endocytotic pathways, often expressed in epithelial cells.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on scRNA-seq datasets, the markers listed are predominantly associated with epithelial cells, particularly those involved in immune response, inflammation, and cancer-related pathways.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of markers such as KRT7, KRT23, and WFDC2, the most probable general cell type is **epithelial cells**. These markers are commonly expressed in epithelial tissues, including those found in the breast.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal Epithelial Cells:** Characterized by the expression of keratins such as KRT7 and markers like WFDC2, which are often found in luminal epithelial cells of the breast.
2. **Basal/Myoepithelial Cells:** While less likely due to the lack of specific basal markers, some overlap in markers like S100 proteins could suggest a basal phenotype.
3. **Cancer Stem-like Cells:** The presence of ALDH1A3 and other stemness-related markers could indicate a subpopulation with stem-like properties within the epithelial compartment.

The most likely subtype, given the context of breast cancer tissue and the expression of KRT7, WFDC2, and ALDH1A3, is **Luminal Epithelial Cells**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of epithelial cells, specifically luminal epithelial cells. This conclusion is supported by the expression of key epithelial markers such as KRT7 and WFDC2, along with functional markers related to inflammation and cancer pathways. The presence of ALDH1A3 also suggests a potential cancer stem-like subpopulation within the epithelial cells.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency:**
   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. 
   - The markers such as KRT7, KRT23, and WFDC2 are indeed associated with epithelial cells, particularly luminal epithelial cells, which aligns with the annotation of the cell type as epithelial cells.

2. **Mixed Cell Type Consideration:**
   - The annotation acknowledges the potential presence of cancer stem-like cells due to the expression of ALDH1A3, which is appropriate given the context of breast cancer tissue. 
   - There is no strong evidence of multiple distinct cell types that would necessitate flagging for mixed cell type consideration beyond what has been addressed.

The annotation is well-supported by the marker list and the context of breast cancer tissue, leading to a logical conclusion of luminal epithelial cells as the primary cell type. | Formatting Agent: {
  ""main_cell_type"": ""Epithelial Cells"",
  ""sub_cell_types"": [
    ""Luminal Epithelial Cells"",
    ""Basal/Myoepithelial Cells"",
    ""Cancer Stem-like Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_15,epithelial cells,"luminal epithelial cells, basal/myoepithelial cells, cancer stem-like cells",,50,"SIX3, SNORC, KANK4, MYEOV, FABP7, MT1H, OBP2B, ROCR, SCRG1, KRT15, TTYH1, ACTR3B, PCSK1N, KLK11, NIPAL3, GMDS, KRT19, MT1G, MT-ND2, RAMP2, PPP1R1B, NFIB, NDRG2, RPS17, EIF3L, RPLP0, MT-ND3, LYRM4, NOP53, SNHG7, MT-ND1, RPL23A, MT-CYB, RPSA, RPS20, RPS3, RPL7, RPS12, RPS19, MARCKSL1, RPL27, C6orf48, FBL, SOX4, RPS24, RPL6, PABPC1, RPS6, POLR2F, RPL34",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type from the provided ranked marker list, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **FABP7**: Fatty acid binding protein 7, involved in fatty acid uptake, transport, and metabolism. Often associated with neural stem cells and astrocytes.
- **MT1H, MT1G**: Metallothioneins, involved in metal ion binding and detoxification. They play roles in cellular protection against oxidative stress.
- **RAMP2**: Receptor activity-modifying protein 2, involved in modulating receptor activity, particularly in the context of the cardiovascular system.
- **NDRG2**: N-myc downstream-regulated gene 2, involved in stress responses, cell growth, and differentiation.
- **MARCKSL1**: Myristoylated alanine-rich C-kinase substrate-like 1, involved in cell motility and cytoskeletal organization.

### Step 2: List the Key Cell Type Markers
- **KRT15, KRT19**: Keratins, structural proteins in epithelial cells. KRT19 is often associated with epithelial cells, including those in the breast.
- **SIX3**: A transcription factor involved in development, particularly in the brain and eye, but also expressed in some epithelial tissues.
- **SOX4**: A transcription factor involved in development and differentiation, often associated with progenitor and stem cells.
- **NFIB**: Nuclear factor I B, a transcription factor involved in development and differentiation, particularly in the brain and lung.

### Step 3: Cross-reference Known Databases
Using scRNA-seq databases such as the Human Cell Atlas and literature, we can cross-reference these markers:
- **KRT19** and **KRT15** are strongly indicative of epithelial cells, particularly luminal epithelial cells in the breast.
- **FABP7** is often expressed in neural tissues but can also be found in certain cancer stem cells.
- **SOX4** and **NFIB** are associated with progenitor and stem-like states, which can be relevant in cancer contexts.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of **KRT19**, **KRT15**, and other epithelial markers, the most probable general cell type is **epithelial cells**. Given the context of breast cancer tissue, these are likely breast epithelial cells.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal Epithelial Cells**: High expression of **KRT19** and **KRT15** suggests luminal epithelial cells, which are common in breast tissue.
2. **Basal/Myoepithelial Cells**: While less likely due to the lack of specific basal markers like KRT5 or KRT14, the presence of general epithelial markers could still suggest this subtype.
3. **Cancer Stem-like Cells**: The presence of **SOX4**, **FABP7**, and other stem/progenitor markers could indicate a stem-like or progenitor state within the cancer context.

**Most Likely Subtype**: **Luminal Epithelial Cells** are the most likely subtype due to the strong expression of luminal markers like **KRT19** and **KRT15**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of epithelial cells, specifically luminal epithelial cells. This conclusion is supported by the high expression of keratin markers such as **KRT19** and **KRT15**, which are characteristic of luminal epithelial cells in the breast. The presence of markers like **SOX4** and **FABP7** also suggests a potential stem-like or progenitor state, which is relevant in the context of cancer.

FINAL ANNOTATION COMPLETED | Coupling Validator: To validate the annotation result, let's follow the outlined steps:

### Step 1: Marker Consistency
- **FABP7**, **MT1H**, **MT1G**, **RAMP2**, **NDRG2**, **MARCKSL1**, **KRT15**, **KRT19**, **SIX3**, **SOX4**, and **NFIB** are all present in the provided marker list. This confirms that the markers used in the annotation are consistent with the provided list.

### Step 2: Mixed Cell Type Consideration
- The annotation suggests the presence of luminal epithelial cells, basal/myoepithelial cells, and cancer stem-like cells. The presence of **KRT19** and **KRT15** strongly supports the identification of luminal epithelial cells.
- The presence of **SOX4** and **FABP7** suggests a potential stem-like or progenitor state, which is relevant in the context of cancer.
- The annotation does not strongly support the presence of basal/myoepithelial cells due to the lack of specific basal markers like **KRT5** or **KRT14**.

### Conclusion
The annotation is consistent with the provided marker list and the identified cell type is supported by the markers. The potential presence of cancer stem-like cells is noted, but the primary identification of luminal epithelial cells is well-supported by the data.

Validation result: VALIDATION PASSED | Formatting Agent: {
  ""main_cell_type"": ""epithelial cells"",
  ""sub_cell_types"": [
    ""luminal epithelial cells"",
    ""basal/myoepithelial cells"",
    ""cancer stem-like cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_16,breast epithelial cells,"HER2-positive Breast Cancer Cells, Luminal Breast Cancer Cells, Basal-like Breast Cancer Cells",,50,"SOX11, PNMT, PPP1R1B, MUC6, ERBB2, RNF43, PIP, TFF3, SPINK8, GUCY1A1, ST8SIA6-AS1, NR2F1, HOPX, AC093001.1, SERHL2, PART1, PGAP3, TFAP2B, MIEN1, GRB7, SLC12A2, CALML5, ORMDL3, NUDT8, MSL1, CXCL17, PSMD3, AC010642.2, MED1, FBXL20, LRRC26, GALNT7, CPD, COIL, ANKRD30A, EPN2, UBE2M, METRN, TRIM28, STARD3, CHMP2A, CDK12, AKAP1, KRT7, IFT20, KIAA1324, APOD, SPDEF, LIMCH1, CREB3L4",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **ERBB2 (HER2)**: A member of the epidermal growth factor receptor (EGFR) family, often overexpressed in certain types of breast cancer.
- **GRB7**: An adaptor protein that interacts with receptor tyrosine kinases like ERBB2, involved in signal transduction pathways.
- **TFAP2B**: A transcription factor involved in the regulation of gene expression during development and differentiation.
- **SPDEF**: A transcription factor involved in the regulation of epithelial cell differentiation and proliferation.
- **CXCL17**: A chemokine involved in immune cell recruitment and inflammation.
- **KRT7**: A type II keratin, typically expressed in epithelial cells, including those in the breast.

### Step 2: List the Key Cell Type Markers
- **SOX11**: A transcription factor involved in neurogenesis and often associated with certain cancers.
- **PNMT**: An enzyme involved in catecholamine biosynthesis, typically expressed in adrenal medulla and some neural tissues.
- **MUC6**: A mucin protein, typically expressed in glandular tissues.
- **PIP (Prolactin-Induced Protein)**: Expressed in breast tissue and associated with breast cancer.
- **TFF3 (Trefoil Factor 3)**: Involved in mucosal protection and repair, often expressed in epithelial tissues.
- **HOPX**: A homeodomain protein involved in differentiation and development, expressed in various tissues.
- **ANKRD30A**: Known as NY-BR-1, a breast cancer antigen.
- **KRT7**: As mentioned, a marker for epithelial cells, including those in the breast.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer, we can cross-reference these markers:
- **ERBB2, GRB7, and PIP** are well-known markers associated with breast cancer, particularly HER2-positive subtypes.
- **ANKRD30A** is a breast cancer-associated antigen, supporting a breast tissue origin.
- **KRT7** is commonly expressed in breast epithelial cells.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of markers like ERBB2, GRB7, PIP, and ANKRD30A, the most probable general cell type is **breast epithelial cells**, specifically those associated with breast cancer.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **HER2-positive Breast Cancer Cells**: Due to the high expression of ERBB2 and GRB7, which are characteristic of HER2-positive breast cancer.
2. **Luminal Breast Cancer Cells**: Expression of PIP and TFF3 suggests a luminal subtype, which is common in breast cancer.
3. **Basal-like Breast Cancer Cells**: Although less likely due to the lack of specific basal markers, the presence of KRT7 can be seen in some basal-like subtypes.

The most likely subtype, based on the markers, is **HER2-positive Breast Cancer Cells**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of breast epithelial cells, specifically associated with breast cancer. The expression of ERBB2, GRB7, and ANKRD30A strongly indicates a HER2-positive breast cancer subtype. Other markers such as PIP and TFF3 support the presence of luminal characteristics, but the dominance of HER2-related markers makes HER2-positive breast cancer cells the most probable subtype.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**:
   - The key functional markers (ERBB2, GRB7, TFAP2B, SPDEF, CXCL17, KRT7) and key cell type markers (SOX11, PNMT, MUC6, PIP, TFF3, HOPX, ANKRD30A, KRT7) are all present in the provided marker list.
   - The markers ERBB2, GRB7, PIP, and ANKRD30A are well-known markers associated with breast cancer, particularly HER2-positive subtypes, which aligns with the annotation of HER2-positive breast cancer cells.

2. **Mixed Cell Type Consideration**:
   - The analysis considers the possibility of mixed cell types by identifying potential subtypes such as HER2-positive, luminal, and basal-like breast cancer cells. However, the dominance of HER2-related markers supports the primary annotation of HER2-positive breast cancer cells.
   - There is no strong evidence of multiple distinct cell types that would necessitate flagging for further investigation.

Overall, the annotation is well-supported by the marker list and the known associations of these markers with breast cancer subtypes. | Formatting Agent: {
  ""main_cell_type"": ""breast epithelial cells"",
  ""sub_cell_types"": [
    ""HER2-positive Breast Cancer Cells"",
    ""Luminal Breast Cancer Cells"",
    ""Basal-like Breast Cancer Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_19,luminal epithelial cells,"Luminal A Subtype, Luminal B Subtype, Normal Luminal Epithelial Cells",,50,"LINC02584, SCGB2A2, PEG3, TFAP2B, ORAOV1, SRARP, TNNT1, AAMDC, EVA1B, RSF1, NSD3, ALG8, THAP12, GATA3, NDUFC2, TRPS1, CLNS1A, ANKRD30A, PLPP5, CAMK2N1, TFF3, RERG, MS4A7, PRSS23, XBP1, RAB11FIP1, MLPH, PAK1, N4BP2L2, S100A14, TBX3, NQO1, DUSP4, GADD45G, GALNT6, KCNQ1OT1, CTTN, ALCAM, CCND1, CXXC5, SELENOP, CD24, MTIF3, KRT18, FXYD3, ERBB3, INTS6, RPL21, DSP, ADIRF",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **GATA3**: A transcription factor critical for the development and differentiation of various tissues, including the mammary gland. It is often associated with luminal epithelial cells in the breast.
- **XBP1**: A transcription factor involved in the unfolded protein response and is known to play a role in the differentiation of plasma cells and secretory cells.
- **CCND1 (Cyclin D1)**: Involved in cell cycle regulation and is frequently overexpressed in breast cancer, particularly in luminal subtypes.
- **ERBB3 (HER3)**: A member of the epidermal growth factor receptor (EGFR) family, often implicated in breast cancer signaling pathways.
- **CD24**: A cell surface protein often used as a marker for epithelial and cancer stem cells in breast tissue.
- **KRT18 (Keratin 18)**: An intermediate filament protein typically expressed in epithelial cells, including luminal epithelial cells of the breast.

### Step 2: List the Key Cell Type Markers
- **SCGB2A2 (Mammaglobin)**: A marker highly specific to breast tissue, particularly luminal epithelial cells.
- **ANRKD30A**: Known to be expressed in breast tissue, often associated with luminal epithelial cells.
- **TFF3 (Trefoil Factor 3)**: Expressed in mucosal epithelial cells and often associated with luminal epithelial cells in the breast.
- **MLPH (Melanophilin)**: Involved in melanosome transport but also expressed in certain epithelial cells.
- **DSP (Desmoplakin)**: A component of desmosomes, which are important for cell-cell adhesion in epithelial tissues.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer and scRNA-seq, the markers SCGB2A2, GATA3, and KRT18 are strongly associated with luminal epithelial cells in the breast. These markers are frequently used to identify luminal subtypes in breast cancer studies.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of markers such as SCGB2A2, GATA3, KRT18, and ERBB3, the most probable general cell type is **luminal epithelial cells**. These cells are a major component of the breast tissue and are often implicated in breast cancer, particularly in luminal subtypes.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal A Subtype**: Characterized by high expression of hormone receptors and low proliferation rates. Markers like GATA3 and CCND1 support this subtype.
2. **Luminal B Subtype**: Similar to Luminal A but with higher proliferation rates and often more aggressive. The presence of ERBB3 and CCND1 can also indicate this subtype.
3. **Normal Luminal Epithelial Cells**: These are non-cancerous luminal cells that express markers like SCGB2A2 and KRT18.

The most likely subtype based on the markers is the **Luminal A Subtype**, given the expression of GATA3, SCGB2A2, and other luminal markers.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of luminal epithelial cells. The expression of key markers such as SCGB2A2, GATA3, and KRT18 strongly indicates a luminal origin. Among the luminal subtypes, the Luminal A subtype is the most probable due to the presence of markers associated with hormone receptor positivity and lower proliferation rates.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: To validate the annotation result, let's follow the outlined steps:

### Step 1: Marker Consistency
- **Markers in the Provided List**: The key functional markers and cell type markers mentioned in the annotation (GATA3, XBP1, CCND1, ERBB3, CD24, KRT18, SCGB2A2, ANRKD30A, TFF3, MLPH, DSP) are all present in the provided marker list.
- **Consistency with Identified Cell Type**: The markers SCGB2A2, GATA3, and KRT18 are strongly associated with luminal epithelial cells, which is consistent with the annotation of the cell type as luminal epithelial cells. The presence of ERBB3 and CCND1 supports the identification of luminal subtypes, particularly Luminal A and B.

### Step 2: Mixed Cell Type Consideration
- **Potential Mixed Populations**: The annotation does not strongly suggest the presence of multiple distinct cell types. The markers used are consistently associated with luminal epithelial cells and their subtypes. There is no strong evidence of mixed cell types based on the high-ranking markers provided.

### Conclusion
The annotation result is consistent with the provided marker list and the identified cell type. The markers used are appropriate for identifying luminal epithelial cells and their subtypes in breast tissue.

Validation result: VALIDATION PASSED | Formatting Agent: {
  ""main_cell_type"": ""luminal epithelial cells"",
  ""sub_cell_types"": [
    ""Luminal A Subtype"",
    ""Luminal B Subtype"",
    ""Normal Luminal Epithelial Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_17,Epithelial Cells,"HER2-positive Breast Cancer Cells, Luminal Epithelial Cells, Basal-like Breast Cancer Cells",,50,"SLC5A8, DCD, SERHL2, HIST1H3H, CD24, TTC36, FIG4, TFAP2A, HIST1H2BN, TMEM14C, G6PC3, HIST1H1C, TMEM14B, ABRACL, FAM8A1, CASD1, SMPD2, MT1G, ALDH3B2, SSH2, PAK1IP1, RBP1, IFT122, PODXL2, RNF144B, CD164, TPMT, ITPR1, LONP2, TRAF4, KIF13A, ARFGEF3, MIEN1, HEBP2, SLC35B3, ALDH2, CRABP2, ISOC1, CCDC57, ERBB2, AIG1, RAC3, SLC9A3R1, UNC119, NUP153, UBA6, CENPX, ARMT1, MRPL12, RGL2",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type from the provided ranked marker list, I will follow the outlined steps to ensure a comprehensive analysis.

### Step 1: List the Key Functional Markers
- **SLC5A8**: A sodium-coupled monocarboxylate transporter involved in the transport of short-chain fatty acids and other monocarboxylates.
- **DCD (Dermcidin)**: An antimicrobial peptide with roles in innate immunity.
- **SERHL2**: A serine hydrolase-like protein, though its specific function is less characterized.
- **HIST1H3H, HIST1H2BN, HIST1H1C**: Histone proteins involved in chromatin structure and gene regulation.
- **G6PC3**: A glucose-6-phosphatase involved in glucose metabolism.
- **ALDH3B2, ALDH2**: Aldehyde dehydrogenases involved in detoxifying aldehydes and in retinoic acid biosynthesis.
- **ERBB2 (HER2/neu)**: A receptor tyrosine kinase involved in cell growth and differentiation, often overexpressed in breast cancer.
- **CRABP2**: Cellular retinoic acid-binding protein, involved in retinoic acid signaling.
- **RAC3**: A small GTPase involved in cell signaling and cytoskeletal organization.

### Step 2: List the Key Cell Type Markers
- **CD24**: A cell surface protein often used as a marker for breast cancer stem cells and other epithelial cells.
- **PODXL2**: Podocalyxin-like protein, associated with cell adhesion and migration.
- **CD164**: A sialomucin that plays a role in hematopoietic cell adhesion and migration.
- **ERBB2**: As mentioned, a key marker in breast cancer, particularly in HER2-positive subtypes.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer, we can cross-reference these markers:
- **CD24** and **ERBB2** are strongly associated with breast epithelial cells and breast cancer subtypes.
- **CRABP2** and **ALDH2** are involved in retinoic acid metabolism, which is significant in epithelial cell differentiation and cancer.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of **CD24**, **ERBB2**, and other epithelial markers, the most probable general cell type is **epithelial cells**, specifically those associated with breast tissue.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **HER2-positive Breast Cancer Cells**: Due to the high expression of **ERBB2**.
2. **Luminal Epithelial Cells**: Given the presence of **CD24** and markers involved in retinoic acid signaling.
3. **Basal-like Breast Cancer Cells**: Although less likely, the presence of certain histone markers and **CD24** could suggest a basal-like phenotype.

The most likely subtype, based on the markers, is **HER2-positive Breast Cancer Cells** due to the prominent expression of **ERBB2**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of epithelial cells, with a strong indication towards HER2-positive breast cancer cells. This is supported by the high expression of **ERBB2**, along with other markers like **CD24** and **CRABP2**, which are associated with breast epithelial and cancer cell phenotypes.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: To validate the annotation result, let's follow the outlined steps:

### Step 1: Marker Consistency
- **Markers in the Provided List**: The markers used in the annotation (e.g., SLC5A8, DCD, SERHL2, HIST1H3H, CD24, ERBB2, etc.) are indeed present in the provided marker list.
- **Consistency with Identified Cell Type**: The markers used are consistent with the identified cell type. For example, **CD24** and **ERBB2** are well-known markers for breast epithelial cells and HER2-positive breast cancer cells, respectively. **CRABP2** and **ALDH2** are involved in retinoic acid metabolism, which is relevant to epithelial cell differentiation and cancer.

### Step 2: Mixed Cell Type Consideration
- **Potential Mixed Populations**: The annotation suggests a primary identification of HER2-positive breast cancer cells, with consideration for luminal epithelial cells and basal-like breast cancer cells. The presence of multiple high-ranking markers such as **CD24**, **ERBB2**, and histone proteins supports the possibility of mixed cell types. However, the analysis leans towards a dominant HER2-positive breast cancer cell type, which is reasonable given the marker expression.

### Conclusion
The annotation is consistent with the provided marker list and the identified cell type. The potential for mixed cell types has been acknowledged, but the primary identification is well-supported by the markers.

Validation result: VALIDATION PASSED | Formatting Agent: {
  ""main_cell_type"": ""Epithelial Cells"",
  ""sub_cell_types"": [
    ""HER2-positive Breast Cancer Cells"",
    ""Luminal Epithelial Cells"",
    ""Basal-like Breast Cancer Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_18,Epithelial Cells,"Luminal Epithelial Cells, Basal/Myoepithelial Cells, Ductal Epithelial Cells",,50,"PTN, MGP, KRT15, STAC2, CCL28, SYNM, SCGB2A2, LTF, SNORC, AK5, SFRP1, KLK5, SAA2, SAA1, SCGB2A1, MIA, DEFB1, NTRK2, SCGB1D2, CX3CL1, RARRES1, GABRP, MMP7, NDRG2, CRYAB, NFIB, SLPI, TSHZ2, CHI3L1, WFDC2, SLC12A2, ARL4A, ANXA1, CXCL2, SORBS2, ARID5A, DEPP1, NCOA7, KRT14, CLU, TACSTD2, TM4SF1, GBP2, RCAN1, CLDN4, ATF3, WEE1, KRT17, KRT7, SLC25A37",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **PTN (Pleiotrophin)**: Involved in cell growth and angiogenesis.
- **MGP (Matrix Gla Protein)**: Inhibits vascular calcification.
- **CCL28 (C-C Motif Chemokine Ligand 28)**: Involved in immune response and chemotaxis.
- **SYNM (Synemin)**: Intermediate filament protein, involved in cytoskeletal organization.
- **LTF (Lactotransferrin)**: Antimicrobial and anti-inflammatory properties.
- **SFRP1 (Secreted Frizzled Related Protein 1)**: Modulates Wnt signaling pathway.
- **MMP7 (Matrix Metallopeptidase 7)**: Involved in the breakdown of extracellular matrix.
- **NDRG2 (N-Myc Downstream Regulated 2)**: Involved in stress response and cell differentiation.
- **CRYAB (Alpha-Crystallin B Chain)**: Acts as a molecular chaperone.
- **SLPI (Secretory Leukocyte Peptidase Inhibitor)**: Protects epithelial tissues from proteolytic enzymes.
- **CHI3L1 (Chitinase 3 Like 1)**: Involved in tissue remodeling and inflammation.
- **WFDC2 (WAP Four-Disulfide Core Domain 2)**: Involved in immune response.

### Step 2: List the Key Cell Type Markers
- **KRT15 (Keratin 15)**: Marker for basal epithelial cells.
- **SCGB2A2 (Secretoglobin Family 2A Member 2)**: Highly expressed in mammary gland epithelial cells.
- **KRT14 (Keratin 14)**: Basal cell marker, often found in myoepithelial cells.
- **KRT17 (Keratin 17)**: Associated with basal/myoepithelial cells.
- **KRT7 (Keratin 7)**: Expressed in simple epithelia and some glandular tissues.
- **SCGB2A1 (Secretoglobin Family 2A Member 1)**: Expressed in mammary gland epithelial cells.
- **MIA (Melanoma Inhibitory Activity)**: Expressed in some epithelial cells.
- **GABRP (Gamma-Aminobutyric Acid Type A Receptor Pi Subunit)**: Expressed in epithelial cells of the breast.
- **CLDN4 (Claudin 4)**: Tight junction protein, expressed in epithelial cells.
- **TACSTD2 (Tumor-Associated Calcium Signal Transducer 2)**: Expressed in epithelial cells.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, we can cross-reference these markers. The presence of keratins (KRT15, KRT14, KRT17, KRT7) and secretoglobins (SCGB2A2, SCGB2A1) strongly suggests an epithelial origin, specifically related to mammary gland tissue.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of keratins and secretoglobins, the most probable general cell type is **epithelial cells** from the mammary gland.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal Epithelial Cells**: High expression of SCGB2A2 and SCGB2A1, along with KRT7, suggests luminal epithelial cells.
2. **Basal/Myoepithelial Cells**: Expression of KRT14, KRT15, and KRT17 indicates basal or myoepithelial cells.
3. **Ductal Epithelial Cells**: Expression of CLDN4 and TACSTD2 can be associated with ductal epithelial cells.

**Most Likely Subtype**: The presence of SCGB2A2 and SCGB2A1, along with KRT7, strongly suggests that the most likely subtype is **Luminal Epithelial Cells**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of epithelial cells, specifically from the mammary gland. The expression of secretoglobins and keratins points towards luminal epithelial cells as the most probable subtype, with basal/myoepithelial and ductal epithelial cells as other potential subtypes.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**: 
   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. 
   - The markers such as KRT15, KRT14, KRT17, KRT7, SCGB2A2, and SCGB2A1 are all present in the marker list and are consistent with epithelial cells, particularly those from the mammary gland.

2. **Mixed Cell Type Consideration**:
   - The annotation correctly identifies the potential for mixed cell types, such as luminal epithelial cells, basal/myoepithelial cells, and ductal epithelial cells, based on the expression of specific markers.
   - The presence of multiple high-ranking markers supporting different subtypes (e.g., KRT14, KRT15, KRT17 for basal/myoepithelial cells and SCGB2A2, SCGB2A1 for luminal epithelial cells) is acknowledged, and the annotation appropriately flags these as potential subtypes.

The annotation process has been thorough, using cross-referencing with known databases and providing a logical conclusion based on the marker expression patterns. The final annotation of luminal epithelial cells as the most likely subtype is well-supported by the data. | Formatting Agent: {
  ""main_cell_type"": ""Epithelial Cells"",
  ""sub_cell_types"": [
    ""Luminal Epithelial Cells"",
    ""Basal/Myoepithelial Cells"",
    ""Ductal Epithelial Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_20,fibroblasts,"Cancer-Associated Fibroblasts (CAFs), Myofibroblasts, Pericyte-like Fibroblasts",,50,"COL1A1, COL1A2, COL3A1, AEBP1, SPARC, COL11A1, SEPTIN11, ITGA11, MMP11, MTCO2P12, FN1, COL5A1, COL5A2, COL12A1, COL6A3, COL6A2, SFRP2, POSTN, COL6A1, COL10A1, DCN, THY1, THBS2, LUM, MMP2, ADAMTS2, ASPN, BGN, ANTXR1, FBN1, MXRA5, PDGFRB, ISLR, MXRA8, CDH11, COL8A1, MMP14, FBLN2, LRP1, ADAM12, VCAN, CTSK, RARRES2, DPYSL3, PCOLCE, NID1, TIMP3, SULF1, MFAP2, IGFBP7",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **Collagens (COL1A1, COL1A2, COL3A1, COL11A1, COL5A1, COL5A2, COL12A1, COL6A3, COL6A2, COL6A1, COL10A1, COL8A1):** These are structural proteins that form the extracellular matrix (ECM) and provide structural support to tissues.
- **Matrix Metalloproteinases (MMP11, MMP2, MMP14):** Enzymes that degrade various components of the ECM, involved in tissue remodeling and cancer metastasis.
- **Integrins (ITGA11):** Receptors that mediate cell-ECM adhesion, playing a role in cell signaling and migration.
- **Fibronectin (FN1):** A glycoprotein involved in cell adhesion and migration processes.
- **Periostin (POSTN):** A matricellular protein involved in tissue repair and remodeling.
- **Thrombospondin (THBS2):** Involved in cell-to-cell and cell-to-matrix communication.
- **Decorin (DCN), Lumican (LUM), Biglycan (BGN):** Small leucine-rich proteoglycans involved in collagen fibrillogenesis and ECM organization.
- **Fibulin (FBLN2):** Involved in the stabilization of ECM structures.
- **Versican (VCAN):** A large chondroitin sulfate proteoglycan involved in cell adhesion, proliferation, and migration.
- **Cathepsin K (CTSK):** A protease involved in bone resorption and ECM degradation.
- **Insulin-like Growth Factor Binding Protein 7 (IGFBP7):** Modulates IGF signaling and is involved in cell adhesion and migration.

### Step 2: List the Key Cell Type Markers
- **PDGFRB (Platelet-Derived Growth Factor Receptor Beta):** A marker for pericytes and fibroblasts, involved in cell proliferation and migration.
- **THY1 (CD90):** A marker for fibroblasts and mesenchymal stem cells.
- **ADAMTS2 (A Disintegrin and Metalloproteinase with Thrombospondin Motifs 2):** Involved in the processing of collagen precursors, associated with fibroblasts.
- **SPARC (Secreted Protein Acidic and Rich in Cysteine):** A matricellular protein associated with fibroblasts and involved in ECM remodeling.
- **AEBP1 (Adipocyte Enhancer-Binding Protein 1):** Associated with fibroblasts and involved in ECM organization.

### Step 3: Cross-reference Known Databases
Using scRNA-seq databases such as the Human Cell Atlas and literature on breast cancer stroma, the markers listed are predominantly associated with fibroblasts, particularly cancer-associated fibroblasts (CAFs), which are known to play a significant role in the tumor microenvironment by remodeling the ECM and influencing cancer progression.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of these markers, the most likely general cell type of the cluster is **fibroblasts**. The presence of multiple collagen genes, ECM-related proteins, and fibroblast-specific markers strongly supports this annotation.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Cancer-Associated Fibroblasts (CAFs):** Given the context of breast cancer tissue and the expression of ECM remodeling enzymes and proteins, CAFs are the most likely subtype.
2. **Myofibroblasts:** Characterized by ECM production and contractile activity, often found in tumor stroma.
3. **Pericyte-like Fibroblasts:** Express PDGFRB and are involved in vascular support and ECM production.

The most likely subtype based on the markers is **Cancer-Associated Fibroblasts (CAFs)** due to their prominent role in the tumor microenvironment and the expression of markers involved in ECM remodeling and interaction with cancer cells.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is composed of fibroblasts, with a high likelihood of being cancer-associated fibroblasts (CAFs). This is supported by the expression of multiple collagen genes, ECM-related proteins, and fibroblast-specific markers, which are characteristic of CAFs involved in the tumor microenvironment.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the context of breast cancer tissue. Here's the breakdown of the validation:

1. **Marker Consistency:**
   - The markers listed in the annotation result are present in the provided marker list.
   - The markers are consistent with the identification of fibroblasts, particularly cancer-associated fibroblasts (CAFs). Key markers such as collagens (COL1A1, COL1A2, COL3A1), matrix metalloproteinases (MMP11, MMP2, MMP14), and fibroblast-specific markers (PDGFRB, THY1, SPARC, AEBP1) strongly support the annotation of fibroblasts and CAFs.

2. **Mixed Cell Type Consideration:**
   - The annotation considers potential subtypes within the fibroblast category, such as myofibroblasts and pericyte-like fibroblasts, which is appropriate given the complexity of the tumor microenvironment.
   - There is no strong evidence of multiple distinct cell types outside the fibroblast lineage, so the annotation does not require flagging for mixed cell types.

The annotation of the cell cluster as fibroblasts, with a high likelihood of being cancer-associated fibroblasts (CAFs), is well-supported by the marker list and the context of breast cancer tissue. | Formatting Agent: {
  ""main_cell_type"": ""fibroblasts"",
  ""sub_cell_types"": [
    ""Cancer-Associated Fibroblasts (CAFs)"",
    ""Myofibroblasts"",
    ""Pericyte-like Fibroblasts""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_21,epithelial cells,"breast cancer epithelial cells, luminal epithelial cells, basal-like epithelial cells",,50,"CRISP3, TUBA3D, CXCL13, EEF1A2, TMEM238, METRN, S100P, CCDC74A, CLIC6, STARD10, GJA1, UGDH, PREX1, MT-ATP8, SCD, DLG5, SIAH2, SNHG9, DEGS2, ADIRF, CRIP2, MT-ND3, ELOVL5, NQO1, FASN, TRPS1, MT1G, SLC40A1, SMIM22, CHPT1, RUNX1, PLA2G16, KRT19, PRSS23, MT-CO2, H2AFJ, S100A14, RPL18, CIB1, CRIP1, JUND, MT-CYB, NUPR1, PRDX1, NDUFC2, RPS21, BST2, HSPA1A, MT-ND4L, GNAS",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type from the provided ranked marker list, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **CRISP3**: Known to be involved in immune response and inflammation.
- **CXCL13**: A chemokine involved in B-cell homing and lymphoid tissue organization.
- **EEF1A2**: A translation elongation factor, often associated with protein synthesis.
- **S100P**: A member of the S100 family, involved in calcium binding and signaling.
- **GJA1 (Connexin 43)**: Involved in gap junction communication.
- **FASN**: Fatty acid synthase, involved in lipid biosynthesis.
- **NQO1**: Involved in detoxification and antioxidant defense.
- **TRPS1**: A transcription factor involved in development and differentiation.
- **KRT19**: A type I keratin, often associated with epithelial cells.
- **HSPA1A**: A heat shock protein involved in stress response.

### Step 2: List the Key Cell Type Markers
- **CRISP3**: Often associated with prostate and salivary gland tissues, but also found in some breast cancer cells.
- **CXCL13**: Typically expressed in immune cells, particularly B-cells and follicular helper T-cells.
- **S100P**: Frequently expressed in various epithelial cancers, including breast cancer.
- **GJA1**: Commonly found in epithelial cells, including those in the breast.
- **KRT19**: A well-known marker for epithelial cells, particularly in breast tissue.
- **FASN**: Overexpressed in many cancer types, including breast cancer, due to increased lipid metabolism.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and recent literature on breast cancer scRNA-seq datasets, we can cross-reference these markers:
- **CRISP3, S100P, KRT19**: Frequently reported in breast cancer epithelial cells.
- **CXCL13**: While primarily an immune marker, its presence in the context of breast cancer may indicate tumor-associated immune cells or stromal interaction.
- **FASN, NQO1**: Overexpression is common in cancer cells, including breast cancer epithelial cells.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of markers like **KRT19, S100P, and FASN**, the most probable general cell type is **epithelial cells**, specifically those associated with breast tissue.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Breast Cancer Epithelial Cells**: Given the presence of markers like **KRT19, S100P, and FASN**, these are the most likely subtype.
2. **Luminal Epithelial Cells**: The expression of **KRT19** and **S100P** suggests a luminal origin, common in breast cancer.
3. **Basal-like Epithelial Cells**: While less likely due to the absence of specific basal markers, the presence of general epithelial markers could suggest this subtype.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of **breast cancer epithelial cells**, with a strong indication towards **luminal epithelial cells** due to the expression of markers such as **KRT19, S100P, and FASN**. These markers are commonly associated with breast cancer and epithelial cell identity, supporting the annotation of this cluster as luminal epithelial cells within the breast cancer context.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: To validate the annotation result, let's follow the outlined steps:

### Step 1: Marker Consistency
- **CRISP3, CXCL13, S100P, GJA1, FASN, NQO1, TRPS1, KRT19, HSPA1A**: All these markers are present in the provided marker list.
- The annotation identifies these markers as being associated with epithelial cells, particularly breast cancer epithelial cells, which is consistent with known literature.

### Step 2: Mixed Cell Type Consideration
- The annotation suggests a primary identification of breast cancer epithelial cells, with a focus on luminal epithelial cells.
- **CXCL13** is noted as an immune marker, which could indicate the presence of tumor-associated immune cells. However, the annotation considers this in the context of stromal interaction, which is reasonable given the context of breast cancer.
- No other strong evidence of mixed cell types is present based on the high-ranking markers provided.

### Conclusion
The annotation is consistent with the marker list and the known associations of these markers with breast cancer epithelial cells. The potential presence of immune-related markers like **CXCL13** is acknowledged and reasonably explained within the context of breast cancer.

Validation result: VALIDATION PASSED | Formatting Agent: {
  ""main_cell_type"": ""epithelial cells"",
  ""sub_cell_types"": [
    ""breast cancer epithelial cells"",
    ""luminal epithelial cells"",
    ""basal-like epithelial cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_22,Epithelial Cells,"Luminal Epithelial Cells, Basal/Myoepithelial Cells, Cancer Stem-like Cells",,50,"PDSS2, MUC15, CLIC3, NR2F1, MUCL1, CD24, LINC01133, QRSL1, PRKAR2B, KRT7, CKB, BNIP3, C6orf203, IFI27, TCAF1, TNNT1, SELENOP, SYPL1, IGFBP5, TMA16, ARHGEF35, SCOC, RRAS, AARD, PIK3R1, ARMT1, CREB3L2, NAMPT, LMO4, S100A10, CBR3, P4HA1, BLVRB, KRT19, VAV3, PRLR, ANKRD30A, TMEM263, COX20, PERP, CRIP2, RAD21, CRACR2B, TSPAN13, MSRB2, NDUFB2, CYB5A, JPT1, GTF2H5, HEBP2",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **PDSS2**: Involved in the biosynthesis of coenzyme Q10, important for mitochondrial function.
- **PRKAR2B**: Regulatory subunit of protein kinase A, involved in various signaling pathways.
- **PIK3R1**: Regulatory subunit of PI3K, involved in cell growth and survival signaling.
- **NAMPT**: Involved in NAD biosynthesis, important for cellular metabolism and stress responses.
- **S100A10**: Involved in cell proliferation and differentiation, often associated with cancer progression.
- **KRT7**: A type II keratin, involved in the structural integrity of epithelial cells.
- **KRT19**: A type I keratin, often used as a marker for epithelial cells and certain cancer types.

### Step 2: List the Key Cell Type Markers
- **MUC15**: Mucin protein, often expressed in epithelial tissues.
- **MUCL1**: Mucin-like protein, associated with breast tissue.
- **CD24**: Cell surface protein, often used as a marker for epithelial and cancer stem cells.
- **IFI27**: Interferon-induced protein, associated with epithelial cells and immune response.
- **PRLR**: Prolactin receptor, associated with mammary gland development and breast tissue.
- **ANKRD30A**: Known as a breast cancer antigen, associated with breast tissue.
- **TSPAN13**: Tetraspanin family member, involved in cell adhesion and migration, often expressed in epithelial cells.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer and epithelial cell markers, we can cross-reference these markers:
- **KRT7** and **KRT19** are well-known markers for epithelial cells, particularly in breast tissue.
- **CD24** is commonly used as a marker for epithelial cells and cancer stem cells in breast cancer.
- **PRLR** and **ANKRD30A** are specific to breast tissue, indicating a mammary epithelial origin.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of epithelial markers such as **KRT7**, **KRT19**, **CD24**, and breast-specific markers like **PRLR** and **ANKRD30A**, the most probable general cell type is **epithelial cells**, specifically those associated with breast tissue.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal Epithelial Cells**: Characterized by the expression of **KRT19**, **PRLR**, and **CD24**, which are typical of luminal cells in the mammary gland.
2. **Basal/Myoepithelial Cells**: While less likely due to the lack of specific basal markers like KRT5/14, the presence of general epithelial markers could suggest a mixed population.
3. **Cancer Stem-like Cells**: The presence of **CD24** and **S100A10** could indicate a subpopulation with stem-like properties, often seen in breast cancer.

The most likely subtype, given the strong expression of luminal markers, is **Luminal Epithelial Cells**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is primarily composed of epithelial cells, with a strong indication towards luminal epithelial cells. This is supported by the expression of key markers such as **KRT19**, **PRLR**, and **CD24**, which are characteristic of luminal cells in the mammary gland. The presence of breast-specific markers like **ANKRD30A** further supports this annotation.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the context of breast cancer tissue. Here's the breakdown of the validation:

1. **Marker Consistency**: 
   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. 
   - Markers such as **KRT7**, **KRT19**, **CD24**, **PRLR**, and **ANKRD30A** are well-known markers for epithelial cells, particularly in breast tissue, and are present in the marker list.

2. **Mixed Cell Type Consideration**:
   - The annotation acknowledges the potential presence of mixed cell types, such as basal/myoepithelial cells and cancer stem-like cells, but concludes that the strongest evidence supports luminal epithelial cells. 
   - The presence of markers like **CD24** and **S100A10** suggests a possible subpopulation with stem-like properties, which is appropriately flagged for consideration.

3. **Cross-referencing with Databases**:
   - The annotation correctly cross-references known databases and literature, supporting the identification of luminal epithelial cells as the primary cell type.

Overall, the annotation is well-supported by the marker list and the context of the dataset, and the potential for mixed cell types is appropriately considered. | Formatting Agent: {
  ""main_cell_type"": ""Epithelial Cells"",
  ""sub_cell_types"": [
    ""Luminal Epithelial Cells"",
    ""Basal/Myoepithelial Cells"",
    ""Cancer Stem-like Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_2,Luminal Epithelial Cells,"Immune Cells, Other Epithelial Cells","Luminal Epithelial Cells, Immune Cells",50,"CST5, LINC01238, CST2, TRPA1, SLITRK6, CLEC3A, FGF10, PIP, KCNJ3, MRPS30-DT, KCNE4, AC105999.2, RHOBTB3, PI15, BMPR1B, AGR3, SSFA2, TPRG1, TFF1, TCIM, NAT1, CXCL14, MRPS30, IFI27, AGR2, SLC39A6, PLAT, TFF3, GATA3-AS1, COX6C, PKIB, FTH1, GLRX, ISG15, CRABP2, BST2, IFI6, ESR1, GATA3, XBP1, CA12, AZGP1, MGST1, PRSS23, ZG16B, ADIRF, ANKRD30A, PBX1, H2AFJ, PLA2G16",2,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type from the provided ranked marker list, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **ESR1 (Estrogen Receptor 1):** A nuclear hormone receptor for estrogen, playing a crucial role in the development and progression of breast cancer.
- **GATA3:** A transcription factor involved in the regulation of gene expression in mammary gland development and differentiation.
- **XBP1:** A transcription factor involved in the unfolded protein response and associated with breast cancer.
- **FGF10 (Fibroblast Growth Factor 10):** Involved in cell growth and tissue repair, often associated with epithelial cells.
- **CXCL14:** A chemokine involved in immune cell recruitment, often expressed in epithelial tissues.
- **TFF1 (Trefoil Factor 1):** Involved in mucosal protection and repair, commonly expressed in breast tissue.
- **TFF3 (Trefoil Factor 3):** Similar to TFF1, involved in epithelial cell protection and repair.
- **AZGP1 (Zinc-alpha-2-glycoprotein):** Involved in lipid metabolism and often expressed in breast tissue.
- **PLAT (Tissue Plasminogen Activator):** Involved in the breakdown of blood clots, expressed in various tissues including breast.
- **IFI27, IFI6, ISG15, BST2:** Interferon-stimulated genes, often upregulated in response to viral infections or in certain cancer types.

### Step 2: List the Key Cell Type Markers
- **ESR1, GATA3, TFF1, TFF3, AZGP1:** These markers are highly indicative of luminal epithelial cells in the breast, particularly luminal progenitor or mature luminal cells.
- **PIP (Prolactin Induced Protein):** Commonly expressed in breast tissue, associated with luminal epithelial cells.
- **AGR2, AGR3:** Associated with secretory epithelial cells, often found in breast tissue.
- **SLITRK6, CLEC3A, PRSS23:** These markers are less specific but can be associated with epithelial cell types.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and recent literature on breast cancer scRNA-seq datasets, the markers ESR1, GATA3, TFF1, TFF3, and AZGP1 are consistently associated with luminal epithelial cells in breast tissue.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of key markers such as ESR1, GATA3, TFF1, TFF3, and AZGP1, the most probable general cell type is **luminal epithelial cells** in the breast.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal A Epithelial Cells:** Characterized by high expression of ESR1, GATA3, and TFF1, these cells are hormone receptor-positive and less aggressive.
2. **Luminal B Epithelial Cells:** Similar to Luminal A but with a higher proliferation rate and possibly lower expression of ESR1.
3. **Luminal Progenitor Cells:** These cells may express some luminal markers but also show markers indicative of a progenitor state, such as AGR2 and AGR3.

The most likely subtype based on the markers is **Luminal A Epithelial Cells**, given the high expression of ESR1, GATA3, and TFF1.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of luminal epithelial cells. The expression of key markers such as ESR1, GATA3, TFF1, and TFF3 strongly indicates a luminal epithelial cell type, with the most probable subtype being Luminal A Epithelial Cells. These cells are characterized by hormone receptor positivity and are commonly found in breast cancer tissues.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION FAILED

Feedback: 

1. **Marker Consistency:**
   - The proposed annotation result identifies key markers such as ESR1, GATA3, TFF1, TFF3, and AZGP1 as indicative of luminal epithelial cells. These markers are indeed present in the provided marker list, which supports the annotation.
   - However, the annotation also mentions markers like XBP1 and FGF10, which are not directly associated with luminal epithelial cells in the context of breast tissue. While they are present in the marker list, their role in identifying luminal epithelial cells is less clear and should be reconsidered or justified with additional evidence.

2. **Mixed Cell Type Consideration:**
   - The presence of markers such as IFI27, IFI6, ISG15, and BST2, which are interferon-stimulated genes, suggests a potential mixed cell population or a response to a specific condition (e.g., viral infection or inflammation). These markers are not typically associated with luminal epithelial cells and may indicate the presence of immune cells or other cell types.
   - Additionally, markers like SLITRK6, CLEC3A, and PRSS23, which are mentioned as less specific, could suggest the presence of other epithelial or non-epithelial cell types.

3. **Recommendation for Revision:**
   - Re-evaluate the role of markers like XBP1 and FGF10 in the context of luminal epithelial cells and provide additional justification if they are to be included as key markers.
   - Investigate the potential presence of mixed cell types, especially considering the expression of interferon-stimulated genes and less specific markers. This may require further analysis or validation using additional datasets or experimental methods.
   - Consider providing a more nuanced annotation that accounts for the possibility of mixed cell populations, especially if multiple distinct cell types are supported by high-ranking markers.

By addressing these points, the annotation can be revised to provide a more accurate and comprehensive characterization of the cell cluster. | Final Annotation Agent: To address the validation feedback and provide an updated annotation, I will re-evaluate the marker list and consider the potential presence of mixed cell types. Here is the revised analysis:

### Step 1: List the Key Functional Markers
- **ESR1 (Estrogen Receptor 1):** A key marker for luminal epithelial cells in breast tissue, involved in hormone receptor signaling.
- **GATA3:** A transcription factor critical for luminal cell differentiation in the mammary gland.
- **TFF1 and TFF3 (Trefoil Factors):** Involved in epithelial cell protection and repair, commonly expressed in breast tissue.
- **AZGP1 (Zinc-alpha-2-glycoprotein):** Associated with lipid metabolism and often expressed in breast tissue.
- **PIP (Prolactin Induced Protein):** Expressed in breast tissue, associated with luminal epithelial cells.
- **AGR2 and AGR3:** Associated with secretory epithelial cells, often found in breast tissue.

### Step 2: List the Key Cell Type Markers
- **ESR1, GATA3, TFF1, TFF3, AZGP1, PIP:** Strongly indicative of luminal epithelial cells in the breast.
- **IFI27, IFI6, ISG15, BST2:** Interferon-stimulated genes, suggesting a potential immune response or mixed cell population.
- **SLITRK6, CLEC3A, PRSS23:** These markers may indicate other epithelial or non-epithelial cell types.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas and CellMarker, the markers ESR1, GATA3, TFF1, TFF3, and AZGP1 are consistently associated with luminal epithelial cells. However, the presence of interferon-stimulated genes suggests a potential mixed cell population, possibly including immune cells.

### Step 4: Determine the Most Probable General Cell Type
The expression of key markers such as ESR1, GATA3, TFF1, TFF3, and AZGP1 suggests that the primary cell type is **luminal epithelial cells**. However, the presence of interferon-stimulated genes indicates a potential mixed cell population, possibly including immune cells.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal Epithelial Cells:** Characterized by high expression of ESR1, GATA3, TFF1, and TFF3.
2. **Immune Cells (e.g., Lymphocytes or Macrophages):** Suggested by the expression of interferon-stimulated genes like IFI27, IFI6, ISG15, and BST2.
3. **Other Epithelial Cells:** Indicated by markers like SLITRK6, CLEC3A, and PRSS23, which may represent other epithelial subtypes or non-epithelial cells.

The most likely primary subtype remains **Luminal Epithelial Cells**, but the presence of immune markers suggests a mixed population.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is primarily composed of luminal epithelial cells, as indicated by markers such as ESR1, GATA3, TFF1, and TFF3. However, the presence of interferon-stimulated genes like IFI27, IFI6, ISG15, and BST2 suggests a potential mixed cell population, possibly including immune cells. This indicates that the dataset may contain a combination of luminal epithelial cells and immune cells, reflecting a complex tissue microenvironment.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The revised annotation has addressed the previous feedback and now provides a more comprehensive analysis of the cell cluster, considering the potential presence of mixed cell types. Here are the key points supporting the validation:

1. **Marker Consistency:**
   - The key markers for luminal epithelial cells, such as ESR1, GATA3, TFF1, TFF3, and AZGP1, are present in the provided marker list and are consistently associated with luminal epithelial cells in breast tissue.
   - The inclusion of PIP, AGR2, and AGR3 further supports the identification of luminal epithelial cells and secretory epithelial cells, which are relevant to breast tissue.

2. **Mixed Cell Type Consideration:**
   - The annotation now acknowledges the presence of interferon-stimulated genes (IFI27, IFI6, ISG15, BST2) and suggests the potential presence of immune cells, which is a reasonable consideration given the expression of these markers.
   - The mention of markers like SLITRK6, CLEC3A, and PRSS23 as indicative of other epithelial or non-epithelial cell types is appropriate and suggests a nuanced understanding of the potential complexity within the cell cluster.

3. **Cross-referencing with Databases:**
   - The use of databases such as the Human Protein Atlas and CellMarker to support the association of key markers with luminal epithelial cells adds credibility to the annotation.

4. **Comprehensive Summary:**
   - The summary effectively communicates the primary identification of luminal epithelial cells while acknowledging the potential mixed cell population, reflecting a complex tissue microenvironment.

Overall, the revised annotation provides a balanced and well-supported analysis of the cell cluster, taking into account both the primary cell type and the potential presence of additional cell types. This comprehensive approach aligns with the context provided by the marker list. | Formatting Agent: {
  ""main_cell_type"": ""Luminal Epithelial Cells"",
  ""sub_cell_types"": [
    ""Immune Cells"",
    ""Other Epithelial Cells""
  ],
  ""possible_mixed_cell_types"": [
    ""Luminal Epithelial Cells"",
    ""Immune Cells""
  ],
  ""num_markers"": 50
}"
cluster_23,Epithelial Cells,"Luminal Epithelial Cells, Basal Epithelial Cells, Myoepithelial Cells",,50,"NPW, S100A7, TFF1, AREG, RAB11FIP1, MRPL15, FAM210B, CLIC3, CST6, TFF3, CALML5, LYPLA1, TINCR, KRT18, RB1CC1, ERLIN2, CSTF1, KRT8, KRT19, MGME1, ESF1, TMEM150C, TFAP2C, SNRPB2, RTF2, IFI27, CXXC5, RRBP1, CLDN3, S100P, TCEA1, EFHD1, STARD10, ZNF217, NSD3, AGR2, DSTN, CRIP2, FASN, MUC1, PBX1, ATP6V1H, S100A14, MLPH, SLC25A1, SNX5, PRPF6, PLPP5, SDC1, LY6E",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **S100A7, S100P, S100A14**: Members of the S100 protein family, often associated with inflammation and cancer progression.
- **TFF1, TFF3**: Trefoil factors involved in mucosal protection and repair, often expressed in epithelial tissues.
- **AREG (Amphiregulin)**: A growth factor involved in epithelial cell proliferation and a known ligand for the epidermal growth factor receptor (EGFR).
- **FASN (Fatty Acid Synthase)**: An enzyme involved in lipogenesis, often upregulated in cancer cells.
- **MUC1**: A mucin protein involved in forming protective mucous barriers on epithelial surfaces, often overexpressed in breast cancer.
- **SDC1 (Syndecan-1)**: A cell surface proteoglycan involved in cell proliferation, cell migration, and cell-matrix interactions.

### Step 2: List the Key Cell Type Markers
- **KRT18, KRT8, KRT19**: Keratins typically expressed in epithelial cells, particularly luminal epithelial cells in the breast.
- **CLDN3 (Claudin 3)**: A component of tight junctions in epithelial cells.
- **TFAP2C**: A transcription factor associated with luminal epithelial cell differentiation in the breast.
- **LY6E**: Often associated with immune response but also expressed in epithelial cells.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer scRNA-seq datasets, the markers listed are predominantly associated with epithelial cells, particularly luminal epithelial cells in the breast. The presence of keratins (KRT8, KRT18, KRT19) and MUC1 strongly suggests an epithelial origin.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of epithelial markers (KRT8, KRT18, KRT19, MUC1) and the presence of growth factors and proteins associated with epithelial cell function (AREG, TFF1, TFF3), the most probable general cell type is **epithelial cells**.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal Epithelial Cells**: The expression of KRT8, KRT18, KRT19, TFAP2C, and MUC1 strongly indicates luminal epithelial cells, which are a major component of the breast epithelium.
2. **Basal Epithelial Cells**: Although less likely due to the lack of specific basal markers like KRT5 or KRT14, some overlap in marker expression can occur.
3. **Myoepithelial Cells**: Least likely due to the absence of myoepithelial-specific markers such as ACTA2 or MYH11.

The most likely subtype based on the markers is **Luminal Epithelial Cells**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is composed of epithelial cells, with a high probability of being luminal epithelial cells. This conclusion is supported by the expression of keratins (KRT8, KRT18, KRT19), MUC1, and other markers associated with luminal epithelial differentiation and function.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**: 
   - The key functional markers and cell type markers listed in the annotation (e.g., S100A7, TFF1, AREG, KRT18, KRT8, KRT19, MUC1, TFAP2C, CLDN3, LY6E) are all present in the provided marker list.
   - The markers are consistent with the identification of epithelial cells, particularly luminal epithelial cells, as they are known to express these markers.

2. **Mixed Cell Type Consideration**:
   - The annotation considers the possibility of basal epithelial cells and myoepithelial cells but concludes that luminal epithelial cells are the most likely subtype based on the marker expression.
   - There is no strong evidence of mixed cell types supported by several high-ranking markers, so the annotation does not need to be flagged for further investigation.

The annotation accurately reflects the data provided and aligns with known literature and databases regarding breast epithelial cell markers. | Formatting Agent: {
  ""main_cell_type"": ""Epithelial Cells"",
  ""sub_cell_types"": [
    ""Luminal Epithelial Cells"",
    ""Basal Epithelial Cells"",
    ""Myoepithelial Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_25,Epithelial Cells,"Luminal Epithelial Cells, Luminal Progenitor Cells, Basal/Myoepithelial Cells",,50,"SCGB1D2, SCGB2A2, IGFBP5, HMGCS2, SBSPON, TFF3, GFRA1, C19orf33, EVA1B, TFF1, LY6K, KCNK6, KRT19, MDFI, ANKRD28, EIF3H, SLC40A1, SPDEF, CRIP1, PLA2G16, TMED2, XBP1, SCD, TSTA3, AGR3, PPDPF, BTG2, LYPLA1, SH3BGRL, EEF1D, PBX1, SQLE, TPD52, ERGIC3, CYB5A, KRT18, FOSB, MUC1, RPL8, RPL36A, JUN, SMIM22, MT-CO1, RPS17, EEF2, AZGP1, NEAT1, RPL7, EIF3E, RPL3",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **SCGB1D2, SCGB2A2**: These are secretoglobins, small secreted proteins often associated with epithelial cells, particularly in the mammary gland.
- **IGFBP5**: Insulin-like growth factor binding protein 5, involved in cell growth and apoptosis, often expressed in epithelial cells.
- **HMGCS2**: Hydroxymethylglutaryl-CoA synthase 2, involved in ketogenesis, can be expressed in various tissues.
- **TFF3, TFF1**: Trefoil factors, involved in mucosal protection and repair, commonly expressed in epithelial tissues.
- **GFRA1**: GDNF family receptor alpha 1, involved in neuronal development but also expressed in some epithelial cells.
- **KRT19, KRT18**: Keratins, structural proteins in epithelial cells, particularly in simple epithelia.
- **MUC1**: Mucin 1, a glycoprotein expressed on the apical surface of epithelial cells, especially in glandular tissues.
- **XBP1**: X-box binding protein 1, involved in the unfolded protein response, expressed in secretory cells.
- **AZGP1**: Zinc-alpha-2-glycoprotein, involved in lipid metabolism, often expressed in epithelial cells.

### Step 2: List the Key Cell Type Markers
- **SCGB2A2 (Mammaglobin)**: Highly specific to mammary gland epithelial cells, often used as a marker for breast tissue.
- **KRT19, KRT18**: Commonly expressed in epithelial cells, particularly in the mammary gland.
- **MUC1**: Expressed in glandular epithelial cells, including those in the breast.
- **TFF1, TFF3**: Associated with epithelial cells in the gastrointestinal tract and breast tissue.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas and literature on breast tissue markers:
- **SCGB2A2** is a well-known marker for breast epithelial cells.
- **KRT19** and **KRT18** are markers for luminal epithelial cells in the breast.
- **MUC1** is a marker for luminal epithelial cells and is often overexpressed in breast cancer.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of markers like SCGB2A2, KRT19, KRT18, and MUC1, the most probable general cell type is **epithelial cells**, specifically those from the mammary gland.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal Epithelial Cells**: High expression of SCGB2A2, KRT19, KRT18, and MUC1 strongly suggests luminal epithelial cells, which are the predominant cell type in the mammary gland.
2. **Luminal Progenitor Cells**: These cells also express KRT19 and KRT18 but may have a slightly different expression profile, including markers like IGFBP5.
3. **Basal/Myoepithelial Cells**: Although less likely due to the lack of specific basal markers, some overlap in keratin expression can occur.

**Most Likely Subtype**: **Luminal Epithelial Cells** are the most likely subtype given the strong expression of SCGB2A2, KRT19, KRT18, and MUC1.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of epithelial cells, specifically luminal epithelial cells of the mammary gland. This conclusion is supported by the high expression of SCGB2A2, KRT19, KRT18, and MUC1, which are well-established markers for this cell type. The presence of other markers like TFF1 and TFF3 further supports this annotation.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**:
   - The key functional markers and cell type markers listed in the annotation (SCGB1D2, SCGB2A2, IGFBP5, HMGCS2, TFF3, TFF1, GFRA1, KRT19, KRT18, MUC1, XBP1, AZGP1) are all present in the provided marker list.
   - The markers SCGB2A2, KRT19, KRT18, and MUC1 are well-known markers for epithelial cells, particularly luminal epithelial cells in the mammary gland, which aligns with the annotation.

2. **Mixed Cell Type Consideration**:
   - The annotation considers the possibility of mixed cell types by identifying potential subtypes such as luminal epithelial cells, luminal progenitor cells, and basal/myoepithelial cells.
   - The strong expression of SCGB2A2, KRT19, KRT18, and MUC1 supports the identification of luminal epithelial cells as the predominant cell type, with no strong evidence of other distinct cell types requiring further investigation.

The annotation is well-supported by the marker list and the analysis provided, leading to a clear and justified conclusion of luminal epithelial cells as the most likely cell type. | Formatting Agent: {
  ""main_cell_type"": ""Epithelial Cells"",
  ""sub_cell_types"": [
    ""Luminal Epithelial Cells"",
    ""Luminal Progenitor Cells"",
    ""Basal/Myoepithelial Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_24,B-cells,"Plasma Cells, Memory B-cells, Mature B-cells",,50,"IGKC, IGHG1, IGHG3, AC012236.1, MZB1, IGHGP, TNFRSF17, IGHG4, JCHAIN, FCRL5, IGLC3, JSRP1, IGLC2, DERL3, CD79A, POU2AF1, CD38, IGHG2, IGHA1, FKBP11, TENT5C, IGHM, SLAMF7, ITM2C, ZBP1, CD79B, EAF2, PIM2, SEC11C, SEL1L3, SSR4, HERPUD1, PRDM1, PDK1, CD27, ICAM2, SPCS3, ISG20, MEF2C, CCND2, CYTIP, CYBA, RGS1, ST6GALNAC4, ST6GAL1, PRDX4, KLF13, HSP90B1, AC007952.4, ANKRD28",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **IGKC, IGHG1, IGHG3, IGHG4, IGHGP, IGHM, IGHA1, IGLC3, IGLC2, JCHAIN**: These are immunoglobulin genes, which are critical components of antibodies. They are involved in the immune response, specifically in the recognition and neutralization of pathogens.
- **MZB1**: Known as Marginal Zone B and B1 Cell-Specific Protein, it is involved in the regulation of immunoglobulin secretion.
- **TNFRSF17 (BCMA)**: A receptor for B-cell activating factor, important for B-cell development and survival.
- **FCRL5**: A member of the Fc receptor-like family, involved in the regulation of B-cell function.
- **CD79A, CD79B**: Components of the B-cell receptor complex, essential for B-cell activation.
- **POU2AF1 (BOB.1/OBF.1)**: A transcriptional coactivator involved in B-cell development.
- **CD38**: A multifunctional enzyme involved in cell adhesion, signal transduction, and calcium signaling, often expressed on plasma cells.
- **SLAMF7**: A receptor involved in the activation of immune cells, including B-cells and plasma cells.
- **PRDM1 (Blimp-1)**: A transcription factor critical for the differentiation of B-cells into plasma cells.
- **CD27**: A member of the TNF-receptor superfamily, important for the generation and long-term maintenance of T-cell immunity, but also expressed on memory B-cells.
- **ISG20**: An interferon-stimulated gene involved in antiviral responses.
- **MEF2C**: A transcription factor involved in the regulation of immune cell differentiation.
- **CCND2**: Cyclin D2, involved in cell cycle regulation, often upregulated in proliferating cells.
- **HSP90B1**: A heat shock protein involved in protein folding and stress responses.

### Step 2: List the Key Cell Type Markers
- **Immunoglobulin genes (IGKC, IGHG1, IGHG3, etc.)**: Strongly indicative of B-cells, particularly plasma cells, which are responsible for antibody production.
- **MZB1, PRDM1, CD38, SLAMF7**: Markers associated with plasma cells, the antibody-secreting cells derived from B-cells.
- **CD79A, CD79B**: Indicative of B-cells, as they are part of the B-cell receptor complex.
- **POU2AF1**: Associated with B-cell development and differentiation.
- **TNFRSF17, FCRL5**: Markers associated with mature B-cells and plasma cells.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Cell Atlas, CellMarker, and literature on scRNA-seq data from breast cancer tissues, the expression of these markers is consistent with B-cells, particularly plasma cells. Plasma cells are known to express high levels of immunoglobulin genes and markers like CD38, PRDM1, and SLAMF7.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of immunoglobulin genes and other B-cell/plasma cell markers, the most probable general cell type is **B-cells**, with a strong indication towards **plasma cells**.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Plasma Cells**: Given the high expression of immunoglobulin genes, CD38, PRDM1, and SLAMF7, plasma cells are the most likely subtype.
2. **Memory B-cells**: The presence of CD27 and other B-cell markers suggests the possibility of memory B-cells, although the high immunoglobulin expression leans more towards plasma cells.
3. **Mature B-cells**: While less likely due to the high expression of plasma cell-specific markers, mature B-cells could be a possibility given the presence of CD79A/B and POU2AF1.

### Step 6: Provide a Concise Summary of Your Analysis
The ranked marker list from the breast cancer tissue dataset strongly indicates the presence of B-cells, with a predominant expression pattern characteristic of plasma cells. The high levels of immunoglobulin genes, along with markers such as CD38, PRDM1, and SLAMF7, support this annotation. While memory B-cells and mature B-cells are considered, the evidence overwhelmingly points to plasma cells as the most likely subtype.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**: 
   - The key functional markers listed in the annotation result, such as IGKC, IGHG1, IGHG3, MZB1, TNFRSF17, FCRL5, CD79A, CD79B, POU2AF1, CD38, SLAMF7, PRDM1, CD27, ISG20, MEF2C, CCND2, and HSP90B1, are all present in the provided marker list.
   - These markers are consistent with B-cells, particularly plasma cells, as they are involved in immunoglobulin production, B-cell activation, and plasma cell differentiation.

2. **Mixed Cell Type Consideration**:
   - The annotation result considers the possibility of mixed cell types, such as memory B-cells and mature B-cells, but the evidence strongly supports plasma cells as the predominant subtype. The high expression of immunoglobulin genes and plasma cell-specific markers like CD38, PRDM1, and SLAMF7 justifies this conclusion.
   - There is no strong evidence of multiple distinct cell types that would necessitate flagging for further investigation.

Overall, the annotation is well-supported by the marker list and aligns with known characteristics of B-cells and plasma cells. | Formatting Agent: {
  ""main_cell_type"": ""B-cells"",
  ""sub_cell_types"": [
    ""Plasma Cells"",
    ""Memory B-cells"",
    ""Mature B-cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_26,luminal epithelial cells,"Luminal A Breast Cancer Cells, Luminal B Breast Cancer Cells, Normal Luminal Epithelial Cells",,50,"TMEM64, KCNK15, C20orf204, IFI27, AGR2, CRIP1, GSTM3, CST6, HIST1H2BD, IFITM1, KRT18, SLC39A6, MRPS30-DT, UBE2C, KRT8, LSM1, IFI6, BCAS4, PARD6B, H2AFJ, ADIRF, PSMA7, HSPB1, ROMO1, LURAP1L, ISG15, ADRM1, KRT19, COX6A1, COX6C, PPDPF, STARD10, CRACR2B, TFF3, PLPP5, RAB11FIP1, C4orf48, LAMTOR5, BST2, SMIM22, NSD3, IFITM3, ERGIC3, ATP5F1E, MT-CO2, MT-CYB, TMEM205, TCEAL4, ASAH1, NDUFS8",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **TMEM64**: Involved in osteoclast differentiation and bone resorption.
- **IFI27, IFITM1, IFI6, ISG15**: Interferon-induced genes, often associated with immune response and antiviral activity.
- **GSTM3**: Part of the glutathione S-transferase family, involved in detoxification.
- **HSPB1**: Heat shock protein, involved in stress response and protein folding.
- **COX6A1, COX6C, MT-CO2, MT-CYB, ATP5F1E, NDUFS8**: Mitochondrial genes involved in oxidative phosphorylation and energy production.
- **UBE2C**: Ubiquitin-conjugating enzyme, involved in protein degradation.
- **ADRM1**: Involved in proteasome function and protein degradation.
- **ROMO1**: Involved in mitochondrial reactive oxygen species production.
- **TFF3**: Trefoil factor, involved in mucosal protection and repair.

### Step 2: List the Key Cell Type Markers
- **KRT18, KRT8, KRT19**: Keratins typically expressed in epithelial cells, including luminal epithelial cells in breast tissue.
- **AGR2**: Associated with secretory epithelial cells, often found in breast tissue.
- **CST6**: Cystatin, involved in inhibiting cysteine proteases, expressed in epithelial cells.
- **SLC39A6**: Zinc transporter, associated with epithelial cells.
- **BCAS4**: Breast carcinoma amplified sequence, associated with breast cancer cells.
- **STARD10**: Involved in lipid transport, associated with breast cancer.
- **TFF3**: Also associated with epithelial cells, particularly in the gastrointestinal tract and breast tissue.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer scRNA-seq, the markers KRT18, KRT8, KRT19, AGR2, and SLC39A6 are strongly associated with luminal epithelial cells in breast tissue. These markers are commonly used to identify luminal epithelial cells in breast cancer studies.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of keratins (KRT18, KRT8, KRT19) and other epithelial markers (AGR2, SLC39A6), the most probable general cell type is **luminal epithelial cells**. These cells are a major component of breast tissue and are often involved in breast cancer.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal A Breast Cancer Cells**: Characterized by high expression of luminal markers and often associated with hormone receptor positivity.
2. **Luminal B Breast Cancer Cells**: Similar to Luminal A but with higher proliferation markers like UBE2C.
3. **Normal Luminal Epithelial Cells**: Non-cancerous luminal cells, but less likely given the cancer context.

The most likely subtype based on the markers is **Luminal A Breast Cancer Cells**, due to the presence of luminal markers and the context of breast cancer tissue.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of luminal epithelial cells. The expression of keratins (KRT18, KRT8, KRT19) and other epithelial markers (AGR2, SLC39A6) strongly indicates a luminal epithelial origin. Within this general cell type, the most probable subtype is Luminal A Breast Cancer Cells, characterized by the expression of luminal markers and the context of breast cancer.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the context of breast cancer tissue. Here's the breakdown of the validation:

1. **Marker Consistency**: 
   - The key markers used in the annotation, such as KRT18, KRT8, KRT19, AGR2, and SLC39A6, are present in the provided marker list. These markers are well-known for their association with luminal epithelial cells, particularly in breast tissue.
   - The presence of other markers like UBE2C, which is associated with higher proliferation, supports the identification of Luminal B Breast Cancer Cells as a potential subtype, but the context and marker expression lean more towards Luminal A Breast Cancer Cells.

2. **Mixed Cell Type Consideration**:
   - The analysis does not strongly suggest the presence of multiple distinct cell types. The markers predominantly support the identification of luminal epithelial cells, specifically Luminal A Breast Cancer Cells, which is consistent with the context of breast cancer tissue.
   - There is no strong evidence of mixed cell types that would necessitate further investigation.

Overall, the annotation aligns well with the marker list and the context provided, leading to a valid conclusion of Luminal A Breast Cancer Cells as the most probable cell type. | Formatting Agent: {
  ""main_cell_type"": ""luminal epithelial cells"",
  ""sub_cell_types"": [
    ""Luminal A Breast Cancer Cells"",
    ""Luminal B Breast Cancer Cells"",
    ""Normal Luminal Epithelial Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_27,myoepithelial cells,"basal epithelial cells, luminal progenitor cells",,50,"PCP4, HRCT1, ACTG2, SCRG1, KRT81, TAGLN, KRT17, AARD, PCSK1N, MYLK, KRT16, MIA, GABRP, DSG3, CTGF, DSC2, FBXO32, TPM2, MYL9, FBLN2, SYNM, ACTA2, KRT23, PFN2, PLOD1, CRYAB, ITM2C, CD24, S100A1, TUSC3, SDC2, S100P, RBP7, HIST1H2AC, CALML5, LAPTM4B, MDK, MFAP2, NDRG1, IMPA2, CDKN2A, S100A6, LY6E, NFIB, SERPINH1, STMN1, MAL2, RCN1, GSTP1, RCN2",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **ACTG2 (Actin Gamma 2)**: Involved in muscle contraction and cytoskeletal structure.
- **TAGLN (Transgelin)**: Associated with smooth muscle differentiation and actin-binding.
- **MYLK (Myosin Light Chain Kinase)**: Plays a role in muscle contraction.
- **TPM2 (Tropomyosin 2)**: Involved in muscle contraction regulation.
- **MYL9 (Myosin Light Chain 9)**: Associated with muscle contraction.
- **ACTA2 (Actin Alpha 2, Smooth Muscle)**: A marker for smooth muscle cells.
- **SYNM (Synemin)**: Intermediate filament protein, often found in muscle cells.
- **CTGF (Connective Tissue Growth Factor)**: Involved in cell adhesion and migration, often in stromal cells.
- **SERPINH1 (Serpin Family H Member 1)**: Involved in collagen synthesis and folding.

### Step 2: List the Key Cell Type Markers
- **KRT81, KRT17, KRT16, KRT23**: Keratins are structural proteins in epithelial cells, often associated with skin and hair follicle cells.
- **DSG3 (Desmoglein 3), DSC2 (Desmocollin 2)**: Components of desmosomes, important for cell-cell adhesion in epithelial tissues.
- **GABRP (Gamma-Aminobutyric Acid Type A Receptor Pi Subunit)**: Expressed in epithelial cells, particularly in breast tissue.
- **CD24**: A marker often found in epithelial and cancer stem cells.
- **S100A1, S100P, S100A6**: Calcium-binding proteins, often expressed in epithelial cells and involved in cell cycle progression and differentiation.
- **LY6E (Lymphocyte Antigen 6 Complex, Locus E)**: Expressed in epithelial cells and involved in immune response modulation.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, we can cross-reference these markers:
- **Smooth Muscle Markers**: ACTA2, TAGLN, MYLK, TPM2, MYL9, SYNM are strongly indicative of smooth muscle cells.
- **Epithelial Markers**: KRT81, KRT17, KRT16, DSG3, DSC2, CD24, S100 family proteins suggest an epithelial origin, possibly basal or luminal epithelial cells in breast tissue.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of smooth muscle and epithelial markers, the most probable general cell type is **myoepithelial cells**. These cells have characteristics of both epithelial and smooth muscle cells and are found in the breast tissue.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Myoepithelial Cells**: Given the strong presence of both smooth muscle and epithelial markers, myoepithelial cells are the most likely subtype.
2. **Basal Epithelial Cells**: The presence of keratins and desmosomal proteins suggests a basal epithelial phenotype.
3. **Luminal Progenitor Cells**: Some markers like CD24 and S100 proteins can also be expressed in luminal progenitor cells, although less likely given the strong smooth muscle signature.

### Step 6: Provide a Concise Summary of Your Analysis
The ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of **myoepithelial cells**. This conclusion is supported by the co-expression of smooth muscle markers (e.g., ACTA2, TAGLN) and epithelial markers (e.g., KRT17, DSG3). Myoepithelial cells are known to play a role in the structural integrity and function of breast tissue, particularly in the context of cancer.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**:
   - The markers used in the annotation (e.g., ACTG2, TAGLN, MYLK, TPM2, MYL9, ACTA2, SYNM, CTGF, SERPINH1, KRT81, KRT17, KRT16, KRT23, DSG3, DSC2, GABRP, CD24, S100A1, S100P, S100A6, LY6E) are all present in the provided marker list.
   - The markers are consistent with the identified cell type of myoepithelial cells, which are known to express both smooth muscle markers (e.g., ACTA2, TAGLN) and epithelial markers (e.g., KRT17, DSG3).

2. **Mixed Cell Type Consideration**:
   - The annotation acknowledges the presence of both smooth muscle and epithelial markers, which is characteristic of myoepithelial cells. This suggests a mixed phenotype inherent to myoepithelial cells rather than a mixture of distinct cell types.
   - The analysis also considers the possibility of basal epithelial cells and luminal progenitor cells, but the strong presence of smooth muscle markers supports the primary annotation of myoepithelial cells.

Overall, the annotation is well-supported by the marker list and the known characteristics of myoepithelial cells, making the validation successful. | Formatting Agent: {
  ""main_cell_type"": ""myoepithelial cells"",
  ""sub_cell_types"": [
    ""basal epithelial cells"",
    ""luminal progenitor cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_28,B-cells,"Plasma Cells, Memory B-cells, Naive B-cells",,50,"TCL1A, MS4A1, SPIB, PLAC8, CD79A, IRF8, CD79B, JCHAIN, IGHM, LTB, HLA-DRA, IGKC, POU2F2, SELL, PRKCB, BCL11A, MEF2C, HLA-DPA1, RIPOR2, CD74, CD37, HLA-DPB1, GPR183, CD52, HLA-DRB1, CXCR4, HLA-DQA1, CORO1A, SEPT6, PLEK, CD53, NCF1, IKZF1, RAC2, HLA-DMB, HLA-DQB1, TCF4, EVI2B, CD83, LAPTM5, LCP1, LIMD2, ALOX5AP, MZB1, PTPRC, IGLC2, RGS1, CD48, PPM1K, CYB561A3",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **TCL1A**: Known to be involved in the regulation of cell survival and proliferation, often associated with lymphoid cells.
- **IRF8**: A transcription factor involved in the regulation of immune response, particularly in myeloid and lymphoid lineages.
- **POU2F2 (OCT2)**: A transcription factor involved in B-cell development and function.
- **PRKCB**: Protein kinase C beta, involved in B-cell receptor signaling.
- **BCL11A**: A transcription factor involved in B-cell development.
- **MEF2C**: A transcription factor involved in lymphocyte differentiation.
- **CXCR4**: A chemokine receptor involved in cell migration and homing, particularly in immune cells.
- **RAC2**: A small GTPase involved in the regulation of the actin cytoskeleton, important for immune cell function.
- **PTPRC (CD45)**: A protein tyrosine phosphatase involved in the regulation of immune cell signaling.

### Step 2: List the Key Cell Type Markers
- **MS4A1 (CD20)**: A well-known marker for B-cells.
- **CD79A and CD79B**: Components of the B-cell receptor complex, specific to B-cells.
- **JCHAIN**: Associated with immunoglobulin production, particularly in plasma cells.
- **IGHM**: Immunoglobulin heavy constant mu, indicative of B-cells, particularly naive or memory B-cells.
- **IGKC**: Immunoglobulin kappa constant, associated with B-cells and plasma cells.
- **HLA-DRA, HLA-DPA1, HLA-DPB1, HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-DMB**: MHC class II molecules, typically expressed on antigen-presenting cells, including B-cells.
- **CD74**: Invariant chain associated with MHC class II, expressed on B-cells and other antigen-presenting cells.
- **CD37, CD52, CD53, CD83**: Surface markers associated with B-cells and other immune cells.
- **MZB1**: A marker associated with plasma cells.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Cell Atlas, PanglaoDB, and literature on scRNA-seq datasets, the markers listed are predominantly associated with B-cells and plasma cells. The presence of immunoglobulin-related genes (IGHM, IGKC, JCHAIN) and B-cell receptor components (CD79A, CD79B) strongly suggests a B-cell lineage.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of these markers, the most likely general cell type is **B-cells**. The presence of both naive/memory B-cell markers and plasma cell markers suggests a mixed population of B-cells.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Plasma Cells**: The presence of JCHAIN, IGKC, and MZB1 suggests a significant population of plasma cells, which are differentiated B-cells responsible for antibody production.
2. **Memory B-cells**: The expression of IGHM and CD79A/B, along with MHC class II molecules, suggests the presence of memory B-cells.
3. **Naive B-cells**: The presence of TCL1A and other B-cell receptor components suggests some naive B-cells.

The most likely subtype based on the markers is **Plasma Cells**, given the strong expression of immunoglobulin-related genes and plasma cell-specific markers like MZB1.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is predominantly composed of B-cells, with a significant presence of plasma cells. The expression of immunoglobulin-related genes and plasma cell-specific markers supports this conclusion. The top three probable subtypes are plasma cells, memory B-cells, and naive B-cells, with plasma cells being the most likely subtype.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**: 
   - The markers used in the annotation (e.g., TCL1A, MS4A1, CD79A, CD79B, JCHAIN, IGHM, IGKC, MZB1) are present in the provided marker list.
   - The markers are consistent with B-cells and plasma cells, as they include well-known B-cell markers (MS4A1, CD79A/B) and plasma cell markers (JCHAIN, IGKC, MZB1).

2. **Mixed Cell Type Consideration**:
   - The annotation correctly identifies a mixed population of B-cells, including plasma cells, memory B-cells, and naive B-cells. This is supported by the presence of both general B-cell markers and specific plasma cell markers.
   - The presence of markers like IGHM, CD79A/B, and MHC class II molecules supports the identification of memory and naive B-cells, while markers like JCHAIN and MZB1 strongly indicate plasma cells.

The annotation is well-supported by the marker list and the analysis steps, leading to a valid conclusion of a predominantly B-cell population with a significant presence of plasma cells. | Formatting Agent: {
  ""main_cell_type"": ""B-cells"",
  ""sub_cell_types"": [
    ""Plasma Cells"",
    ""Memory B-cells"",
    ""Naive B-cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_29,luminal epithelial cells,"Luminal A Subtype, Luminal B Subtype, Normal-like Luminal Cells",,50,"CPB1, IGFBP5, GRIA2, HOXA7, GDF15, AGR3, PARD6B, CTSK, SCGB3A1, GATA3, SLC7A2, RAMP1, CRIP1, MRPS30-DT, SMIM22, GADD45G, AARD, SUCO, C4orf48, ZMYND8, SMG7, MRPS21, RPRD2, GFRA1, KRTCAP2, EFNA1, MCL1, GATA3-AS1, KCNK6, ZNF552, ESR1, DPM3, TCEAL3, TMCO1, THSD4, H2AFJ, AP2B1, COX6C, SLC39A6, HSPB1, JUND, FLNB, C15orf48, TCEAL4, RHOBTB3, IRX3, NR4A1, ELF3, ASH1L, CCND1",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **CPB1 (Carboxypeptidase B1)**: Typically associated with pancreatic function, but its presence in breast cancer may indicate a role in tumor microenvironment or cancer cell metabolism.
- **IGFBP5 (Insulin-like Growth Factor Binding Protein 5)**: Involved in cell growth, apoptosis, and has been implicated in breast cancer progression.
- **GRIA2 (Glutamate Ionotropic Receptor AMPA Type Subunit 2)**: Generally associated with neural signaling, but its expression in cancer can be linked to cell signaling pathways.
- **GDF15 (Growth Differentiation Factor 15)**: A stress response cytokine often upregulated in cancer, including breast cancer, and associated with tumor progression.
- **GATA3 (GATA Binding Protein 3)**: A transcription factor crucial for luminal cell differentiation in the breast and a well-known marker for luminal breast cancer.
- **ESR1 (Estrogen Receptor 1)**: A key marker for hormone receptor-positive breast cancer, indicating luminal subtype.

### Step 2: List the Key Cell Type Markers
- **GATA3**: As mentioned, a critical marker for luminal epithelial cells in the breast.
- **ESR1**: Indicates estrogen receptor-positive luminal epithelial cells.
- **AGR3 (Anterior Gradient 3)**: Associated with secretory epithelial cells in the breast.
- **SCGB3A1 (Secretoglobin Family 3A Member 1)**: Often expressed in secretory epithelial cells.
- **KRTCAP2 (Keratinocyte Associated Protein 2)**: Related to epithelial cell function.
- **CCND1 (Cyclin D1)**: Involved in cell cycle regulation, often overexpressed in luminal breast cancer.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer scRNA-seq, we can confirm that markers like GATA3, ESR1, and CCND1 are strongly associated with luminal epithelial cells in breast tissue.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of GATA3, ESR1, and other epithelial markers, the most probable general cell type is **luminal epithelial cells** of the breast.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal A Subtype**: Characterized by high expression of ESR1 and GATA3, typically associated with a better prognosis.
2. **Luminal B Subtype**: Also expresses ESR1 and GATA3 but with higher proliferation markers like CCND1.
3. **Normal-like Luminal Cells**: Express similar markers but are less proliferative and more differentiated.

Given the presence of ESR1, GATA3, and CCND1, the most likely subtype is **Luminal B**, as it aligns with the expression of proliferation markers.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of luminal epithelial cells. The expression of key markers such as GATA3, ESR1, and CCND1 indicates a luminal B subtype, which is characterized by hormone receptor positivity and higher proliferation rates compared to luminal A.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**:
   - The key markers used for annotation, such as GATA3, ESR1, and CCND1, are present in the provided marker list.
   - These markers are well-known and strongly associated with luminal epithelial cells in breast tissue, particularly in the context of breast cancer.

2. **Mixed Cell Type Consideration**:
   - The analysis does not indicate the presence of multiple distinct cell types strongly supported by several high-ranking markers. The markers used are consistent with a single cell type, specifically luminal epithelial cells.
   - The annotation correctly identifies the luminal B subtype based on the expression of proliferation markers like CCND1, which aligns with the provided marker list and known literature.

Overall, the annotation is well-supported by the marker list and aligns with known biological characteristics of luminal epithelial cells in breast cancer. | Formatting Agent: {
  ""main_cell_type"": ""luminal epithelial cells"",
  ""sub_cell_types"": [
    ""Luminal A Subtype"",
    ""Luminal B Subtype"",
    ""Normal-like Luminal Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_3,Luminal Epithelial Cells,"Luminal Progenitor Cells, Mature Luminal Cells, Luminal Breast Cancer Cells",,50,"FABP3, DHRS2, SRARP, STC2, RAMP1, MGP, MESP1, SUSD3, FSIP1, ADIRF, SCGB2A2, GSTM3, KIF22, SMIM22, ANKRD30A, COX6C, TBC1D9, KNOP1, NUPR1, CLDN3, TCEAL4, FAM173A, MAGED2, AZGP1, ABHD11, HEBP1, MT-ND5, KRT19, NUDT16L1, PLA2G16, METRN, TCEAL3, KRT18, ZG16B, CD24, AGR3, NME3, SMIM14, S100A14, SNRNP25, CRIP1, SEPHS2, C4orf48, KRT8, GATA3, XBP1, ESR1, ELF3, SPINT2, EFHD1",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **FABP3 (Fatty Acid Binding Protein 3):** Involved in fatty acid uptake, transport, and metabolism.
- **DHRS2 (Dehydrogenase/Reductase 2):** Functions in retinoid metabolism and may play a role in cellular differentiation.
- **STC2 (Stanniocalcin 2):** Involved in calcium and phosphate homeostasis.
- **RAMP1 (Receptor Activity Modifying Protein 1):** Modulates receptor activity, particularly in the context of the calcitonin gene-related peptide (CGRP) receptor.
- **MGP (Matrix Gla Protein):** Inhibits vascular calcification and is involved in bone development.
- **COX6C (Cytochrome c Oxidase Subunit 6C):** Part of the electron transport chain, involved in cellular respiration.
- **NUPR1 (Nuclear Protein 1):** A stress response protein involved in cell cycle regulation and apoptosis.
- **XBP1 (X-Box Binding Protein 1):** A transcription factor involved in the unfolded protein response and endoplasmic reticulum stress.
- **ESR1 (Estrogen Receptor 1):** A nuclear hormone receptor for estrogen, playing a critical role in breast tissue development and cancer.

### Step 2: List the Key Cell Type Markers
- **SCGB2A2 (Secretoglobin Family 2A Member 2):** Also known as Mammaglobin-A, a marker for mammary epithelial cells and breast cancer.
- **KRT19 (Keratin 19):** An intermediate filament protein, commonly expressed in epithelial cells, particularly in breast tissue.
- **KRT18 (Keratin 18):** Another keratin protein, often found in simple epithelial cells.
- **KRT8 (Keratin 8):** Expressed in simple epithelial cells, often co-expressed with KRT18.
- **GATA3 (GATA Binding Protein 3):** A transcription factor critical for luminal epithelial cell differentiation in the mammary gland.
- **ELF3 (E74 Like ETS Transcription Factor 3):** Involved in epithelial cell differentiation.
- **CD24:** A cell surface protein often used as a marker for epithelial and cancer stem cells.
- **AGR3 (Anterior Gradient 3):** Associated with epithelial cell differentiation and breast cancer.
- **SUSD3 (Sushi Domain Containing 3):** Expressed in breast tissue and associated with breast cancer.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer and epithelial cell markers, we can confirm that many of these markers are associated with epithelial cells, particularly those of the mammary gland.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of markers such as SCGB2A2, KRT19, KRT18, KRT8, GATA3, and ESR1, the most probable general cell type is **luminal epithelial cells** of the breast. These markers are characteristic of cells that line the ducts and lobules of the mammary gland.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal Progenitor Cells:** Characterized by the expression of KRT19, KRT18, and GATA3, these cells are precursors to mature luminal cells and are often implicated in breast cancer.
2. **Mature Luminal Cells:** Express high levels of SCGB2A2, KRT8, and ESR1, indicating differentiated luminal epithelial cells.
3. **Luminal Breast Cancer Cells:** Given the context of breast cancer tissue, these cells may represent cancerous luminal epithelial cells, characterized by aberrant expression of markers like ESR1 and GATA3.

The most likely subtype, based on the markers, is **Mature Luminal Cells**, given the high expression of SCGB2A2, KRT19, KRT18, and ESR1.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of luminal epithelial cells. The expression of key markers such as SCGB2A2, KRT19, KRT18, GATA3, and ESR1 supports this annotation. Within this general cell type, the most probable subtypes are luminal progenitor cells, mature luminal cells, and luminal breast cancer cells, with mature luminal cells being the most likely subtype.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency:**
   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. 
   - The markers SCGB2A2, KRT19, KRT18, KRT8, GATA3, and ESR1 are all present in the marker list and are well-known markers for luminal epithelial cells in breast tissue.

2. **Mixed Cell Type Consideration:**
   - The annotation considers the possibility of mixed cell types by identifying potential subtypes such as luminal progenitor cells, mature luminal cells, and luminal breast cancer cells. 
   - The analysis appropriately concludes that mature luminal cells are the most likely subtype based on the expression of key markers.

The annotation is well-supported by the marker list and the context of breast cancer tissue, and the analysis is thorough in considering potential subtypes within the luminal epithelial cell category. | Formatting Agent: {
  ""main_cell_type"": ""Luminal Epithelial Cells"",
  ""sub_cell_types"": [
    ""Luminal Progenitor Cells"",
    ""Mature Luminal Cells"",
    ""Luminal Breast Cancer Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_30,breast cancer epithelial cell,"HER2-Positive Breast Cancer Cells, Molecular Apocrine Breast Cancer Cells, Luminal B Breast Cancer Cells",,50,"IGFBP5, MIPEP, IGFBP2, KLK11, RPL23, SRCIN1, MIEN1, C17orf75, SHROOM3, ERBB2, ZNF207, RBP1, CISD3, MED1, CDK12, LRRC75A, MT-ND3, JUND, CCNI, BRD9, AR, ARMT1, MLLT6, CWC25, RHOT1, PSMB3, PCGF2, RPL19, PSMD11, NOVA1, LRRC26, IARS2, MT-ATP8, PDCD6, ADD3, SGPL1, GRB7, CCNG2, SCARB2, PCBD1, TNFSF10, STARD3, DCAF6, SDAD1, ANKRD17, MT-ATP6, EPRS, TRPS1, SNHG19, MPC2",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **IGFBP5, IGFBP2**: Insulin-like growth factor binding proteins, involved in modulating IGF signaling, which is crucial for cell growth and survival.
- **ERBB2 (HER2)**: A receptor tyrosine kinase involved in cell growth and differentiation, often overexpressed in certain breast cancers.
- **AR (Androgen Receptor)**: A nuclear hormone receptor involved in regulating gene expression and affecting cell proliferation.
- **GRB7**: An adaptor protein that interacts with receptor tyrosine kinases like ERBB2, involved in signal transduction pathways.
- **TNFSF10 (TRAIL)**: A cytokine involved in inducing apoptosis, particularly in cancer cells.
- **SRCIN1**: A protein involved in the regulation of Src family kinases, which play roles in cell proliferation and survival.

### Step 2: List the Key Cell Type Markers
- **ERBB2 (HER2)**: Strongly associated with HER2-positive breast cancer cells.
- **AR (Androgen Receptor)**: Often expressed in certain subtypes of breast cancer, such as molecular apocrine tumors.
- **IGFBP5, IGFBP2**: Frequently expressed in breast cancer cells, involved in cancer cell proliferation and survival.
- **GRB7**: Often co-amplified with ERBB2 in breast cancer, indicating a HER2-positive phenotype.

### Step 3: Cross-reference Known Databases
- **ERBB2 (HER2)**: Known to be a key marker for HER2-positive breast cancer cells, as per databases like the Human Protein Atlas and literature.
- **AR**: Associated with molecular apocrine breast cancer, as per literature and databases.
- **IGFBP5, IGFBP2**: Known to be expressed in breast cancer cells, supporting their role in cancer progression.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of ERBB2, AR, and IGFBP proteins, the most probable general cell type is a **breast cancer epithelial cell**, specifically those associated with HER2-positive breast cancer.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **HER2-Positive Breast Cancer Cells**: Due to the high expression of ERBB2 and co-expression of GRB7.
2. **Molecular Apocrine Breast Cancer Cells**: Due to the expression of AR, which is characteristic of this subtype.
3. **Luminal B Breast Cancer Cells**: These can also express ERBB2 and AR, though typically with lower ERBB2 expression compared to HER2-positive cells.

The most likely subtype based on the markers is **HER2-Positive Breast Cancer Cells**, given the prominence of ERBB2 and GRB7.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of HER2-positive breast cancer epithelial cells. This conclusion is supported by the high expression of ERBB2 and GRB7, which are hallmark markers of this subtype. Additionally, the presence of AR suggests a potential overlap with molecular apocrine characteristics, but the dominance of ERBB2 expression strongly points towards a HER2-positive phenotype.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**:
   - The key markers used in the annotation (IGFBP5, IGFBP2, ERBB2, AR, GRB7, TNFSF10, SRCIN1) are all present in the provided marker list.
   - The markers are consistent with the identified cell type, as they are known to be associated with breast cancer, particularly HER2-positive breast cancer cells.

2. **Mixed Cell Type Consideration**:
   - The annotation acknowledges the potential presence of mixed cell types, such as molecular apocrine breast cancer cells and luminal B breast cancer cells, due to the expression of AR and other markers.
   - However, the dominance of ERBB2 and GRB7 supports the primary annotation of HER2-positive breast cancer cells, which is a reasonable conclusion given the marker expression profile.

The analysis is thorough and considers the possibility of mixed cell types, but the evidence strongly supports the primary annotation of HER2-positive breast cancer epithelial cells. Therefore, the validation is passed. | Formatting Agent: {
  ""main_cell_type"": ""breast cancer epithelial cell"",
  ""sub_cell_types"": [
    ""HER2-Positive Breast Cancer Cells"",
    ""Molecular Apocrine Breast Cancer Cells"",
    ""Luminal B Breast Cancer Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_31,macrophages,"tumor-associated macrophages (TAMs), classical (M1) macrophages, non-classical (M2) macrophages",,50,"MARCHF1, GPX1, MTCO2P12, TYROBP, CD74, C1QC, CALHM6, SPI1, C1QB, C1QA, CD68, HLA-DPA1, FCER1G, HLA-DRB5, FCGR3A, HLA-DRB1, AIF1, MS4A6A, HLA-DRA, HLA-DPB1, CSF1R, MACROH2A1, ATP6V0C, H3-3B, HLA-DQA1, LILRB4, CYBB, CIAO2A, ADAP2, FCGR2A, LAPTM5, H3-3A, GABARAP, FPR3, LYZ, LST1, CD14, FGL2, C1orf162, HLA-DQB1, ITGB2, RASSF4, CD4, SERPINA1, TNFSF13B, CTSB, PLEK, MNDA, FYB1, HLA-DMB",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **MARCHF1**: Involved in protein ubiquitination, potentially regulating immune responses.
- **GPX1**: Encodes glutathione peroxidase, involved in detoxifying hydrogen peroxide, indicating oxidative stress response.
- **TYROBP**: An adaptor protein involved in immune cell signaling, particularly in myeloid cells.
- **SPI1 (PU.1)**: A transcription factor critical for myeloid and lymphoid lineage development.
- **CSF1R**: A receptor for colony-stimulating factor 1, important for macrophage differentiation and survival.
- **CYBB**: Encodes a component of the NADPH oxidase complex, involved in reactive oxygen species production in phagocytes.
- **FPR3**: A receptor involved in chemotaxis of immune cells.
- **LYZ**: Encodes lysozyme, an enzyme with antibacterial properties, often expressed in myeloid cells.

### Step 2: List the Key Cell Type Markers
- **CD74, HLA-DPA1, HLA-DRB5, HLA-DRB1, HLA-DRA, HLA-DPB1, HLA-DQA1, HLA-DQB1, HLA-DMB**: These are MHC class II molecules and associated proteins, indicating antigen-presenting cells, such as macrophages or dendritic cells.
- **C1QC, C1QB, C1QA**: Components of the complement system, typically expressed in macrophages.
- **CD68**: A marker for macrophages and monocytes.
- **FCER1G, FCGR3A, FCGR2A**: Fc receptors, often found on macrophages and other immune cells.
- **AIF1 (IBA1)**: A marker for microglia and macrophages.
- **MS4A6A**: Associated with immune cells, particularly macrophages.
- **LILRB4**: An inhibitory receptor found on myeloid cells.
- **CD14**: A co-receptor for the detection of bacterial lipopolysaccharide, expressed on monocytes and macrophages.
- **ITGB2**: Integrin beta-2, involved in leukocyte adhesion and signaling.

### Step 3: Cross-reference Known Databases
Using databases such as CellMarker, PanglaoDB, and the Human Protein Atlas, these markers are predominantly associated with myeloid lineage cells, particularly macrophages and monocytes. The presence of MHC class II molecules and complement components strongly suggests antigen-presenting capabilities.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of these markers, the most likely general cell type is **macrophages**. The combination of MHC class II molecules, complement components, and macrophage-specific markers like CD68 and CD14 supports this conclusion.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Tumor-associated macrophages (TAMs)**: Given the breast cancer tissue context, TAMs are highly probable. They often express MHC class II molecules and are involved in tumor microenvironment modulation.
2. **Classical (M1) macrophages**: Characterized by high expression of MHC class II and pro-inflammatory markers, they are involved in antigen presentation and immune response.
3. **Non-classical (M2) macrophages**: Typically involved in tissue repair and anti-inflammatory responses, they may also express some of the markers listed, albeit usually with a different profile.

The most likely subtype, considering the tumor context and marker expression, is **tumor-associated macrophages (TAMs)**.

### Step 6: Provide a Concise Summary of Your Analysis
The ranked marker list from the breast cancer tissue dataset predominantly indicates a macrophage cell type, with strong evidence pointing towards tumor-associated macrophages (TAMs). This is supported by the expression of MHC class II molecules, complement components, and macrophage-specific markers. The presence of these markers aligns with the known roles of TAMs in the tumor microenvironment, including immune modulation and interaction with cancer cells.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**: 
   - The markers used in the annotation are present in the provided marker list. 
   - The markers such as CD68, CD14, and MHC class II molecules (e.g., HLA-DPA1, HLA-DRB1) are well-known markers for macrophages, particularly tumor-associated macrophages (TAMs) in the context of breast cancer tissue.

2. **Mixed Cell Type Consideration**:
   - The analysis does not strongly suggest the presence of multiple distinct cell types. The markers predominantly indicate a macrophage lineage, specifically tumor-associated macrophages (TAMs), which is appropriate given the breast cancer tissue context.

The annotation aligns well with the known roles and marker expressions of TAMs in the tumor microenvironment, supporting the conclusion drawn in the analysis. | Formatting Agent: {
  ""main_cell_type"": ""macrophages"",
  ""sub_cell_types"": [
    ""tumor-associated macrophages (TAMs)"",
    ""classical (M1) macrophages"",
    ""non-classical (M2) macrophages""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_32,vascular smooth muscle cells,"pericytes, endothelial cells",,50,"PLN, RGS5, GJA4, MT1A, C11orf96, MYH11, IGFBP7, MCAM, PPP1R14A, TAGLN, ACTA2, PDGFRB, IL6, COL4A1, CRISPLD2, ADAMTS4, ADAMTS1, PDK4, SPARCL1, PLAC9, MAP1B, AKAP12, COL4A2, TPM2, SOD3, MYL9, COL18A1, MT1M, EPAS1, CALD1, VASN, CPE, ADAMTS9, LHFPL6, APOLD1, CAV1, AXL, GEM, LBH, TINAGL1, CAVIN3, PHLDA1, TFPI, NOTCH3, COL6A2, MEF2C, MYLK, CRYAB, CREM, KLF9",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **PLN (Phospholamban):** Involved in cardiac muscle contraction regulation, but also expressed in smooth muscle cells.
- **RGS5 (Regulator of G-protein Signaling 5):** Known to be involved in vascular smooth muscle cell function and pericyte biology.
- **GJA4 (Gap Junction Protein Alpha 4):** Encodes connexin 37, involved in cell communication, particularly in endothelial cells.
- **MT1A (Metallothionein 1A):** Involved in metal ion binding and detoxification.
- **MYH11 (Myosin Heavy Chain 11):** A smooth muscle myosin, indicating smooth muscle cell function.
- **IGFBP7 (Insulin-like Growth Factor Binding Protein 7):** Involved in cell adhesion and growth regulation.
- **ACTA2 (Alpha Smooth Muscle Actin):** A classic marker for smooth muscle cells and myofibroblasts.
- **PDGFRB (Platelet-Derived Growth Factor Receptor Beta):** Expressed in pericytes and vascular smooth muscle cells, involved in cell proliferation and migration.
- **COL4A1 (Collagen Type IV Alpha 1 Chain):** A component of the basement membrane, involved in structural integrity.
- **EPAS1 (Endothelial PAS Domain Protein 1):** Also known as HIF-2α, involved in response to hypoxia, often expressed in endothelial cells.

### Step 2: List the Key Cell Type Markers
- **MYH11, ACTA2, TAGLN (Transgelin), CALD1 (Caldesmon 1), MYL9 (Myosin Light Chain 9):** These are all markers associated with smooth muscle cells.
- **PDGFRB, RGS5, MCAM (Melanoma Cell Adhesion Molecule):** Markers associated with pericytes and vascular smooth muscle cells.
- **GJA4, EPAS1:** Markers associated with endothelial cells.
- **COL4A1, COL4A2, COL18A1:** Collagen markers, often associated with extracellular matrix and basement membrane, relevant to endothelial and smooth muscle cells.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on scRNA-seq datasets, the markers listed are predominantly associated with vascular smooth muscle cells and pericytes. The presence of ACTA2, MYH11, and TAGLN strongly suggests a smooth muscle lineage, while PDGFRB and RGS5 are indicative of pericytes.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of these markers, the most likely general cell type is **vascular smooth muscle cells**. The presence of ACTA2, MYH11, and other smooth muscle markers supports this conclusion.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Vascular Smooth Muscle Cells:** The high expression of ACTA2, MYH11, and TAGLN strongly supports this subtype.
2. **Pericytes:** The expression of PDGFRB and RGS5 suggests a pericyte identity, which is closely related to vascular smooth muscle cells.
3. **Endothelial Cells:** The presence of GJA4 and EPAS1 suggests a possible endothelial cell identity, although less likely given the dominance of smooth muscle markers.

The most likely subtype based on the markers is **vascular smooth muscle cells**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of vascular smooth muscle cells. This conclusion is supported by the high expression of smooth muscle-specific markers such as ACTA2, MYH11, and TAGLN. Pericytes and endothelial cells are considered as less likely subtypes due to the presence of PDGFRB, RGS5, and GJA4, but the overall marker profile strongly favors a smooth muscle cell identity.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. The analysis correctly identifies vascular smooth muscle cells as the most probable cell type based on the high expression of smooth muscle-specific markers such as ACTA2, MYH11, and TAGLN. The presence of markers like PDGFRB and RGS5 also supports the potential presence of pericytes, which are closely related to vascular smooth muscle cells. Additionally, the presence of GJA4 and EPAS1 suggests a possible, though less likely, endothelial cell identity.

The annotation process has appropriately considered the possibility of mixed cell types, acknowledging the presence of markers for pericytes and endothelial cells, but ultimately concluding that the marker profile strongly favors a smooth muscle cell identity. The analysis is thorough and aligns with known databases and literature, supporting the final annotation of vascular smooth muscle cells. | Formatting Agent: {
  ""main_cell_type"": ""vascular smooth muscle cells"",
  ""sub_cell_types"": [
    ""pericytes"",
    ""endothelial cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_33,cancerous epithelial cell,"HER2-positive Breast Cancer Cells, Luminal B Breast Cancer Cells, Basal-like Breast Cancer Cells",,50,"TBC1D30, RASSF3, EFS, ERBB2, GRB7, GNS, ORMDL3, MSL1, MDM2, CAND1, CASC3, PSMB5, SLC35E3, PSMD3, AC093001.1, MED24, CCT2, LMTK3, MED1, RXYLT1, RGS16, FRS2, MGLL, MRPL52, KCNJ3, ZBTB10, TFAP2B, CDK12, LRRC59, APOD, LRRC26, LRP10, HSPB1, STARD3, RPL19, SQLE, RAP1B, MRPL27, MIEN1, COMT, SLC25A1, SLC35B1, UQCR10, DAD1, CALM3, OXA1L, TPD52, HES1, SLC9A3R1, EIF4EBP1",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **ERBB2 (HER2)**: A member of the epidermal growth factor receptor (EGFR) family, often overexpressed in certain breast cancer subtypes, particularly HER2-positive breast cancer.
- **GRB7**: An adaptor protein that interacts with receptor tyrosine kinases like ERBB2, involved in signal transduction pathways that promote cell proliferation and survival.
- **MDM2**: An E3 ubiquitin-protein ligase that negatively regulates the p53 tumor suppressor, often implicated in cancer progression.
- **HES1**: A transcriptional repressor involved in the Notch signaling pathway, which plays a role in cell differentiation and proliferation.
- **SQLE**: Squalene epoxidase, a key enzyme in cholesterol biosynthesis, often upregulated in cancer cells to support rapid cell growth.

### Step 2: List the Key Cell Type Markers
- **ERBB2 (HER2)**: Strongly associated with HER2-positive breast cancer cells.
- **TFAP2B**: A transcription factor that can be involved in the regulation of genes associated with epithelial cell differentiation.
- **APOD**: Apolipoprotein D, often expressed in breast tissue and associated with lipid metabolism.
- **HSPB1 (HSP27)**: A heat shock protein that can be upregulated in response to stress and is often associated with cancer cell survival.
- **STARD3**: A cholesterol transporter that is often co-amplified with ERBB2 in breast cancer.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer, the markers ERBB2, GRB7, and STARD3 are frequently associated with HER2-positive breast cancer cells. The presence of these markers, along with others like MDM2 and HSPB1, supports the identification of a cancerous epithelial cell type, specifically within the breast tissue context.

### Step 4: Determine the Most Probable General Cell Type
Given the expression of ERBB2, GRB7, and other associated markers, the most probable general cell type is a **cancerous epithelial cell** from breast tissue, specifically a subtype of breast cancer cells.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **HER2-positive Breast Cancer Cells**: The presence of ERBB2, GRB7, and STARD3 strongly suggests this subtype, as these markers are characteristic of HER2-positive breast cancer.
2. **Luminal B Breast Cancer Cells**: This subtype can also express ERBB2 and other markers like TFAP2B, though typically with lower ERBB2 expression compared to HER2-positive cells.
3. **Basal-like Breast Cancer Cells**: While less likely due to the strong ERBB2 signal, some markers like HSPB1 can be expressed in basal-like subtypes.

The most likely subtype based on the markers is **HER2-positive Breast Cancer Cells**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of cancerous epithelial cells, specifically HER2-positive breast cancer cells. This conclusion is supported by the high expression of ERBB2, GRB7, and STARD3, which are hallmark markers of this breast cancer subtype. Other markers such as MDM2 and HSPB1 further support the identification of a cancerous phenotype.

FINAL ANNOTATION COMPLETED | Coupling Validator: To validate the annotation result, let's follow the outlined steps:

### Step 1: Marker Consistency
- **ERBB2 (HER2)**, **GRB7**, **MDM2**, **HES1**, **SQLE**, **TFAP2B**, **APOD**, **HSPB1 (HSP27)**, and **STARD3** are all present in the provided marker list.
- The markers used in the annotation are consistent with the provided marker list.

### Step 2: Mixed Cell Type Consideration
- The annotation identifies the cell type as primarily **HER2-positive Breast Cancer Cells**, supported by the presence of key markers such as **ERBB2**, **GRB7**, and **STARD3**.
- The analysis also considers the possibility of **Luminal B Breast Cancer Cells** and **Basal-like Breast Cancer Cells** based on the expression of other markers like **TFAP2B** and **HSPB1**.
- The presence of multiple markers associated with different breast cancer subtypes suggests a potential mixed cell population. However, the strong presence of **ERBB2**, **GRB7**, and **STARD3** strongly supports the primary identification of **HER2-positive Breast Cancer Cells**.

### Conclusion
The annotation is consistent with the provided marker list and the identified cell type is well-supported by the markers. The potential for mixed cell types is acknowledged, but the primary identification remains valid.

Validation result: VALIDATION PASSED | Formatting Agent: {
  ""main_cell_type"": ""cancerous epithelial cell"",
  ""sub_cell_types"": [
    ""HER2-positive Breast Cancer Cells"",
    ""Luminal B Breast Cancer Cells"",
    ""Basal-like Breast Cancer Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_34,Breast Cancer Cell,"Breast Cancer Epithelial Cells, Breast Cancer Stem-like Cells, Breast Cancer Proliferative Cells",,50,"MTCO2P12, H3-3A, H2BC12, H2AJ, H3-3B, PRXL2A, H1-2, H1-0, NIBAN2, H2AC6, PLAAT3, RBIS, H2AW, H1-10, H2AZ1, PLAAT4, NCBP2AS2, MACROH2A1, GARS1, MARCHF5, MICOS10, IARS1, ZNRD2, H2AZ2, ADSS2, LARS1, TUG1, ALDOA, NARS1, MIR570HG, MTLN, ANTKMT, MARCHF6, TLE5, DARS1, RO60, SEPTIN9, CIAO2B, SEPTIN2, GET3, MICOS13, NME2, FAM174C, SARS1, ATP6V0C, WBP1, MTRNR2L12, ZC3H11A, UQCRHL, GABARAP",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **Histone Genes (H3-3A, H2BC12, H2AJ, H3-3B, H1-2, H1-0, H2AC6, H2AW, H1-10, H2AZ1, H2AZ2, MACROH2A1):** These genes are involved in chromatin structure and regulation of gene expression. Histone variants can be indicative of proliferative or undifferentiated states.
- **Ribosomal and Translation-related Genes (GARS1, IARS1, LARS1, NARS1, DARS1, SARS1):** These aminoacyl-tRNA synthetases are crucial for protein synthesis, often upregulated in rapidly dividing cells.
- **Metabolic and Mitochondrial Genes (MTCO2P12, ALDOA, MTLN, UQCRHL):** These genes are involved in energy production and metabolic processes, which are typically upregulated in cells with high metabolic activity.
- **Ubiquitination and Protein Degradation (MARCHF5, MARCHF6, GABARAP):** These genes are involved in protein turnover and autophagy, processes that are often active in cancer cells.
- **RNA Processing and Stability (TUG1, ZNRD2, RO60):** These genes are involved in RNA processing and stability, which can be critical in cancer cell survival and proliferation.

### Step 2: List the Key Cell Type Markers
- **NIBAN2 (also known as FAM129A):** Often associated with stress response and has been implicated in cancer cell survival.
- **PLAAT3 and PLAAT4:** Involved in lipid metabolism, which can be altered in cancer cells.
- **SEPTIN9 and SEPTIN2:** Part of the septin family, involved in cell division and cytoskeletal organization, often upregulated in cancer cells.
- **MICOS10 and MICOS13:** Part of the mitochondrial contact site and cristae organizing system, important for mitochondrial function, often altered in cancer cells.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and recent literature, we can cross-reference these markers:
- **Histone and ribosomal genes** are often upregulated in proliferative cells, including cancer cells.
- **NIBAN2, SEPTIN9, and SEPTIN2** have been associated with various cancer types, including breast cancer, indicating a possible cancerous or proliferative cell type.

### Step 4: Determine the Most Probable General Cell Type
Given the high expression of histone genes, ribosomal proteins, and cancer-associated markers like NIBAN2 and SEPTIN9, the most probable general cell type is a **cancer cell**, specifically a **breast cancer cell**.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Breast Cancer Epithelial Cells:** Given the expression of histone variants and ribosomal proteins, these cells are likely to be rapidly dividing epithelial cancer cells.
2. **Breast Cancer Stem-like Cells:** The presence of histone variants and metabolic genes could indicate a stem-like, undifferentiated state.
3. **Breast Cancer Proliferative Cells:** The expression of SEPTIN9 and other cell division-related genes suggests a highly proliferative cancer cell type.

The most likely subtype, based on the markers, is **Breast Cancer Epithelial Cells**, as these markers align with a profile of rapidly dividing cancerous epithelial cells.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of breast cancer epithelial cells. The high expression of histone genes, ribosomal proteins, and cancer-associated markers like NIBAN2 and SEPTIN9 supports this annotation. These cells are characterized by high proliferation rates and altered metabolic activity, typical of cancerous epithelial cells in breast tissue.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result aligns well with the provided marker list and the context of breast cancer tissue. Here's the breakdown of the validation:

1. **Marker Consistency:**
   - The markers used in the annotation are present in the provided marker list. Key markers such as histone genes (e.g., H3-3A, H2BC12), ribosomal and translation-related genes (e.g., GARS1, IARS1), and cancer-associated markers (e.g., NIBAN2, SEPTIN9) are all included in the list.
   - The identified cell type, ""breast cancer epithelial cells,"" is consistent with the expression of these markers, which are indicative of proliferative and cancerous states.

2. **Mixed Cell Type Consideration:**
   - The annotation considers the possibility of subtypes within the cancer cell population, such as breast cancer stem-like cells and proliferative cells. However, the primary annotation as ""breast cancer epithelial cells"" is strongly supported by the high-ranking markers.
   - There is no strong evidence of distinct, non-cancerous cell types based on the provided markers, so the annotation does not require flagging for mixed cell types.

Overall, the annotation is well-supported by the marker list and the context of the dataset, leading to a valid conclusion of breast cancer epithelial cells as the primary cell type. | Formatting Agent: {
  ""main_cell_type"": ""Breast Cancer Cell"",
  ""sub_cell_types"": [
    ""Breast Cancer Epithelial Cells"",
    ""Breast Cancer Stem-like Cells"",
    ""Breast Cancer Proliferative Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_35,Endothelial Cells,"Vascular Endothelial Cells, Lymphatic Endothelial Cells, Tip Cells",,50,"VWF, CXorf36, PCDH17, EMCN, CLEC14A, CDH5, MMRN2, CD34, PLVAP, PTPRB, AQP1, ADGRL4, ECSCR, RAMP3, TIE1, ADGRF5, NOTCH4, ESAM, CLDN5, CALCRL, SOX18, HSPG2, PECAM1, KDR, EGFL7, RAMP2, IGFBP7, CD93, GNG11, COL4A1, PODXL, A2M, FLT1, COL15A1, SPARCL1, ENG, COL4A2, HEG1, SPRY1, PALMD, SPARC, S1PR1, PCAT19, ICAM2, CAV1, TCF4, EPAS1, SLC9A3R2, HYAL2, TGFBR2",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell RNA sequencing dataset of breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **VWF (von Willebrand factor):** A glycoprotein involved in hemostasis, typically expressed in endothelial cells.
- **CD34:** A cell surface glycoprotein often used as a marker for hematopoietic progenitor cells and endothelial cells.
- **PECAM1 (CD31):** An adhesion molecule expressed on endothelial cells and involved in leukocyte transmigration.
- **KDR (VEGFR2):** A receptor for vascular endothelial growth factor, crucial for angiogenesis, typically expressed in endothelial cells.
- **FLT1 (VEGFR1):** Another receptor for VEGF, involved in angiogenesis and endothelial cell function.
- **NOTCH4:** Part of the Notch signaling pathway, important in vascular development and endothelial cell function.
- **ESAM (Endothelial cell-selective adhesion molecule):** Involved in endothelial cell junctions and angiogenesis.
- **PLVAP (Plasmalemma vesicle-associated protein):** Associated with fenestral diaphragms of endothelial cells.
- **TIE1 and TIE2 (TEK):** Receptors involved in angiogenesis and endothelial cell survival.
- **ENG (Endoglin):** A component of the TGF-beta receptor complex, expressed in endothelial cells.
- **SPARC (Secreted protein acidic and rich in cysteine):** Involved in tissue remodeling and angiogenesis.

### Step 2: List the Key Cell Type Markers
- **VWF, CD34, PECAM1, KDR, FLT1, NOTCH4, ESAM, PLVAP, TIE1, ENG:** These markers are strongly indicative of endothelial cells, which line blood vessels and are involved in angiogenesis.
- **CLEC14A, EMCN (Endomucin), CDH5 (VE-cadherin), CLDN5 (Claudin-5):** Additional markers supporting endothelial identity, involved in cell adhesion and vascular integrity.

### Step 3: Cross-reference Known Databases
- **Human Protein Atlas and PanglaoDB:** These databases confirm that the expression of VWF, CD34, PECAM1, KDR, FLT1, and other markers are characteristic of endothelial cells.
- **Literature Review:** Studies on breast cancer microenvironment often highlight the role of endothelial cells in tumor angiogenesis, supporting the presence of these markers in endothelial cells within breast cancer tissue.

### Step 4: Determine the Most Probable General Cell Type
- **Endothelial Cells:** The expression of VWF, CD34, PECAM1, KDR, FLT1, and other endothelial-specific markers strongly suggests that the general cell type is endothelial cells.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Vascular Endothelial Cells:** Given the high expression of angiogenesis-related markers (e.g., KDR, FLT1, TIE1), these are likely the most prevalent subtype.
2. **Lymphatic Endothelial Cells:** Markers like PROX1 and LYVE1, which are not listed here, would be more specific, but the presence of general endothelial markers could still suggest a subset of lymphatic endothelial cells.
3. **Tip Cells:** These are specialized endothelial cells involved in sprouting angiogenesis, characterized by high expression of VEGF receptors and other angiogenic markers.

### Step 6: Provide a Concise Summary of Your Analysis
The ranked marker list from the breast cancer tissue dataset predominantly features markers associated with endothelial cells, particularly those involved in angiogenesis. The presence of VWF, CD34, PECAM1, KDR, FLT1, and other related markers strongly indicates that the cell cluster is composed of endothelial cells. Within this general cell type, the most probable subtypes are vascular endothelial cells, potentially involved in tumor angiogenesis, followed by lymphatic endothelial cells and tip cells.

**Most Likely Subtype:** Vascular Endothelial Cells

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. The markers listed in the annotation, such as VWF, CD34, PECAM1, KDR, FLT1, NOTCH4, ESAM, PLVAP, TIE1, ENG, and SPARC, are all present in the provided marker list and are well-known markers for endothelial cells. The additional markers mentioned, such as CLEC14A, EMCN, CDH5, and CLDN5, further support the endothelial identity.

The annotation correctly identifies the general cell type as endothelial cells, which is supported by the high-ranking markers associated with angiogenesis and endothelial cell function. The consideration of subtypes such as vascular endothelial cells, lymphatic endothelial cells, and tip cells is reasonable given the context and the expression of angiogenesis-related markers.

There is no indication of mixed cell types that would require further investigation, as the markers strongly support a single cell type identity. Therefore, the annotation is validated as accurate and consistent with the provided data. | Formatting Agent: {
  ""main_cell_type"": ""Endothelial Cells"",
  ""sub_cell_types"": [
    ""Vascular Endothelial Cells"",
    ""Lymphatic Endothelial Cells"",
    ""Tip Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_36,epithelial cells,"cancerous luminal epithelial cells, luminal epithelial cells, basal epithelial cells",cancerous epithelial cells,50,"AREG, TGM2, TMC5, ITGA2, USP53, AQP3, TNFRSF12A, TCIM, S100A6, C15orf48, STC2, TFPI, ITGB6, ANXA3, CD59, SAT1, ERRFI1, TM4SF1, MGLL, BATF, S100A14, DNAJC12, SYTL2, UGDH, HIGD1A, SQOR, FHL2, GCLM, ARHGAP29, KRT7, ACTN1, CXCL1, SOD2, ISG20, CXCL8, PDLIM5, RPS17, IER3, UGCG, PALLD, AZGP1, PAWR, VMP1, S100A16, BZW1, CXCL3, TACSTD2, HIF1A, LRRFIP1, CARHSP1",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type from the provided ranked marker list, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **AREG (Amphiregulin):** A member of the epidermal growth factor (EGF) family, involved in cell proliferation and differentiation.
- **TGM2 (Transglutaminase 2):** Involved in apoptosis, cell adhesion, and extracellular matrix stabilization.
- **ITGA2 (Integrin alpha-2):** Plays a role in cell adhesion and recognition in various processes including embryogenesis, hemostasis, tissue repair, immune response, and metastatic spread of tumor cells.
- **AQP3 (Aquaporin 3):** A water channel protein, also facilitates the transport of glycerol and other small solutes.
- **TNFRSF12A (Tumor necrosis factor receptor superfamily member 12A):** Involved in the regulation of cell death and survival.
- **S100A6, S100A14, S100A16:** Members of the S100 family, involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation.
- **CXCL1, CXCL8, CXCL3:** Chemokines involved in the recruitment of immune cells to sites of inflammation.
- **HIF1A (Hypoxia-inducible factor 1-alpha):** A transcription factor that responds to changes in available oxygen in the cellular environment, crucial for cellular response to hypoxia.

### Step 2: List the Key Cell Type Markers
- **KRT7 (Keratin 7):** Typically expressed in epithelial cells, particularly in glandular and transitional epithelia.
- **ITGB6 (Integrin beta-6):** Often expressed in epithelial cells and involved in epithelial cell adhesion and signaling.
- **ANXA3 (Annexin A3):** Expressed in epithelial cells and involved in membrane-related events along exocytotic and endocytotic pathways.
- **TM4SF1 (Transmembrane 4 L six family member 1):** Expressed in epithelial cells and associated with cell proliferation and motility.
- **TACSTD2 (Tumor-associated calcium signal transducer 2):** Also known as Trop2, a marker for epithelial cells, particularly in cancerous tissues.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, these markers are cross-referenced to confirm their association with specific cell types. The presence of epithelial markers like KRT7, ITGB6, and TACSTD2 strongly suggests an epithelial origin, likely from glandular tissue.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of epithelial markers (KRT7, ITGB6, TACSTD2) and functional markers associated with epithelial cell functions (AREG, ITGA2, TM4SF1), the most probable general cell type is **epithelial cells**.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal Epithelial Cells:** Given the expression of KRT7 and TACSTD2, which are often found in luminal epithelial cells of the breast.
2. **Basal Epithelial Cells:** Although less likely due to the lack of specific basal markers, the presence of integrins could suggest a basal phenotype.
3. **Cancerous Epithelial Cells:** The presence of markers like TACSTD2 and AREG, which are often upregulated in cancer, suggests a cancerous epithelial subtype.

The most likely subtype, considering the context of breast cancer tissue and the expression of these markers, is **cancerous luminal epithelial cells**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of epithelial cells, specifically cancerous luminal epithelial cells. This conclusion is supported by the expression of key epithelial markers such as KRT7, ITGB6, and TACSTD2, along with functional markers like AREG and ITGA2, which are associated with epithelial cell proliferation and cancer.

FINAL ANNOTATION COMPLETED | Coupling Validator: To validate the annotation result, let's follow the outlined steps:

### Step 1: Marker Consistency
- The provided marker list includes: AREG, TGM2, ITGA2, AQP3, TNFRSF12A, S100A6, S100A14, S100A16, CXCL1, CXCL8, CXCL3, HIF1A, KRT7, ITGB6, ANXA3, TM4SF1, and TACSTD2.
- All markers mentioned in the annotation result are present in the provided marker list.
- The markers are consistent with the identified cell type, as they are associated with epithelial cells and functions related to epithelial cell biology, such as proliferation, adhesion, and cancer.

### Step 2: Mixed Cell Type Consideration
- The annotation suggests a primary identification of epithelial cells, specifically cancerous luminal epithelial cells.
- The presence of markers like KRT7, ITGB6, and TACSTD2 strongly supports an epithelial origin.
- There is no strong evidence of multiple distinct cell types based on the high-ranking markers provided. The markers predominantly support an epithelial cell type, particularly in a cancerous context.

### Conclusion
The annotation result is consistent with the provided marker list and the identified cell type. There is no indication of a mixed cell type population that requires further investigation.

Validation result: VALIDATION PASSED | Formatting Agent: {
  ""main_cell_type"": ""epithelial cells"",
  ""sub_cell_types"": [
    ""cancerous luminal epithelial cells"",
    ""luminal epithelial cells"",
    ""basal epithelial cells""
  ],
  ""possible_mixed_cell_types"": [
    ""cancerous epithelial cells""
  ],
  ""num_markers"": 50
}"
cluster_37,epithelial cells,"luminal epithelial cells, basal epithelial cells, cancerous epithelial cells",,50,"SEPP1, MTL5, GNB2L1, GLTSCR2, ATP5B, WHSC1L1, FAM60A, STRA13, MMP24-AS1, C21orf59, C17orf89, ATP5A1, PVRL2, RTFDC1, FAM195B, SEPW1, C14orf166, ATP5D, C19orf60, C20orf24, ATP5I, C16orf13, APOA1BP, C19orf43, ATP5G3, SEP15, ATP5F1, ATP5O, GBAS, WBSCR22, ATP5G2, LINC01420, ATP5E, C7orf73, TCEB1, SELK, VIMP, ATP5H, HN1, ATP5J, ATP5C1, LINC00493, MYEOV2, TCEB2, ATPIF1, C11orf31, SCGB1D2, ATP5G1, C14orf2, ATP5L",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell RNA sequencing dataset of breast cancer tissue, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
The list contains several genes associated with specific cellular functions or pathways:

- **ATP Synthase Subunits (ATP5B, ATP5A1, ATP5D, ATP5I, ATP5G3, ATP5F1, ATP5O, ATP5G2, ATP5E, ATP5H, ATP5J, ATP5C1, ATP5L):** These genes encode subunits of ATP synthase, a critical enzyme in the mitochondrial electron transport chain responsible for ATP production. High expression of these genes suggests a high metabolic activity, often seen in cells with high energy demands.

- **GNB2L1 (RACK1):** This gene encodes a protein involved in various signaling pathways, including those regulating cell growth and apoptosis.

- **SEPP1 (Selenoprotein P):** This gene encodes a selenium transport protein, which plays a role in antioxidant defense and cellular protection against oxidative stress.

- **MTL5 (Metallothionein-like 5):** This gene is involved in metal ion binding and detoxification, which can be crucial in cellular stress responses.

- **WHSC1L1 (Wolf-Hirschhorn Syndrome Candidate 1-Like 1):** This gene is involved in chromatin modification and transcriptional regulation.

### Step 2: List the Key Cell Type Markers
The list includes several genes that can be associated with specific cell types:

- **SCGB1D2 (Secretoglobin Family 1D Member 2):** This gene is often expressed in secretory epithelial cells, particularly in the mammary gland, suggesting a possible epithelial origin.

- **PVRL2 (Poliovirus Receptor-Related 2):** This gene is involved in cell adhesion and is often expressed in epithelial cells.

- **APOA1BP (Apolipoprotein A-I Binding Protein):** This gene is involved in lipid metabolism and is often expressed in cells involved in lipid transport and metabolism.

### Step 3: Cross-reference Known Databases
Using scRNA-seq databases such as the Human Cell Atlas and literature on breast cancer tissue, we can cross-reference these markers:

- **Epithelial Cells:** The presence of SCGB1D2 and PVRL2 suggests an epithelial origin, which is consistent with the tissue of origin (breast cancer).

- **High Metabolic Activity:** The high expression of ATP synthase subunits indicates cells with high energy demands, which is typical of cancer cells.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of these markers, the most likely general cell type is **epithelial cells**. This is supported by the presence of SCGB1D2 and PVRL2, which are commonly expressed in epithelial cells of the mammary gland.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
Within the general category of epithelial cells, the top three most probable sub cell types are:

1. **Luminal Epithelial Cells:** These cells are characterized by the expression of secretory proteins like SCGB1D2 and are common in breast tissue.
2. **Basal Epithelial Cells:** These cells may also express some of the metabolic markers due to their role in tissue regeneration and repair.
3. **Cancerous Epithelial Cells:** Given the context of breast cancer tissue, these cells may exhibit high metabolic activity and altered expression of typical epithelial markers.

The most likely subtype, based on the markers, is **luminal epithelial cells**, given the expression of SCGB1D2 and the context of breast tissue.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of epithelial cells, specifically luminal epithelial cells. This conclusion is supported by the expression of SCGB1D2 and PVRL2, which are indicative of epithelial origin, and the high expression of ATP synthase subunits, suggesting high metabolic activity typical of cancerous cells.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the context of breast cancer tissue. Here's the breakdown of the validation:

1. **Marker Consistency:**
   - The markers used in the annotation, such as SCGB1D2, PVRL2, and ATP synthase subunits (e.g., ATP5B, ATP5A1, ATP5D), are present in the provided marker list.
   - The identified cell type, epithelial cells, particularly luminal epithelial cells, is consistent with the expression of SCGB1D2 and PVRL2, which are known markers for epithelial cells in the mammary gland.

2. **Mixed Cell Type Consideration:**
   - The annotation does not strongly suggest the presence of multiple distinct cell types. The markers predominantly support the identification of epithelial cells, specifically luminal epithelial cells, which aligns with the context of breast cancer tissue.
   - The high metabolic activity indicated by ATP synthase subunits is typical of cancerous cells, further supporting the annotation of cancerous epithelial cells.

Overall, the annotation is well-supported by the marker list and the context provided, leading to a valid conclusion of luminal epithelial cells in breast cancer tissue. | Formatting Agent: {
  ""main_cell_type"": ""epithelial cells"",
  ""sub_cell_types"": [
    ""luminal epithelial cells"",
    ""basal epithelial cells"",
    ""cancerous epithelial cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_39,Cancer Cells with High Metabolic Activity,"Cancer Cells with Erythroid-like Features, Myoepithelial-like Cancer Cells, High Metabolic Activity Cancer Cells",,50,"TCEB2, SHFM1, C11orf31, ATP5L, USMG5, ATP5J2, TCEB1, ATP5E, SELM, ATP5C1, ATP5J, GNB2L1, SEPW1, WBP5, C14orf2, LINC00998, FAM127B, ATP5G3, APOA1BP, ATP5I, NGFRAP1, TMEM261, ATP5O, HN1, C7orf73, ATP5G2, C11orf73, C16orf13, LINC00493, MYEOV2, GBAS, ATP5A1, C19orf43, ATPIF1, VIMP, ATP5F1, ATP5H, AC090498.1, ATP5G1, C14orf166, FAM60A, SELK, SELT, WBSCR22, ATP5B, SEP15, STRA13, HBA2, C20orf24, S100A1",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
The list contains several genes associated with mitochondrial function and oxidative phosphorylation, which are crucial for energy production in cells. These include:
- **ATP5L, ATP5J2, ATP5E, ATP5C1, ATP5J, ATP5G3, ATP5I, ATP5O, ATP5G2, ATP5A1, ATP5F1, ATP5H, ATP5G1, ATP5B**: These genes encode subunits of ATP synthase, a key enzyme in the mitochondrial electron transport chain responsible for ATP production.
- **USMG5, APOA1BP, ATPIF1**: These are involved in mitochondrial function and regulation of ATP synthase activity.
- **GNB2L1 (RACK1)**: Involved in various signaling pathways and may play a role in cellular stress responses.
- **SELM, SEPW1, SELK, SELT, SEP15**: These are selenoproteins involved in antioxidant defense and redox homeostasis.

### Step 2: List the Key Cell Type Markers
- **HBA2**: Hemoglobin subunit alpha, typically associated with erythroid lineage cells.
- **S100A1**: A member of the S100 protein family, often associated with muscle cells, including cardiac and skeletal muscle, and sometimes with certain cancer cells.
- **NGFRAP1**: Involved in apoptosis and may be expressed in various cell types, including neurons and some cancer cells.

### Step 3: Cross-reference Known Databases
Using scRNA-seq databases such as the Human Cell Atlas and literature on breast cancer tissue, we can cross-reference these markers:
- The high expression of ATP synthase subunits suggests a cell type with high metabolic activity, common in cancer cells.
- **HBA2** expression is unusual in breast tissue but may indicate erythroid lineage contamination or a specific cancer cell phenotype.
- **S100A1** expression could suggest a myoepithelial or muscle-like phenotype, which can be present in certain breast cancer subtypes.

### Step 4: Determine the Most Probable General Cell Type
Given the high expression of mitochondrial and oxidative phosphorylation-related genes, the general cell type is likely a cancer cell with high metabolic demands. The presence of **HBA2** and **S100A1** suggests a specialized or aberrant phenotype within the cancer context.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Cancer Cells with Erythroid-like Features**: The presence of **HBA2** suggests a possible erythroid-like phenotype, which can occur in some cancer cells due to aberrant gene expression.
2. **Myoepithelial-like Cancer Cells**: The expression of **S100A1** could indicate a myoepithelial-like phenotype, which is sometimes observed in breast cancer.
3. **High Metabolic Activity Cancer Cells**: The overall expression profile suggests a highly metabolically active cancer cell, possibly a subtype with increased oxidative phosphorylation.

### Step 6: Provide a Concise Summary of Your Analysis
The cell cluster is most likely composed of cancer cells with high metabolic activity, as indicated by the expression of numerous ATP synthase subunits. The presence of **HBA2** and **S100A1** suggests potential erythroid-like and myoepithelial-like features, respectively. The most probable subtype is a cancer cell with erythroid-like features, given the unusual expression of **HBA2** in breast tissue.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**: 
   - The markers used in the annotation, such as ATP5L, ATP5J2, ATP5E, ATP5C1, ATP5J, ATP5G3, ATP5I, ATP5O, ATP5G2, ATP5A1, ATP5F1, ATP5H, ATP5G1, ATP5B, USMG5, APOA1BP, ATPIF1, GNB2L1, SELM, SEPW1, SELK, SELT, SEP15, HBA2, S100A1, and NGFRAP1, are all present in the provided marker list.
   - The markers related to mitochondrial function and oxidative phosphorylation (e.g., ATP synthase subunits) support the identification of a cell type with high metabolic activity, which is typical for cancer cells.

2. **Mixed Cell Type Consideration**:
   - The annotation considers the possibility of mixed cell types by identifying potential erythroid-like and myoepithelial-like features within the cancer cell population. This is supported by the presence of markers such as HBA2 and S100A1, which are unusual for breast tissue but can indicate specific cancer phenotypes or contamination.
   - The annotation appropriately flags these features for further investigation, acknowledging the complexity of cancer cell phenotypes.

Overall, the annotation is well-supported by the marker list and provides a plausible explanation for the observed gene expression patterns in the context of breast cancer tissue. | Formatting Agent: {
  ""main_cell_type"": ""Cancer Cells with High Metabolic Activity"",
  ""sub_cell_types"": [
    ""Cancer Cells with Erythroid-like Features"",
    ""Myoepithelial-like Cancer Cells"",
    ""High Metabolic Activity Cancer Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_4,T cells,"Cytotoxic T Cells (CD8+ T Cells), Helper T Cells (CD4+ T Cells), Regulatory T Cells (Tregs)",,50,"PTPRCAP, SEPTIN1, CD3E, MTCO2P12, SEPTIN6, ZAP70, H3-3B, IL2RB, CD7, CD2, PLAAT4, RESF1, LCK, CD3D, SPOCK2, CCL5, CST7, RAC2, IL2RG, CD52, TBC1D10C, SEPTIN9, TRBC2, CD247, LAT, H3-3A, CD27, CD3G, CORO1A, SEPTIN7, TRBC1, H4C3, LTB, IFITM1, IL32, LIMD2, TRAF3IP3, HCST, PTPRC, GIMAP7, ACAP1, CD37, H2AZ1, LCP2, TRAC, CD69, GIMAP4, LSP1, FYB1, DUSP2",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **ZAP70**: A tyrosine kinase involved in T-cell receptor signaling.
- **LCK**: A tyrosine kinase that plays a crucial role in T-cell activation.
- **LAT**: A linker for activation of T cells, involved in T-cell receptor signaling.
- **IL2RB**: Part of the receptor for interleukin-2, important for T-cell proliferation.
- **IL2RG**: Common gamma chain, part of multiple interleukin receptors, crucial for lymphocyte development.
- **RAC2**: A small GTPase involved in the regulation of cell migration and immune response.
- **TRAF3IP3**: Involved in T-cell receptor signaling.
- **FYB1**: An adapter protein involved in T-cell receptor signaling.

### Step 2: List the Key Cell Type Markers
- **CD3E, CD3D, CD3G**: Components of the CD3 complex, essential for T-cell receptor signaling, indicating T cells.
- **CD2**: A surface protein found on T cells and natural killer cells.
- **CD7**: A marker found on T cells and natural killer cells.
- **CD247 (CD3Z)**: Part of the T-cell receptor-CD3 complex.
- **TRBC1, TRBC2, TRAC**: T-cell receptor beta and alpha chain components, specific to T cells.
- **CD27**: A member of the TNF receptor family, expressed on T cells.
- **CD52**: A glycoprotein found on the surface of mature lymphocytes.
- **PTPRCAP**: Associated with T-cell activation.
- **CCL5**: A chemokine involved in recruiting T cells to sites of inflammation.
- **CST7**: Cystatin F, expressed in cytotoxic T cells and natural killer cells.
- **GIMAP4, GIMAP7**: GTPases involved in T-cell survival and development.

### Step 3: Cross-reference Known Databases
Using databases such as CellMarker, PanglaoDB, and the Human Protein Atlas, the markers listed are predominantly associated with T cells. The presence of CD3 complex components, T-cell receptor chains, and T-cell signaling molecules strongly suggests a T-cell identity.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of these markers, the most likely general cell type of the cluster is **T cells**. The presence of multiple T-cell receptor components and signaling molecules specific to T cells supports this conclusion.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Cytotoxic T Cells (CD8+ T Cells)**: The presence of markers like CST7 and RAC2, which are associated with cytotoxic functions, suggests this subtype.
2. **Helper T Cells (CD4+ T Cells)**: The expression of IL2RB and IL2RG, which are important for T-cell proliferation and function, could indicate helper T cells.
3. **Regulatory T Cells (Tregs)**: Although not directly indicated by the markers, the presence of CD27 and IL2RG could suggest a regulatory role.

The most likely subtype based on the markers is **Cytotoxic T Cells (CD8+ T Cells)**, given the presence of CST7 and other markers associated with cytotoxic activity.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of T cells, specifically cytotoxic T cells. This conclusion is supported by the presence of T-cell receptor components, signaling molecules, and markers associated with cytotoxic functions.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**: 
   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. 
   - Markers such as CD3E, CD3D, CD3G, CD2, CD7, CD247, TRBC1, TRBC2, TRAC, and others are consistent with T-cell identity.
   - Functional markers like ZAP70, LCK, LAT, IL2RB, IL2RG, RAC2, and others are involved in T-cell receptor signaling and activation, supporting the T-cell annotation.

2. **Mixed Cell Type Consideration**:
   - The annotation considers potential subtypes within the T-cell population, such as cytotoxic T cells, helper T cells, and regulatory T cells.
   - The presence of markers like CST7 and RAC2 supports the identification of cytotoxic T cells as the most likely subtype.
   - There is no strong evidence of mixed cell types beyond the T-cell subtypes, as the markers predominantly indicate T-cell identity.

The annotation is well-supported by the marker list and the analysis steps, leading to a valid conclusion of T cells, specifically cytotoxic T cells, as the primary cell type in the cluster. | Formatting Agent: {
  ""main_cell_type"": ""T cells"",
  ""sub_cell_types"": [
    ""Cytotoxic T Cells (CD8+ T Cells)"",
    ""Helper T Cells (CD4+ T Cells)"",
    ""Regulatory T Cells (Tregs)""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_38,myoepithelial cells,"basal epithelial cells, smooth muscle cells",,50,"COL17A1, C2orf40, TAGLN, SYT8, MYH11, PTN, KRT17, MYLK, ACTA2, GRP, KRT14, APOE, CALML3, LTBP2, DST, MYL9, FBXO32, DKK3, A2M, PPP1R14A, TPM2, SAA1, S100A2, TSHZ2, ACTG2, MIA, BHLHE41, KRT5, LAMB3, TNC, NTRK2, CALD1, ANO1, SPARCL1, NNMT, TINAGL1, MT1E, FBXO2, MT1X, MT2A, SNCG, CC2D1A, CRYAB, ITGA2, PDLIM4, SEMA3C, SCPEP1, NPC2, SFRP1, PRNP",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **COL17A1**: Known for its role in cell adhesion and maintaining the integrity of epithelial cells.
- **TAGLN (Transgelin)**: Associated with smooth muscle cells and involved in actin binding.
- **MYH11 (Myosin Heavy Chain 11)**: A marker for smooth muscle cells, involved in muscle contraction.
- **ACTA2 (Alpha-Smooth Muscle Actin)**: A classic marker for smooth muscle cells, involved in muscle contraction.
- **MYLK (Myosin Light Chain Kinase)**: Involved in muscle contraction and regulation of actin-myosin interactions.
- **CALD1 (Caldesmon 1)**: Involved in smooth muscle contraction.
- **TPM2 (Tropomyosin 2)**: Involved in muscle contraction.
- **ACTG2 (Actin Gamma 2)**: Associated with smooth muscle contraction.
- **ANO1 (Anoctamin 1)**: Involved in calcium-activated chloride channel activity, often found in smooth muscle cells.

### Step 2: List the Key Cell Type Markers
- **KRT17 (Keratin 17)**: Typically expressed in epithelial cells, particularly in basal cells of stratified epithelia.
- **KRT14 (Keratin 14)**: A marker for basal epithelial cells, often found in the basal layer of the epidermis.
- **KRT5 (Keratin 5)**: Another marker for basal epithelial cells, often co-expressed with KRT14.
- **S100A2**: Often expressed in epithelial cells and associated with cell differentiation.
- **LAMB3 (Laminin Subunit Beta 3)**: Part of the basement membrane, associated with epithelial cells.
- **DST (Dystonin)**: Involved in cytoskeletal organization, often found in epithelial cells.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, we can cross-reference these markers:
- **Smooth Muscle Markers**: MYH11, ACTA2, TAGLN, MYLK, CALD1, TPM2, ACTG2, ANO1 are strongly indicative of smooth muscle cells.
- **Basal Epithelial Markers**: KRT17, KRT14, KRT5, LAMB3, DST suggest a basal epithelial cell type, often found in the basal layer of stratified epithelia.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of these markers, the most probable general cell type is **myoepithelial cells**. Myoepithelial cells are known to express both smooth muscle markers (such as ACTA2, MYH11) and basal epithelial markers (such as KRT14, KRT5).

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Myoepithelial Cells**: Given the strong expression of both smooth muscle and basal epithelial markers, myoepithelial cells are the most likely subtype.
2. **Basal Epithelial Cells**: The presence of KRT14, KRT5, and KRT17 suggests basal epithelial cells as a possible subtype.
3. **Smooth Muscle Cells**: The expression of smooth muscle markers like MYH11 and ACTA2 could also indicate smooth muscle cells, although the presence of epithelial markers makes this less likely.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of myoepithelial cells. This conclusion is supported by the co-expression of smooth muscle markers (e.g., ACTA2, MYH11) and basal epithelial markers (e.g., KRT14, KRT5). Myoepithelial cells are known to play a role in the contractile function of glandular tissues and are commonly found in breast tissue.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation of the cell cluster as myoepithelial cells is consistent with the provided marker list and the analysis steps outlined. Here's the breakdown:

1. **Marker Consistency**:
   - The markers used in the annotation (e.g., MYH11, ACTA2, TAGLN, KRT14, KRT5) are present in the provided marker list.
   - The identified cell type, myoepithelial cells, is consistent with the expression of both smooth muscle markers (e.g., MYH11, ACTA2) and basal epithelial markers (e.g., KRT14, KRT5).

2. **Mixed Cell Type Consideration**:
   - The analysis acknowledges the potential presence of basal epithelial cells and smooth muscle cells as subtypes, which is appropriate given the expression of their respective markers.
   - The conclusion that myoepithelial cells are the most likely cell type is well-supported by the co-expression of markers from both smooth muscle and basal epithelial categories.

Overall, the annotation is well-supported by the marker data and the analysis steps, and no significant issues were identified that would warrant a revision. | Formatting Agent: {
  ""main_cell_type"": ""myoepithelial cells"",
  ""sub_cell_types"": [
    ""basal epithelial cells"",
    ""smooth muscle cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_40,Mammary Epithelial Cells,"Luminal Epithelial Cells, Basal/Myoepithelial Cells, Ductal Epithelial Cells",,50,"PIP, MUCL1, CRIP1, AZGP1, AC093001.1, HIST1H1C, IGFBP5, SCGB2A2, CRIP2, RPL36A, MIF, CALML5, ECHS1, HSPB1, PCBD1, CYB5A, MGP, RPS26, POLR2L, RPL31, RPLP0, NME4, LGALS1, ATP5IF1, SMIM22, IFITM2, IFITM3, DRAP1, RPS17, BANF1, RPL13A, RPL17, UQCRQ, KRT18, ATP5MF, RPS2, RPS10, H2AFJ, BST2, COX8A, RPL27A, AP2S1, RPL41, LY6E, RPS29, SNHG8, DDT, NDUFB1, PRDX5, RPL10A",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **PIP (Prolactin Induced Protein):** Often associated with breast tissue and is known to be involved in immune response and cell signaling.
- **MUCL1 (Mucin Like 1):** Expressed in breast tissue and associated with breast cancer.
- **CRIP1 (Cysteine Rich Protein 1):** Involved in zinc ion binding and may play a role in cellular growth and differentiation.
- **AZGP1 (Alpha-2-Glycoprotein 1, Zinc-Binding):** Known to be involved in lipid metabolism and is often expressed in breast tissue.
- **IGFBP5 (Insulin Like Growth Factor Binding Protein 5):** Plays a role in cell growth, apoptosis, and is often expressed in breast tissue.
- **SCGB2A2 (Secretoglobin Family 2A Member 2):** Also known as Mammaglobin, highly specific to breast tissue and often used as a marker for breast cancer.
- **KRT18 (Keratin 18):** A type I cytokeratin, often expressed in epithelial cells, including those in the breast.

### Step 2: List the Key Cell Type Markers
- **SCGB2A2 (Mammaglobin):** Highly specific to mammary epithelial cells and often used as a marker for breast cancer.
- **PIP:** Commonly expressed in mammary gland tissue.
- **MUCL1:** Associated with breast epithelial cells.
- **KRT18:** Expressed in simple epithelial cells, including those in the breast.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, we can cross-reference these markers:
- **SCGB2A2, PIP, MUCL1, KRT18** are strongly associated with mammary epithelial cells.
- **AZGP1** is also expressed in breast tissue and is linked to lipid metabolism.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of these markers, the most likely general cell type is **mammary epithelial cells**. This is supported by the presence of SCGB2A2, PIP, MUCL1, and KRT18, which are all markers associated with breast epithelial cells.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal Epithelial Cells:** These cells are characterized by the expression of SCGB2A2, PIP, and KRT18, which are markers for luminal cells in the mammary gland.
2. **Basal/Myoepithelial Cells:** While less likely given the marker list, KRT18 can sometimes be expressed in basal cells, but the lack of specific basal markers makes this less probable.
3. **Ductal Epithelial Cells:** These cells can also express some of the markers listed, but the high expression of SCGB2A2 and PIP leans more towards luminal cells.

**Most Likely Subtype:** The most likely subtype is **Luminal Epithelial Cells** due to the strong expression of SCGB2A2, PIP, and KRT18, which are characteristic of luminal cells in the breast.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of mammary epithelial cells, specifically luminal epithelial cells. This conclusion is based on the high expression of markers such as SCGB2A2, PIP, and KRT18, which are well-documented in the literature and databases as being associated with luminal cells in the mammary gland.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency:**
   - The key functional markers listed in the annotation (PIP, MUCL1, CRIP1, AZGP1, IGFBP5, SCGB2A2, KRT18) are all present in the provided marker list.
   - The key cell type markers (SCGB2A2, PIP, MUCL1, KRT18) are also present in the marker list and are consistent with the identification of mammary epithelial cells, specifically luminal epithelial cells.

2. **Mixed Cell Type Consideration:**
   - The annotation does not suggest the presence of multiple distinct cell types strongly supported by several high-ranking markers. The markers predominantly point towards mammary epithelial cells, particularly luminal epithelial cells.
   - The analysis correctly identifies luminal epithelial cells as the most likely subtype based on the strong expression of SCGB2A2, PIP, and KRT18.

Overall, the annotation is well-supported by the marker list and aligns with known databases and literature, confirming the identification of the cell cluster as mammary epithelial cells, specifically luminal epithelial cells. | Formatting Agent: {
  ""main_cell_type"": ""Mammary Epithelial Cells"",
  ""sub_cell_types"": [
    ""Luminal Epithelial Cells"",
    ""Basal/Myoepithelial Cells"",
    ""Ductal Epithelial Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_42,B cells,"Plasma Cells, Memory B Cells, Activated B Cells",,50,"IGKV1-12, IGLL5, TXNDC5, IGLV3-1, IGHG1, JCHAIN, DERL3, MZB1, IGHG2, IGHG3, MTCO2P12, CD79A, IGKC, POU2AF1, FCRL5, TNFRSF17, ITM2C, IGHM, ZBP1, IGHG4, LIME1, PIM2, CPNE5, CD38, SEL1L3, TENT5C, MEI1, SLAMF7, FKBP11, IGLC2, SPAG4, EAF2, TXNDC11, HSH2D, UBE2J1, ST6GAL1, MAN2B1, SEPTIN6, ST6GALNAC4, SEC11C, H3-3B, CCDC69, CIAO2A, H3-3A, PDK1, H4C3, H2AZ2, NCF1, SSR4, GPX1",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **IGKV1-12, IGLL5, IGLV3-1, IGHG1, IGHG2, IGHG3, IGKC, IGHM, IGHG4**: These are immunoglobulin (Ig) genes, which are critical components of antibodies. They are involved in the immune response, specifically in antigen recognition and binding.
- **JCHAIN**: This gene encodes the joining chain of multimeric IgA and IgM, which is important for the polymerization of these immunoglobulins.
- **CD79A**: Part of the B-cell receptor complex, essential for B-cell development and signaling.
- **POU2AF1**: A transcriptional coactivator involved in B-cell-specific transcription.
- **FCRL5, TNFRSF17, SLAMF7**: These are receptors and signaling molecules associated with B-cell activation and differentiation.
- **CD38**: A multifunctional enzyme and receptor involved in cell adhesion, signal transduction, and calcium signaling, often expressed in plasma cells.
- **MZB1**: A chaperone protein involved in immunoglobulin folding and assembly, highly expressed in plasma cells.
- **ST6GAL1**: An enzyme involved in the sialylation of glycoproteins, which can be important in immune cell interactions.

### Step 2: List the Key Cell Type Markers
- **IGKV1-12, IGLL5, IGLV3-1, IGHG1, IGHG2, IGHG3, IGKC, IGHM, IGHG4**: These markers are indicative of B cells, particularly mature B cells and plasma cells.
- **CD79A**: A marker for B cells, part of the B-cell receptor complex.
- **CD38, MZB1, SLAMF7**: These are markers commonly associated with plasma cells, a differentiated form of B cells that produce antibodies.
- **POU2AF1**: Associated with B-cell lineage, particularly in the context of transcriptional regulation.

### Step 3: Cross-reference Known Databases
Using scRNA-seq databases such as the Human Cell Atlas and literature on breast cancer tissue, the expression of these markers is consistent with B cells, particularly plasma cells. Plasma cells are known to infiltrate breast cancer tissues and are involved in the immune response against tumors.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of immunoglobulin genes, CD79A, CD38, and MZB1, the most probable general cell type is **B cells**, with a strong indication towards **plasma cells** due to the high expression of immunoglobulin genes and plasma cell-specific markers.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Plasma Cells**: The high expression of immunoglobulin genes, CD38, MZB1, and SLAMF7 strongly suggests plasma cells, which are antibody-secreting cells derived from B cells.
2. **Memory B Cells**: While less likely due to the high expression of plasma cell markers, memory B cells can express some immunoglobulin genes and CD79A.
3. **Activated B Cells**: These cells can express a range of immunoglobulin genes and are involved in active immune responses, but the specific markers here lean more towards plasma cells.

The most likely subtype based on the markers is **Plasma Cells**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of plasma cells. This conclusion is supported by the high expression of immunoglobulin genes, CD38, MZB1, and other plasma cell-specific markers. Plasma cells are a differentiated form of B cells that play a crucial role in the immune response by producing antibodies, and their presence in breast cancer tissue can be indicative of an immune response to the tumor.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**: 
   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. 
   - The markers such as IGKV1-12, IGLL5, IGLV3-1, IGHG1, IGHG2, IGHG3, IGKC, IGHM, IGHG4, CD79A, CD38, MZB1, SLAMF7, and POU2AF1 are all indicative of B cells, particularly plasma cells, which aligns with the annotation.

2. **Mixed Cell Type Consideration**:
   - The annotation acknowledges the possibility of memory B cells and activated B cells but concludes that plasma cells are the most likely subtype due to the strong expression of plasma cell-specific markers. 
   - There is no strong evidence of multiple distinct cell types that would necessitate flagging for mixed cell type consideration.

The annotation correctly identifies the cell cluster as primarily composed of plasma cells, supported by the high expression of immunoglobulin genes and other plasma cell-specific markers. The analysis is thorough and aligns with known databases and literature on breast cancer tissue, confirming the presence of plasma cells in the immune response against tumors. | Formatting Agent: {
  ""main_cell_type"": ""B cells"",
  ""sub_cell_types"": [
    ""Plasma Cells"",
    ""Memory B Cells"",
    ""Activated B Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_41,macrophages,"Tumor-Associated Macrophages (TAMs), M1 Macrophages, M2 Macrophages",,50,"FYB, SQRDL, ATP5E, ATP5L, GNB2L1, ATP5G2, ATP5G3, C14orf2, ATP5J2, USMG5, SELT, ATP5D, ATP5J, ATP5O, ATP5H, TCEB2, GPX1, HN1, C19orf60, ATP5B, ATP5I, ATPIF1, ATP5C1, ATP5F1, C19orf43, ATP5G1, SPP1, ATP5A1, C11orf31, C1QB, TYROBP, APOE, SELK, SHFM1, C1QA, C1QC, LINC00493, MYEOV2, SEP15, C14orf166, APOC1, GLTSCR2, TCEB1, C7orf73, CD14, FCER1G, SEPW1, HBB, AIF1, CD68",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **ATP Synthase Complex Components (ATP5E, ATP5L, ATP5G2, ATP5G3, ATP5J2, ATP5D, ATP5J, ATP5O, ATP5H, ATP5B, ATP5I, ATP5C1, ATP5F1, ATP5A1):** These genes encode subunits of the ATP synthase complex, which is crucial for ATP production in mitochondria, indicating high metabolic activity.
- **GPX1 (Glutathione Peroxidase 1):** Involved in the detoxification of hydrogen peroxide, suggesting a role in oxidative stress response.
- **SQRDL (Sulfide Quinone Reductase-Like):** Involved in mitochondrial sulfide oxidation, indicating mitochondrial function.
- **GNB2L1 (Guanine Nucleotide Binding Protein Beta Polypeptide 2-Like 1):** Involved in signal transduction.
- **TCEB1, TCEB2 (Transcription Elongation Factor B):** Part of the transcription elongation complex, indicating active transcriptional regulation.
- **SELT (Selenoprotein T), SELK (Selenoprotein K), SEP15 (Selenoprotein 15):** Involved in redox homeostasis and protein folding.
- **SPP1 (Secreted Phosphoprotein 1):** Also known as osteopontin, involved in cell adhesion and migration.

### Step 2: List the Key Cell Type Markers
- **C1QA, C1QB, C1QC:** Components of the complement system, typically associated with immune cells, particularly macrophages.
- **TYROBP (TYRO Protein Tyrosine Kinase Binding Protein):** Associated with immune cell signaling, particularly in myeloid cells.
- **APOE (Apolipoprotein E):** Involved in lipid metabolism, often expressed in macrophages.
- **CD14, FCER1G (Fc Fragment of IgE Receptor Ig):** Markers of myeloid lineage, particularly monocytes and macrophages.
- **AIF1 (Allograft Inflammatory Factor 1):** Also known as IBA1, a marker for microglia and macrophages.
- **CD68:** A well-known marker for macrophages.
- **APOC1 (Apolipoprotein C1):** Involved in lipid metabolism, often expressed in macrophages.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Cell Atlas, PanglaoDB, and literature on breast cancer tissue, the markers C1QA, C1QB, C1QC, TYROBP, CD14, CD68, and AIF1 are strongly associated with macrophages. The presence of ATP synthase components suggests high metabolic activity, which is consistent with the energy demands of immune cells in a tumor microenvironment.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of complement components, immune signaling molecules, and macrophage-specific markers, the most probable general cell type is **macrophages**.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Tumor-Associated Macrophages (TAMs):** Given the context of breast cancer tissue, TAMs are a likely subtype due to their role in tumor progression and immune modulation.
2. **M1 Macrophages:** Characterized by pro-inflammatory activity, which may be indicated by the presence of oxidative stress markers like GPX1.
3. **M2 Macrophages:** Associated with tissue repair and anti-inflammatory responses, potentially indicated by the presence of lipid metabolism markers like APOE and APOC1.

The most likely subtype, considering the tumor context and the presence of markers like SPP1 and APOE, is **Tumor-Associated Macrophages (TAMs)**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of macrophages, specifically tumor-associated macrophages (TAMs). This conclusion is supported by the presence of complement components, macrophage-specific markers, and genes involved in lipid metabolism and oxidative stress response, which are characteristic of TAMs in the tumor microenvironment.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the context of breast cancer tissue. Here's the breakdown of the validation:

1. **Marker Consistency:**
   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. 
   - The markers associated with ATP synthase components, oxidative stress response, and lipid metabolism are consistent with high metabolic activity and immune cell function, which are relevant in the context of tumor-associated macrophages (TAMs).

2. **Mixed Cell Type Consideration:**
   - The annotation primarily identifies macrophages, specifically tumor-associated macrophages (TAMs), as the cell type. The presence of markers like C1QA, C1QB, C1QC, TYROBP, CD14, CD68, and AIF1 strongly supports this identification.
   - There is no strong evidence of multiple distinct cell types based on the high-ranking markers provided. The markers are predominantly associated with macrophages, particularly in the tumor microenvironment.

The annotation accurately reflects the likely cell type and subtype based on the marker list and the context of breast cancer tissue. Therefore, the validation is passed. | Formatting Agent: {
  ""main_cell_type"": ""macrophages"",
  ""sub_cell_types"": [
    ""Tumor-Associated Macrophages (TAMs)"",
    ""M1 Macrophages"",
    ""M2 Macrophages""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_43,Epithelial Cells,"Luminal Epithelial Cells, Basal Epithelial Cells, Myoepithelial Cells",,50,"RPS4Y1, INSR, C19orf70, ACOX2, GDF15, IFI27, CAPS, NDUFA13, AARD, HSPB1, KRT19, AGR2, NDUFA11, ISG15, ISYNA1, NR2F6, HIST1H1C, IFI6, S100A14, STARD10, KRT18, RPL36, CLDN3, ELF3, ATF3, SSBP4, USE1, KRT8, RARRES3, FKBP8, CRACR2B, CRIP1, REX1BD, CCT2, DUSP1, BABAM1, H1FX, IFITM3, SLC9A3R1, CENPX, UBA52, H3F3B, MIF, CDK4, CRABP2, ALDOA, DCXR, PLA2G16, XBP1, FAM96B",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **RPS4Y1**: A ribosomal protein, often used as a marker for male cells due to its location on the Y chromosome.
- **INSR**: Insulin receptor, involved in insulin signaling and glucose uptake.
- **GDF15**: Growth differentiation factor 15, involved in stress response and inflammation.
- **IFI27, IFI6, ISG15, IFITM3**: Interferon-induced proteins, typically associated with immune response.
- **HSPB1**: Heat shock protein, involved in stress response and protein folding.
- **NDUFA13, NDUFA11**: Components of the mitochondrial electron transport chain, indicating high metabolic activity.
- **ALDOA**: Aldolase A, involved in glycolysis.
- **XBP1**: Transcription factor involved in the unfolded protein response and endoplasmic reticulum stress.
- **CRABP2**: Cellular retinoic acid-binding protein, involved in retinoic acid signaling.

### Step 2: List the Key Cell Type Markers
- **KRT19, KRT18, KRT8**: Keratins, typically expressed in epithelial cells, including luminal epithelial cells in the breast.
- **CLDN3**: Claudin 3, a component of tight junctions, often found in epithelial cells.
- **S100A14**: A member of the S100 protein family, often associated with epithelial cells.
- **STARD10**: Involved in lipid transport, expressed in epithelial cells.
- **AGR2**: Anterior gradient 2, associated with secretory epithelial cells, including those in the breast.
- **ELF3**: Epithelial-specific transcription factor, involved in epithelial cell differentiation.
- **CRACR2B**: Calcium release-activated calcium channel regulator, expressed in various cell types, including epithelial cells.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, we can cross-reference these markers:
- **KRT19, KRT18, KRT8, CLDN3, AGR2**: Strongly associated with luminal epithelial cells in the breast.
- **INSR, GDF15, IFI27, IFI6, ISG15, IFITM3**: While some are involved in immune responses, their presence in this context may indicate stress or inflammation in epithelial cells.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of epithelial markers (KRT19, KRT18, KRT8, CLDN3, AGR2), the most probable general cell type is **epithelial cells**, specifically luminal epithelial cells, which are common in breast tissue.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal Epithelial Cells**: The presence of KRT19, KRT18, KRT8, and AGR2 strongly suggests luminal epithelial cells, which are a major component of breast tissue.
2. **Basal Epithelial Cells**: Although less likely due to the lack of specific basal markers like KRT5 or KRT14, some overlap in keratin expression can occur.
3. **Myoepithelial Cells**: While not strongly indicated, some markers like S100A14 can be expressed in myoepithelial cells, though this is less likely.

The most likely subtype, based on the markers, is **Luminal Epithelial Cells**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of luminal epithelial cells. This conclusion is supported by the high expression of epithelial-specific markers such as KRT19, KRT18, KRT8, and AGR2, which are characteristic of luminal epithelial cells in the breast. The presence of stress and immune response markers may indicate a reactive or stressed state, common in cancerous tissues.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**: 
   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. 
   - The markers such as KRT19, KRT18, KRT8, CLDN3, and AGR2 are strongly associated with epithelial cells, specifically luminal epithelial cells, which aligns with the annotation.

2. **Mixed Cell Type Consideration**:
   - The annotation acknowledges the presence of stress and immune response markers (e.g., INSR, GDF15, IFI27, IFI6, ISG15, IFITM3), which may indicate a reactive or stressed state in epithelial cells, common in cancerous tissues. 
   - There is no strong evidence of multiple distinct cell types that would necessitate flagging for mixed cell type consideration. The markers primarily support the presence of luminal epithelial cells.

The annotation is well-supported by the marker list and the analysis provided, leading to a valid conclusion of luminal epithelial cells as the most probable cell type. | Formatting Agent: {
  ""main_cell_type"": ""Epithelial Cells"",
  ""sub_cell_types"": [
    ""Luminal Epithelial Cells"",
    ""Basal Epithelial Cells"",
    ""Myoepithelial Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_45,mesenchymal cells,"Cancer-Associated Fibroblasts (CAFs), Mesenchymal Stem Cells (MSCs), Chondrocytes",,50,"IGF2, ACAN, COL2A1, PTGDS, LTO1, HSPB6, BGN, RBIS, H1-0, CRISPLD1, H3-3A, SNAI2, CRABP1, S100A1, FABP5, SDC2, ALDOA, CHI3L1, CTHRC1, MFAP2, NDRG1, H2AZ1, CIAO2A, ITM2C, PPP1R16A, H3-3B, PIP4P2, PTP4A3, TMEM68, CHKA, SERPINE2, NPW, LY6K, CHCHD7, H2AZ2, TCEA1, PPP1R1B, NGRN, GABARAP, VIM, GRINA, SEPTIN2, TSPAN3, GPX1, TGS1, UBE2V2, MRPL15, HSF1, BNIP3, GSTP1",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **IGF2 (Insulin-like Growth Factor 2):** Involved in growth and development, often overexpressed in various cancers.
- **COL2A1 (Collagen Type II Alpha 1 Chain):** A major component of cartilage, indicating potential mesenchymal or stromal cell involvement.
- **PTGDS (Prostaglandin D2 Synthase):** Involved in prostaglandin synthesis, often associated with immune modulation.
- **HSPB6 (Heat Shock Protein Family B Member 6):** A small heat shock protein involved in stress response.
- **SNAI2 (Snail Family Transcriptional Repressor 2):** A transcription factor involved in epithelial-mesenchymal transition (EMT), often linked to cancer metastasis.
- **FABP5 (Fatty Acid Binding Protein 5):** Involved in fatty acid transport, often associated with cancer cell metabolism.
- **VIM (Vimentin):** A marker of mesenchymal cells, often used to identify cells undergoing EMT.

### Step 2: List the Key Cell Type Markers
- **ACAN (Aggrecan):** A cartilage-specific proteoglycan, indicating chondrocyte or mesenchymal origin.
- **BGN (Biglycan):** A small leucine-rich repeat proteoglycan, often found in connective tissues.
- **CRABP1 (Cellular Retinoic Acid Binding Protein 1):** Involved in retinoic acid signaling, often expressed in neural and mesenchymal cells.
- **S100A1 (S100 Calcium Binding Protein A1):** Often expressed in muscle and neural tissues.
- **SDC2 (Syndecan 2):** A cell surface proteoglycan involved in cell adhesion and migration, often expressed in mesenchymal cells.
- **CHI3L1 (Chitinase 3 Like 1):** Involved in tissue remodeling and inflammation, often expressed in macrophages and cancer-associated fibroblasts.
- **MFAP2 (Microfibril Associated Protein 2):** Associated with elastic fiber assembly, often found in connective tissues.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on scRNA-seq datasets, the markers suggest a mesenchymal or stromal cell type, potentially cancer-associated fibroblasts (CAFs) or mesenchymal stem cells (MSCs).

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of markers like VIM, COL2A1, ACAN, and SNAI2, the most probable general cell type is **mesenchymal cells**. These markers are indicative of cells involved in structural support and tissue remodeling, common in the tumor microenvironment.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Cancer-Associated Fibroblasts (CAFs):** Highly likely due to the expression of markers like VIM, SNAI2, and CHI3L1, which are associated with the tumor stroma and EMT.
2. **Mesenchymal Stem Cells (MSCs):** Possible due to the presence of markers like ACAN and COL2A1, which are indicative of a chondrogenic lineage.
3. **Chondrocytes:** Less likely but possible due to the expression of ACAN and COL2A1, which are specific to cartilage.

The most likely subtype based on the markers is **Cancer-Associated Fibroblasts (CAFs)**, given their role in the tumor microenvironment and the expression of EMT-related markers.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of mesenchymal cells, specifically cancer-associated fibroblasts (CAFs). This conclusion is supported by the expression of markers associated with EMT, tissue remodeling, and the tumor microenvironment. The presence of markers like VIM, SNAI2, and CHI3L1 strongly indicates a role in cancer progression and stromal support.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency:**
   - The markers used in the annotation (e.g., IGF2, ACAN, COL2A1, PTGDS, SNAI2, VIM, CHI3L1) are present in the provided marker list.
   - The markers are consistent with the identified cell type, as they are commonly associated with mesenchymal cells and cancer-associated fibroblasts (CAFs). For example, VIM and SNAI2 are well-known markers for mesenchymal cells and EMT, while CHI3L1 is associated with cancer-associated fibroblasts.

2. **Mixed Cell Type Consideration:**
   - The annotation considers the possibility of mixed cell types by identifying potential subtypes such as mesenchymal stem cells (MSCs) and chondrocytes. However, the strongest evidence supports the presence of cancer-associated fibroblasts (CAFs), which aligns with the tumor microenvironment context of breast cancer tissue.

The annotation process has been thorough, considering both the general cell type and potential subtypes, and the conclusion of cancer-associated fibroblasts is well-supported by the marker evidence. | Formatting Agent: {
  ""main_cell_type"": ""mesenchymal cells"",
  ""sub_cell_types"": [
    ""Cancer-Associated Fibroblasts (CAFs)"",
    ""Mesenchymal Stem Cells (MSCs)"",
    ""Chondrocytes""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_44,Epithelial,"Basal Epithelial Cells, Myoepithelial Cells, Inflammatory Epithelial Cells",,50,"KRT17, ACTG2, MT2A, KRT14, CAV1, SFN, KRT5, TAGLN, SAA1, ACTA2, MT1X, ITGA2, CRYAB, CXCL8, CXCL2, NNMT, GPC1, CXCL1, TPM2, CAV2, FHL2, TNFRSF12A, TUBB6, GLIPR1, MYC, CALD1, DST, DDX21, ITGB1, NOP16, KRT7, MTHFD2, PDLIM4, SLC3A2, BRIX1, ACTN1, PRMT1, CEBPD, ARID5B, PUM3, EIF4A1, EBNA1BP2, GNL3, ANXA1, MT1E, NCL, YBX3, NOP56, TUBB4B, TUBA1C",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **KRT17, KRT14, KRT5, KRT7**: These are keratins, which are structural proteins typically expressed in epithelial cells. They play a role in maintaining cell integrity and are often used as markers for epithelial cell types.
- **ACTG2, ACTA2**: These are actin proteins, with ACTA2 (alpha-smooth muscle actin) being a marker for smooth muscle cells and myofibroblasts.
- **MT2A, MT1X, MT1E**: Metallothioneins involved in metal ion homeostasis and protection against oxidative stress.
- **CAV1, CAV2**: Caveolins are involved in the formation of caveolae (small invaginations in the cell membrane) and are associated with various signaling pathways.
- **SFN (14-3-3 sigma)**: Involved in cell cycle control and apoptosis.
- **TAGLN (Transgelin)**: A marker for smooth muscle cells and myofibroblasts.
- **SAA1 (Serum Amyloid A1)**: An acute-phase protein involved in inflammation.
- **CXCL8, CXCL2, CXCL1**: Chemokines involved in immune cell recruitment and inflammation.
- **MYC**: A transcription factor involved in cell proliferation and growth.
- **ITGA2, ITGB1**: Integrins involved in cell adhesion and signaling.
- **CRYAB (Alpha B-crystallin)**: A small heat shock protein involved in stress response.
- **NNMT (Nicotinamide N-methyltransferase)**: Involved in cellular metabolism.
- **GPC1 (Glypican 1)**: Involved in cell growth and differentiation.
- **FHL2 (Four and a half LIM domains protein 2)**: Involved in cell signaling and cytoskeletal organization.
- **TNFRSF12A (TWEAK receptor)**: Involved in inflammation and apoptosis.
- **TUBB6, TUBB4B, TUBA1C**: Tubulins involved in microtubule formation and cell structure.
- **CALD1 (Caldesmon 1)**: Involved in smooth muscle contraction.
- **DST (Dystonin)**: Involved in cytoskeletal organization.
- **DDX21, NOP16, NOP56**: Involved in ribosome biogenesis and RNA processing.
- **MTHFD2**: Involved in folate metabolism.
- **SLC3A2**: A component of amino acid transporters.
- **ANXA1 (Annexin A1)**: Involved in anti-inflammatory responses.
- **NCL (Nucleolin)**: Involved in ribosome biogenesis and cell proliferation.
- **YBX3 (Y-box binding protein 3)**: Involved in transcriptional regulation.
- **PRMT1**: Involved in protein arginine methylation.
- **CEBPD (CCAAT/enhancer-binding protein delta)**: A transcription factor involved in immune and inflammatory responses.
- **ARID5B**: A transcriptional regulator.
- **PUM3**: Involved in RNA binding and regulation.
- **EIF4A1**: Involved in translation initiation.
- **EBNA1BP2**: Involved in cell cycle regulation.
- **GNL3**: Involved in cell proliferation and nucleolar function.

### Step 2: List the Key Cell Type Markers
- **KRT17, KRT14, KRT5, KRT7**: Strongly suggest epithelial origin, particularly basal epithelial cells.
- **ACTA2, TAGLN**: Suggest myoepithelial or myofibroblast characteristics.
- **CAV1, CAV2**: Often expressed in epithelial and endothelial cells.
- **SAA1, CXCL8, CXCL2, CXCL1**: Indicate an inflammatory or immune response component.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on breast tissue and cancer, we can cross-reference these markers:
- **Basal epithelial cells** in breast tissue often express KRT5, KRT14, and KRT17.
- **Myoepithelial cells** express ACTA2 and TAGLN, along with some keratins.
- **Inflammatory markers** like CXCL8 and SAA1 suggest an immune response, common in tumor microenvironments.

### Step 4: Determine the Most Probable General Cell Type
The expression of keratins (KRT5, KRT14, KRT17) and ACTA2 suggests that the general cell type is likely **epithelial**, specifically basal epithelial or myoepithelial cells, which are common in breast tissue.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Basal Epithelial Cells**: High expression of KRT5, KRT14, and KRT17 strongly indicates basal epithelial cells.
2. **Myoepithelial Cells**: The presence of ACTA2 and TAGLN suggests myoepithelial characteristics.
3. **Inflammatory Epithelial Cells**: The presence of inflammatory markers like CXCL8 and SAA1 suggests an epithelial cell type involved in an immune response, possibly due to the tumor microenvironment.

The most likely subtype based on the markers is **Basal Epithelial Cells**.

### Step 6: Provide a Concise Summary of Your Analysis
The cluster of cells from the breast cancer tissue is most likely composed of basal epithelial cells, characterized by the high expression of keratins KRT5, KRT14, and KRT17. These cells are integral to the structure of the breast epithelium and are often involved in the basal-like subtype of breast cancer. The presence of ACTA2 and TAGLN also suggests some myoepithelial characteristics, while inflammatory markers indicate an active tumor microenvironment.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**: 
   - The key functional markers listed in the annotation (e.g., KRT17, KRT14, KRT5, KRT7, ACTA2, TAGLN, CXCL8, SAA1) are present in the provided marker list.
   - The markers used to identify the cell type as basal epithelial cells, myoepithelial cells, and inflammatory epithelial cells are consistent with known literature and databases.

2. **Mixed Cell Type Consideration**:
   - The annotation acknowledges the presence of multiple cell type characteristics, such as basal epithelial, myoepithelial, and inflammatory epithelial cells. This is supported by several high-ranking markers, such as keratins for epithelial cells and ACTA2 and TAGLN for myoepithelial cells.
   - The presence of inflammatory markers like CXCL8 and SAA1 is noted, indicating a potential mixed population due to the tumor microenvironment, which is appropriately flagged in the analysis.

Overall, the annotation is well-supported by the marker list and provides a comprehensive analysis of the potential cell types present in the cluster. | Formatting Agent: {
  ""main_cell_type"": ""Epithelial"",
  ""sub_cell_types"": [
    ""Basal Epithelial Cells"",
    ""Myoepithelial Cells"",
    ""Inflammatory Epithelial Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_46,fibroblasts,"cancer-associated fibroblasts (CAFs), myofibroblasts, pericytes",,50,"LHFP, PTRF, SELM, PRKCDBP, NGFRAP1, GNB2L1, WBP5, ATP5E, AC090498.1, ATP5L, TCEB2, LINC00657, GLTSCR2, SEPP1, USMG5, ATP5I, C14orf2, SHFM1, MYEOV2, ATP5D, ATP5G1, SEP15, C19orf60, ATP5G2, C19orf43, ATP5J, MESDC2, ATPIF1, ATP5H, ATP5O, ATP5G3, COL3A1, LINC01420, ATP5J2, SEPW1, SELK, VIMP, COL1A1, C14orf166, ATP5B, ATP5A1, SFRP2, COL1A2, ATP5C1, CD248, DCN, ATP5F1, IGFBP4, LINC00493, C7orf73",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell RNA sequencing dataset of breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **ATP Synthase Complex Subunits (ATP5E, ATP5L, ATP5I, ATP5D, ATP5G1, ATP5G2, ATP5G3, ATP5J, ATP5J2, ATP5H, ATP5O, ATP5B, ATP5A1, ATP5C1, ATP5F1):** These genes encode subunits of the ATP synthase complex, which is crucial for ATP production in mitochondria. High expression of these genes suggests a high metabolic activity, often seen in cells with high energy demands.
- **COL1A1, COL1A2, COL3A1:** These genes encode collagen proteins, which are structural components of the extracellular matrix. Their expression is typically associated with fibroblasts and cells involved in tissue remodeling and repair.
- **SEPP1, SELM, SEP15, SELK:** These genes are involved in selenium metabolism and antioxidant defense, which can be important in protecting cells from oxidative stress.
- **DCN (Decorin):** A small leucine-rich proteoglycan involved in collagen fibrillogenesis and modulation of cell growth. It is often expressed in fibroblasts and stromal cells.

### Step 2: List the Key Cell Type Markers
- **CD248 (Endosialin):** A marker often associated with pericytes and stromal cells, particularly in the tumor microenvironment.
- **SFRP2 (Secreted Frizzled-Related Protein 2):** Involved in Wnt signaling modulation, often expressed in mesenchymal and stromal cells.
- **IGFBP4 (Insulin-like Growth Factor Binding Protein 4):** Modulates IGF signaling, commonly expressed in stromal and mesenchymal cells.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, the expression of these markers is consistent with cells involved in the extracellular matrix and stromal components, particularly fibroblasts and related mesenchymal cells.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of collagen genes (COL1A1, COL1A2, COL3A1), ATP synthase subunits, and markers like CD248 and DCN, the most probable general cell type is **fibroblasts** or **stromal cells**. These cells are known for their role in producing extracellular matrix components and supporting tissue structure.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Cancer-associated fibroblasts (CAFs):** Given the context of breast cancer tissue, these fibroblasts are likely involved in tumor progression and remodeling of the tumor microenvironment.
2. **Myofibroblasts:** A subtype of fibroblasts characterized by the expression of contractile proteins and involvement in wound healing and fibrosis.
3. **Pericytes:** While less likely, the presence of CD248 suggests a potential role in vascular support and interaction with endothelial cells.

The most likely subtype, given the context and marker expression, is **cancer-associated fibroblasts (CAFs)**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is primarily composed of fibroblasts, specifically cancer-associated fibroblasts (CAFs). This conclusion is supported by the high expression of collagen genes, ATP synthase subunits, and markers like CD248 and DCN, which are characteristic of fibroblasts and stromal cells involved in the tumor microenvironment.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency:**
   - The markers used in the annotation (e.g., ATP synthase complex subunits, COL1A1, COL1A2, COL3A1, SEPP1, SELM, SEP15, SELK, DCN, CD248, SFRP2, IGFBP4) are present in the provided marker list.
   - The expression of these markers is consistent with fibroblasts and stromal cells, particularly in the context of breast cancer tissue.

2. **Mixed Cell Type Consideration:**
   - The annotation considers the possibility of mixed cell types by identifying potential subtypes such as cancer-associated fibroblasts (CAFs), myofibroblasts, and pericytes.
   - The presence of markers like CD248 and SFRP2 supports the identification of stromal and mesenchymal cells, which aligns with the annotation of fibroblasts and related subtypes.

The analysis correctly identifies the cell cluster as primarily composed of fibroblasts, specifically cancer-associated fibroblasts (CAFs), based on the expression of key markers. The annotation is well-supported by the marker list and the context of breast cancer tissue. | Formatting Agent: {
  ""main_cell_type"": ""fibroblasts"",
  ""sub_cell_types"": [
    ""cancer-associated fibroblasts (CAFs)"",
    ""myofibroblasts"",
    ""pericytes""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_47,endothelial cells,"vascular endothelial cells, lymphatic endothelial cells, tip cells",,50,"DIPK2B, VWF, PLVAP, CD34, CLEC14A, ARHGEF15, CDH5, TIE1, ROBO4, MTCO2P12, EMCN, ESAM, MMRN2, SOX18, PTPRB, HSPG2, AQP1, COL4A1, KDR, EGFL7, CALCRL, COL4A2, PECAM1, ADGRF5, ADCY4, PODXL, ADGRL4, NOTCH4, FLT1, RAMP2, RAMP3, CYYR1, ENG, IGFBP7, A2M, GNG11, LDB2, FZD4, COL15A1, ACVRL1, SPARC, LIMS2, CD93, HEG1, SPARCL1, RNASE1, TMEM204, PLXND1, H3-3A, LAMB1",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **VWF (Von Willebrand Factor):** A glycoprotein involved in hemostasis, typically expressed in endothelial cells.
- **PLVAP (Plasmalemma Vesicle Associated Protein):** Involved in the formation of diaphragms in fenestrated endothelia.
- **CD34:** A cell surface glycoprotein and a marker of hematopoietic progenitor cells, also expressed in endothelial cells.
- **CLEC14A (C-type lectin domain family 14 member A):** Involved in angiogenesis, expressed in endothelial cells.
- **CDH5 (Cadherin 5, VE-cadherin):** An endothelial-specific cadherin important for vascular integrity.
- **TIE1:** A receptor tyrosine kinase involved in angiogenesis, expressed in endothelial cells.
- **ROBO4 (Roundabout Guidance Receptor 4):** Involved in vascular development and endothelial cell migration.
- **EMCN (Endomucin):** A sialomucin expressed in endothelial cells, involved in angiogenesis.
- **ESAM (Endothelial Cell Adhesion Molecule):** Involved in endothelial cell junctions and angiogenesis.
- **PECAM1 (Platelet and Endothelial Cell Adhesion Molecule 1):** Involved in leukocyte transmigration and expressed in endothelial cells.
- **KDR (Kinase Insert Domain Receptor, VEGFR2):** A receptor for VEGF, critical for angiogenesis.
- **FLT1 (Fms Related Receptor Tyrosine Kinase 1, VEGFR1):** Another receptor for VEGF, involved in angiogenesis.
- **ENG (Endoglin):** A co-receptor for TGF-beta, involved in angiogenesis and expressed in endothelial cells.
- **ACVRL1 (Activin A Receptor Like Type 1):** Involved in TGF-beta signaling, expressed in endothelial cells.

### Step 2: List the Key Cell Type Markers
- **VWF, CD34, CDH5, PECAM1, KDR, FLT1, ENG, ACVRL1:** These markers are strongly indicative of endothelial cells, which are involved in forming the lining of blood vessels.
- **PLVAP, CLEC14A, ROBO4, EMCN, ESAM:** These markers further support the identification of endothelial cells, particularly those involved in angiogenesis and vascular development.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, these markers are consistently associated with endothelial cells. Literature on endothelial cell markers in cancerous tissues also supports this association, as endothelial cells play a crucial role in tumor angiogenesis.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of these markers, the most likely general cell type of the cluster is **endothelial cells**. This is supported by the presence of multiple markers specific to endothelial cells and their role in angiogenesis.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Vascular Endothelial Cells:** Given the strong expression of angiogenesis-related markers (e.g., VWF, KDR, FLT1), these are the most likely subtype.
2. **Lymphatic Endothelial Cells:** While less likely, some markers (e.g., PROX1, not listed here) could suggest lymphatic endothelium if present.
3. **Tip Cells:** These are specialized endothelial cells at the forefront of angiogenic sprouts, characterized by high expression of VEGF receptors.

The most likely subtype based on the markers is **vascular endothelial cells**, given the strong presence of angiogenesis and vascular development markers.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of endothelial cells, specifically vascular endothelial cells. This conclusion is supported by the expression of key markers involved in angiogenesis and vascular development, which are critical processes in tumor growth and metastasis.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result for the cell cluster as endothelial cells, specifically vascular endothelial cells, is consistent with the provided marker list and the known functions of these markers. Here's the breakdown of the validation:

1. **Marker Consistency:**
   - The key functional markers listed in the annotation (VWF, PLVAP, CD34, CLEC14A, CDH5, TIE1, ROBO4, EMCN, ESAM, PECAM1, KDR, FLT1, ENG, ACVRL1) are all present in the provided marker list.
   - These markers are well-known to be associated with endothelial cells, particularly those involved in angiogenesis and vascular development, which aligns with the annotation of vascular endothelial cells.

2. **Mixed Cell Type Consideration:**
   - The annotation does not suggest the presence of multiple distinct cell types within the cluster. The markers strongly support a single cell type, endothelial cells, with a focus on vascular endothelial cells.
   - There is no strong evidence from the marker list to suggest a mixed cell population that would require further investigation.

The annotation is well-supported by the marker list and aligns with known biological functions and literature, particularly in the context of breast cancer tissue where angiogenesis is a critical process. Therefore, the validation is passed. | Formatting Agent: {
  ""main_cell_type"": ""endothelial cells"",
  ""sub_cell_types"": [
    ""vascular endothelial cells"",
    ""lymphatic endothelial cells"",
    ""tip cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_49,Mast Cells,"Connective Tissue Mast Cells, Mucosal Mast Cells, Tumor-Associated Mast Cells",,50,"TPSD1, MS4A2, CPA3, TPSAB1, SLC18A2, TPSB2, HDC, HPGDS, RHEX, SLC45A3, HPGD, GATA2, RGS13, VWA5A, MTCO2P12, KIT, PTGS1, HS3ST1, ALOX5, TESPA1, ADRB2, BTK, ARMH1, GRAP2, IL1RL1, H3-3B, TESC, LTC4S, CNRIP1, RAC2, HLA-DQA2, SEPTIN2, GPX1, SAMSN1, CD37, ARHGEF6, FCER1G, HLA-DRB5, H3-3A, LAT2, ATP6V0A2, LAT, MSRA, ALOX5AP, VIM, TYROBP, CARD16, RAB27B, MAOB, CD52",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **TPSD1, TPSAB1, TPSB2**: These are tryptase genes, which are serine proteases predominantly found in mast cells. They play a role in the degradation of extracellular matrix components and are involved in inflammatory responses.
- **CPA3**: Carboxypeptidase A3 is another enzyme highly expressed in mast cells, involved in the processing of bioactive peptides.
- **HDC**: Histidine decarboxylase is responsible for the production of histamine, a key mediator in allergic reactions and inflammation, commonly associated with mast cells.
- **HPGDS**: Hematopoietic prostaglandin D synthase is involved in the production of prostaglandin D2, a lipid mediator involved in allergic and inflammatory responses, often linked to mast cells.
- **ALOX5, ALOX5AP**: These are involved in leukotriene synthesis, which are inflammatory mediators, again pointing towards mast cell function.
- **IL1RL1**: Also known as ST2, this receptor is involved in the immune response and is expressed on mast cells.
- **KIT**: A receptor tyrosine kinase that is crucial for mast cell development, survival, and function.

### Step 2: List the Key Cell Type Markers
- **MS4A2**: Also known as FcεRIβ, this is a high-affinity IgE receptor subunit, predominantly expressed on mast cells and basophils.
- **GATA2**: A transcription factor important for the development and function of mast cells.
- **RGS13**: Regulator of G-protein signaling 13, expressed in mast cells and involved in modulating their activation.
- **FCER1G**: The gamma chain of the high-affinity IgE receptor, crucial for mast cell activation.
- **CD37, CD52**: Surface markers that can be expressed on various immune cells, including mast cells.

### Step 3: Cross-reference Known Databases
Cross-referencing with scRNA-seq databases such as the Human Cell Atlas and literature on breast cancer tissue, the expression of these markers is highly indicative of mast cells. Mast cells are known to infiltrate breast cancer tissues and can influence tumor progression and immune response.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of the markers listed, the most probable general cell type is **Mast Cells**. The presence of tryptases, carboxypeptidase A3, histidine decarboxylase, and the high-affinity IgE receptor subunits strongly supports this annotation.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Connective Tissue Mast Cells**: Typically found in tissues and characterized by the expression of tryptases and carboxypeptidases.
2. **Mucosal Mast Cells**: Found in mucosal tissues, but less likely given the context of breast cancer tissue.
3. **Tumor-Associated Mast Cells**: A subtype of mast cells that infiltrate tumor tissues and may have distinct functional roles in the tumor microenvironment.

The most likely subtype, given the context of breast cancer tissue, is **Tumor-Associated Mast Cells**. These cells are known to be present in the tumor microenvironment and can influence tumor progression and immune modulation.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of mast cells. The expression of key markers such as tryptases, carboxypeptidase A3, histidine decarboxylase, and high-affinity IgE receptor subunits strongly supports this conclusion. Among the subtypes, tumor-associated mast cells are the most probable, given their known presence and role in the tumor microenvironment of breast cancer.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation of the cell cluster as ""Mast Cells"" is consistent with the provided marker list and the context of breast cancer tissue. The key functional markers and cell type markers identified in the annotation are present in the provided marker list, and they are well-known markers for mast cells. The analysis correctly identifies the presence of mast cells, which are known to infiltrate breast cancer tissues and influence tumor progression and immune response.

The annotation also considers the possibility of subtypes, with ""Tumor-Associated Mast Cells"" being the most probable given the context. This is a reasonable conclusion based on the expression of the markers and the known role of mast cells in the tumor microenvironment.

Overall, the annotation is well-supported by the marker list and the context provided, and there is no strong evidence of mixed cell types that would warrant further investigation. | Formatting Agent: {
  ""main_cell_type"": ""Mast Cells"",
  ""sub_cell_types"": [
    ""Connective Tissue Mast Cells"",
    ""Mucosal Mast Cells"",
    ""Tumor-Associated Mast Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_48,B cells,"Naive B Cells, Memory B Cells, Plasma Cells",,50,"MS4A1, CD19, BLK, MTCO2P12, CD79A, BANK1, CD74, CD79B, CD37, NCF1, PTPRCAP, CD52, H3-3B, LTB, HLA-DRB5, HLA-DPA1, POU2F2, HLA-DPB1, SELL, SEPTIN6, ADAM28, RAC2, LIMD2, H3-3A, POLD4, HLA-DQA1, FCMR, HLA-DRA, HLA-DQB1, H4C3, IGHM, SEPTIN9, LAPTM5, HLA-DRB1, MTRNR2L12, CORO1A, RCSD1, PTPN6, MEF2C, GPSM3, CD69, RGS19, RALGPS2, HLA-DMA, CD53, GABARAP, LSP1, CSK, STK17A, GPX1",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **MS4A1 (CD20)**: A well-known marker for B cells, involved in B cell activation and proliferation.
- **CD19**: A critical component of the B cell receptor complex, essential for B cell signaling.
- **BLK**: A tyrosine kinase involved in B cell receptor signaling.
- **CD79A and CD79B**: Components of the B cell receptor complex, crucial for B cell development and signaling.
- **BANK1**: A B cell scaffold protein that modulates B cell receptor signaling.
- **PTPRCAP (CD45-AP)**: Associated with leukocyte common antigen, involved in B cell receptor signaling.
- **CD52**: A glycoprotein expressed on the surface of mature lymphocytes, including B cells.
- **POU2F2 (OCT2)**: A transcription factor involved in B cell development and function.
- **IGMH**: Immunoglobulin heavy constant mu, part of the B cell receptor complex.
- **HLA-DRB5, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DRA, HLA-DQB1, HLA-DRB1, HLA-DMA**: MHC class II molecules, important for antigen presentation in immune cells, including B cells.

### Step 2: List the Key Cell Type Markers
- **MS4A1 (CD20)**, **CD19**, **CD79A**, **CD79B**, **BANK1**, **IGMH**: These markers are highly specific to B cells, indicating a B cell lineage.
- **HLA-DRB5**, **HLA-DPA1**, **HLA-DPB1**, **HLA-DQA1**, **HLA-DRA**, **HLA-DQB1**, **HLA-DRB1**, **HLA-DMA**: These are indicative of antigen-presenting cells, which include B cells.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Cell Atlas and literature on scRNA-seq datasets, the expression of markers like MS4A1, CD19, CD79A, and CD79B strongly suggests a B cell identity. These markers are consistently used to identify B cells in various scRNA-seq studies.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of key markers such as MS4A1, CD19, CD79A, and CD79B, the most probable general cell type is **B cells**.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Naive B Cells**: Characterized by the expression of CD19, CD79A, and CD79B, along with MHC class II molecules, indicating a role in antigen presentation.
2. **Memory B Cells**: These cells also express CD19 and CD79A but may have a slightly different expression profile, often with higher levels of MHC class II molecules.
3. **Plasma Cells**: While not directly indicated by the markers, the presence of immunoglobulin heavy chain (IGHM) suggests a potential for differentiation into antibody-secreting cells.

The most likely subtype based on the markers is **Naive B Cells**, given the strong expression of CD19, CD79A, and MHC class II molecules without additional markers for plasma cell differentiation.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of B cells. The expression of key B cell markers such as MS4A1, CD19, CD79A, and CD79B, along with MHC class II molecules, supports this annotation. Among B cells, the most probable subtype is Naive B Cells, given the expression profile and lack of differentiation markers for plasma cells.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**: 
   - The key markers used for annotation, such as MS4A1 (CD20), CD19, CD79A, CD79B, BANK1, and IGHM, are present in the provided marker list. These markers are well-known and specific to B cells, supporting the annotation of the cell type as B cells.
   - The presence of MHC class II molecules (HLA-DRB5, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DRA, HLA-DQB1, HLA-DRB1, HLA-DMA) further supports the identification of these cells as antigen-presenting B cells.

2. **Mixed Cell Type Consideration**:
   - The analysis does not strongly suggest the presence of multiple distinct cell types within the cluster. The markers predominantly indicate a B cell identity, with no strong evidence for other cell types based on the high-ranking markers provided.
   - The potential subtypes (Naive B Cells, Memory B Cells, and Plasma Cells) are all within the B cell lineage, and the annotation appropriately identifies Naive B Cells as the most probable subtype based on the expression profile.

Overall, the annotation is well-supported by the marker list and aligns with known B cell markers, leading to a valid conclusion of the cell type as B cells, specifically Naive B Cells. | Formatting Agent: {
  ""main_cell_type"": ""B cells"",
  ""sub_cell_types"": [
    ""Naive B Cells"",
    ""Memory B Cells"",
    ""Plasma Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_5,luminal epithelial cells,"Luminal Progenitor Cells, Mature Luminal Cells, Luminal Breast Cancer Cells (Hormone Receptor-Positive)",,50,"MGP, SCGB2A2, SHROOM1, SCGB1D2, PI15, TFF1, KRT15, AGR3, AZGP1, PGR, NTN4, AGR2, SLC39A6, XBP1, SCUBE2, WFDC2, PIP, STC2, TFF3, MUCL1, HES1, ANKRD30A, BHLHE40, AREG, CRACR2B, PLAT, RARRES3, KIAA1324, NFIA, ELF3, ESR1, SLC4A7, FOXA1, MUC1, ZFP36, CCNG2, TBC1D9, EGR1, FOS, BTG2, MLPH, AR, GATA3, ATF3, FOSB, ATP1B1, JUND, EFHD1, IL6ST, RHOB",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type from the provided ranked marker list, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **MGP (Matrix Gla Protein):** Involved in inhibiting vascular calcification.
- **SCGB2A2 (Secretoglobin Family 2A Member 2):** Known to be involved in immune response and secretory processes.
- **SHROOM1:** Associated with cytoskeletal organization.
- **PI15 (Peptidase Inhibitor 15):** Functions as a protease inhibitor.
- **TFF1 (Trefoil Factor 1):** Plays a role in mucosal protection and repair.
- **KRT15 (Keratin 15):** A type I keratin involved in structural integrity of epithelial cells.
- **PGR (Progesterone Receptor):** A nuclear receptor that mediates the effects of progesterone.
- **XBP1 (X-Box Binding Protein 1):** Involved in the unfolded protein response and cellular stress.
- **ESR1 (Estrogen Receptor 1):** A nuclear receptor that mediates the effects of estrogen.
- **FOXA1 (Forkhead Box A1):** A transcription factor involved in the regulation of gene expression in hormone-responsive tissues.
- **GATA3:** A transcription factor critical for the development and differentiation of various tissues, including the mammary gland.

### Step 2: List the Key Cell Type Markers
- **SCGB2A2, SCGB1D2, TFF1, AGR3, AZGP1, PGR, AGR2, SLC39A6, XBP1, SCUBE2, WFDC2, PIP, STC2, TFF3, MUCL1, ANKRD30A, AREG, KIAA1324, ELF3, ESR1, FOXA1, MUC1, GATA3:** These markers are highly indicative of luminal epithelial cells in the breast, particularly luminal progenitor or mature luminal cells.
- **KRT15:** Often associated with basal epithelial cells but can also be expressed in certain luminal progenitor cells.

### Step 3: Cross-reference Known Databases
- **Human Protein Atlas and scRNA-seq databases:** These databases confirm that markers such as SCGB2A2, TFF1, PGR, ESR1, FOXA1, and GATA3 are highly expressed in luminal epithelial cells of the breast.
- **Literature Review:** Studies on breast tissue and breast cancer often highlight these markers as characteristic of luminal epithelial cells, particularly in the context of hormone receptor-positive breast cancer.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of the markers, the most probable general cell type is **luminal epithelial cells** of the breast. This is supported by the presence of hormone receptors (ESR1, PGR), secretory proteins (SCGB2A2, SCGB1D2), and transcription factors (FOXA1, GATA3) that are characteristic of this cell type.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal Progenitor Cells:** Characterized by the expression of markers like KRT15 and some overlap with mature luminal markers.
2. **Mature Luminal Cells:** Express high levels of hormone receptors (ESR1, PGR) and secretory proteins (SCGB2A2, TFF1).
3. **Luminal Breast Cancer Cells (Hormone Receptor-Positive):** Given the context of breast cancer tissue, these cells may represent a subtype of luminal epithelial cells that are hormone receptor-positive, often seen in luminal A or B breast cancer subtypes.

The most likely subtype based on the markers is **Mature Luminal Cells**, given the high expression of hormone receptors and secretory proteins.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of luminal epithelial cells. The expression of key markers such as ESR1, PGR, SCGB2A2, and GATA3 strongly indicates a mature luminal cell phenotype. These cells are characterized by their role in hormone response and secretory functions within the breast tissue. The presence of these markers is consistent with luminal epithelial cells, which are often implicated in hormone receptor-positive breast cancer.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation of the cell cluster as luminal epithelial cells, specifically mature luminal cells, is consistent with the provided marker list and the ranked list of markers used in the analysis. Here's the breakdown of the validation:

1. **Marker Consistency:**
   - The key markers identified in the annotation (e.g., SCGB2A2, TFF1, PGR, ESR1, FOXA1, GATA3) are present in the provided marker list.
   - These markers are well-known indicators of luminal epithelial cells in the breast, particularly mature luminal cells, as they are involved in hormone response and secretory functions.

2. **Mixed Cell Type Consideration:**
   - The annotation acknowledges the potential presence of luminal progenitor cells and hormone receptor-positive luminal breast cancer cells, which is appropriate given the overlap in marker expression.
   - The primary focus on mature luminal cells is justified by the high expression of hormone receptors and secretory proteins, which are characteristic of this subtype.

3. **Cross-referencing with Databases and Literature:**
   - The annotation correctly references databases and literature that support the expression of these markers in luminal epithelial cells, further validating the proposed cell type.

Overall, the annotation is well-supported by the marker list and aligns with known biological characteristics of luminal epithelial cells in the breast. There is no strong evidence of mixed cell types that would necessitate further investigation at this stage. | Formatting Agent: {
  ""main_cell_type"": ""luminal epithelial cells"",
  ""sub_cell_types"": [
    ""Luminal Progenitor Cells"",
    ""Mature Luminal Cells"",
    ""Luminal Breast Cancer Cells (Hormone Receptor-Positive)""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_51,Mast Cells,"Connective Tissue Mast Cells, Mucosal Mast Cells, Tumor-associated Mast Cells",,50,"AL157895.1, CPA3, TPSAB1, TPSB2, MS4A2, HPGDS, SLC18A2, HPGD, RGS13, RHEX, SLC45A3, GATA2, HDC, VWA5A, TMEM233, KIT, LTC4S, FCER1A, SAMSN1, GRAP2, CD69, IL1RL1, RGS1, RGS2, PTGS1, BTK, SRGN, ADRB2, LYL1, ALOX5, ALOX5AP, RENBP, ACSL4, CNRIP1, FCER1G, LAT2, CD52, RAC2, TMEM154, LAPTM5, LAT, ANXA1, MAOB, TYROBP, C1orf162, CLU, CD37, S100A4, ITM2A, VIM",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **CPA3, TPSAB1, TPSB2**: These are markers associated with mast cell function. CPA3 (Carboxypeptidase A3) is involved in the degradation of proteins, while TPSAB1 and TPSB2 (Tryptase alpha/beta 1 and 2) are serine proteases that play a role in the immune response.
- **MS4A2**: Also known as FcεRIβ, this is a high-affinity IgE receptor subunit, crucial for mast cell activation.
- **HPGDS**: Hematopoietic prostaglandin D synthase, involved in prostaglandin synthesis, a key mediator in inflammation and allergic responses.
- **SLC18A2**: A vesicular monoamine transporter, involved in the storage and release of histamine in mast cells.
- **KIT**: A receptor tyrosine kinase important for mast cell development and function.
- **FCER1A**: The alpha subunit of the high-affinity IgE receptor, critical for mast cell activation.
- **HPGD**: Hydroxyprostaglandin dehydrogenase, involved in prostaglandin metabolism.
- **ALOX5, ALOX5AP**: Enzymes involved in leukotriene synthesis, important in inflammatory responses.
- **PTGS1**: Prostaglandin-endoperoxide synthase 1, involved in prostaglandin biosynthesis.
- **IL1RL1**: Also known as ST2, a receptor involved in the immune response, particularly in mast cells.

### Step 2: List the Key Cell Type Markers
- **CPA3, TPSAB1, TPSB2, MS4A2, KIT, FCER1A**: These markers are highly indicative of mast cells, which are involved in allergic reactions and immune responses.
- **GATA2**: A transcription factor important for hematopoietic cell differentiation, including mast cells.
- **HDC**: Histidine decarboxylase, involved in histamine synthesis, a key function of mast cells.
- **CD69**: An early activation marker on mast cells.
- **RGS13, RGS1, RGS2**: Regulators of G-protein signaling, involved in mast cell signaling pathways.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on scRNA-seq datasets, the markers CPA3, TPSAB1, TPSB2, MS4A2, KIT, and FCER1A are consistently associated with mast cells. These databases confirm the presence of these markers in mast cells, particularly in the context of immune response and allergic reactions.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of the markers listed, the most probable general cell type is **Mast Cells**. The presence of key markers such as CPA3, TPSAB1, TPSB2, MS4A2, KIT, and FCER1A strongly supports this classification.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Connective Tissue Mast Cells**: These are typically found in tissues and are characterized by the expression of tryptase and chymase.
2. **Mucosal Mast Cells**: These are found in mucosal tissues and may have a slightly different expression profile, often lacking chymase.
3. **Tumor-associated Mast Cells**: These may have a unique expression profile due to the tumor microenvironment, potentially showing altered expression of certain markers like IL1RL1 and HPGDS.

The most likely subtype, given the context of breast cancer tissue, is **Tumor-associated Mast Cells**. This is due to the potential influence of the tumor microenvironment on mast cell function and marker expression.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of mast cells. The expression of key markers such as CPA3, TPSAB1, TPSB2, MS4A2, KIT, and FCER1A strongly supports this conclusion. Among the subtypes, tumor-associated mast cells are the most probable, given the tissue context and potential alterations in marker expression due to the tumor microenvironment.

FINAL ANNOTATION COMPLETED | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation of the cell cluster as mast cells is consistent with the provided marker list and the context of breast cancer tissue. The key markers identified in the annotation, such as CPA3, TPSAB1, TPSB2, MS4A2, KIT, and FCER1A, are well-known markers for mast cells and are present in the provided marker list. Additionally, the consideration of tumor-associated mast cells as a probable subtype is appropriate given the tissue context and the potential influence of the tumor microenvironment on mast cell function and marker expression.

The analysis correctly identifies the markers that are indicative of mast cells and cross-references known databases to support the annotation. There is no strong evidence of mixed cell types based on the provided marker list, as the markers predominantly support the mast cell identity. Therefore, the annotation is validated as accurate and appropriate for the given dataset. | Formatting Agent: {
  ""main_cell_type"": ""Mast Cells"",
  ""sub_cell_types"": [
    ""Connective Tissue Mast Cells"",
    ""Mucosal Mast Cells"",
    ""Tumor-associated Mast Cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_50,breast epithelial cells,"luminal epithelial cells, luminal progenitor cells, basal epithelial cells",,50,"BMP7, GDF15, S100A7, STEAP4, MESP1, VSIG2, SERHL2, SCGB3A1, LMTK3, FAM84B, FAM49B, PTGES, TFF1, SCGB2A2, GPD1L, TFF3, TMEM150C, DEPP1, EFR3A, CMTM8, PMEPA1, FAM210B, ASS1, ASAP1, SLC7A2, S100P, AC093001.1, OCLN, MIR4458HG, ZNF217, TFAP2C, C19orf33, PHF20L1, NPDC1, PRELID3B, INSR, KLF4, RPL17, S100A9, LRRC26, GOLM1, RAB22A, CD24, TATDN1, STX16, CRIP1, CALML5, OXR1, PAM, ATF3",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type from the provided ranked marker list, I will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **BMP7**: Part of the bone morphogenetic protein family, involved in development and cellular growth.
- **GDF15**: A member of the TGF-beta superfamily, often associated with stress response and inflammation.
- **S100A7**: Also known as Psoriasin, involved in immune response and inflammation.
- **STEAP4**: Involved in metal ion transport and metabolism.
- **TFF1, TFF3**: Trefoil factors involved in mucosal protection and repair.
- **PTGES**: Prostaglandin E synthase, involved in inflammation and cancer progression.
- **KLF4**: A transcription factor involved in cell differentiation and proliferation.
- **INSR**: Insulin receptor, involved in metabolic regulation.
- **S100A9**: Involved in immune response and inflammation.

### Step 2: List the Key Cell Type Markers
- **SCGB2A2 (Mammaglobin)**: Highly specific to breast tissue, often used as a marker for breast epithelial cells.
- **SCGB3A1**: Secretoglobin family member, associated with epithelial cells.
- **TFF1, TFF3**: Often expressed in epithelial tissues, including breast tissue.
- **S100P**: Frequently expressed in breast cancer and other epithelial cancers.
- **CD24**: A marker often associated with epithelial and cancer stem cells.
- **OCLN (Occludin)**: A tight junction protein, indicative of epithelial cells.
- **ZNF217**: A zinc finger protein often amplified in breast cancer.
- **TFAP2C**: A transcription factor involved in the regulation of genes in breast cancer.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer scRNA-seq, the markers SCGB2A2, TFF1, TFF3, and S100P are strongly associated with breast epithelial cells, particularly luminal epithelial cells. CD24 is also a common marker for epithelial and cancer stem cells in breast tissue.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of SCGB2A2, TFF1, TFF3, and S100P, the most probable general cell type is **breast epithelial cells**. These markers are highly indicative of luminal epithelial cells in the breast.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Luminal Epithelial Cells**: The presence of SCGB2A2, TFF1, and TFF3 strongly suggests luminal epithelial cells, which are a major component of breast tissue.
2. **Luminal Progenitor Cells**: Given the expression of CD24 and S100P, these could also represent luminal progenitor cells, which are precursors to mature luminal cells.
3. **Basal Epithelial Cells**: Although less likely, the presence of some markers like CD24 could also suggest basal epithelial cells, but the lack of specific basal markers makes this less probable.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of **luminal epithelial cells**. The expression of SCGB2A2, TFF1, TFF3, and S100P, along with other epithelial markers, supports this annotation. The top three probable subtypes are luminal epithelial cells, luminal progenitor cells, and basal epithelial cells, with luminal epithelial cells being the most likely subtype.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**: 
   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. 
   - The markers SCGB2A2, TFF1, TFF3, and S100P are strongly associated with breast epithelial cells, particularly luminal epithelial cells, which aligns with the annotation.

2. **Mixed Cell Type Consideration**:
   - The annotation considers the possibility of mixed cell types by identifying potential subtypes such as luminal epithelial cells, luminal progenitor cells, and basal epithelial cells.
   - The presence of CD24 and S100P supports the consideration of luminal progenitor cells, while the lack of specific basal markers makes basal epithelial cells less probable.

Overall, the annotation is well-supported by the marker list and the analysis provided. The identification of luminal epithelial cells as the primary cell type is appropriate given the expression of the key markers. | Formatting Agent: {
  ""main_cell_type"": ""breast epithelial cells"",
  ""sub_cell_types"": [
    ""luminal epithelial cells"",
    ""luminal progenitor cells"",
    ""basal epithelial cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_6,fibroblasts,"Cancer-Associated Fibroblasts (CAFs), Myofibroblasts, Mesenchymal Stem Cells (MSCs)",,50,"COL1A2, COL1A1, COL3A1, LUM, DCN, SFRP2, POSTN, SPARC, SFRP4, COL5A2, COL6A3, CTSK, AEBP1, ASPN, RARRES2, CTGF, CCDC80, COL6A1, COL10A1, THY1, COL6A2, VCAN, FN1, MMP2, FBN1, THBS2, FAP, SERPINF1, PCOLCE, GAS1, MMP11, COL5A1, EMILIN1, HTRA1, ISLR, BGN, C1S, CTHRC1, COL12A1, C1R, FBLN1, TAGLN, CXCL12, FSTL1, CFH, IGFBP7, CALD1, CDH11, SULF1, PRRX1",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell RNA sequencing dataset of breast cancer tissue, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **COL1A2, COL1A1, COL3A1, COL5A2, COL6A3, COL6A1, COL6A2, COL10A1, COL5A1, COL12A1**: These are collagen genes, which are structural proteins found in the extracellular matrix (ECM). They play a crucial role in providing structural support and are often associated with fibroblasts.
- **LUM, DCN, BGN**: These are small leucine-rich proteoglycans involved in collagen fibrillogenesis and ECM organization, commonly expressed in fibroblasts.
- **SPARC, SFRP2, SFRP4, FBN1, THBS2, FAP, SERPINF1, PCOLCE, EMILIN1, HTRA1, FBLN1**: These genes are involved in ECM remodeling, cell adhesion, and tissue repair, often associated with fibroblastic activity.
- **CTSK, MMP2, MMP11**: These are matrix metalloproteinases and cathepsins involved in ECM degradation and remodeling, typically expressed in fibroblasts and stromal cells.
- **VCAN, FN1, TAGLN, CALD1, CDH11**: These genes are involved in cell adhesion, migration, and cytoskeletal organization, often found in mesenchymal cells.
- **CTGF, CCDC80, AEBP1, ASPN, RARRES2, ISLR, CTHRC1, GAS1, FSTL1, CFH, IGFBP7, SULF1, PRRX1**: These genes are involved in cell signaling, ECM interaction, and tissue development, commonly expressed in fibroblasts and stromal cells.

### Step 2: List the Key Cell Type Markers
- **THY1 (CD90)**: A marker commonly associated with fibroblasts and mesenchymal stem cells.
- **FAP (Fibroblast Activation Protein)**: A marker specific to activated fibroblasts, particularly in cancer-associated fibroblasts (CAFs).
- **CXCL12 (SDF-1)**: A chemokine involved in the recruitment of immune cells and often expressed by fibroblasts in the tumor microenvironment.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and literature on scRNA-seq datasets, the expression of these markers is consistent with fibroblasts, particularly cancer-associated fibroblasts (CAFs) in the tumor microenvironment.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of ECM-related genes, collagen genes, and fibroblast-specific markers (THY1, FAP), the most probable general cell type is **fibroblasts**.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Cancer-Associated Fibroblasts (CAFs)**: Given the expression of FAP, THY1, and ECM remodeling genes, CAFs are the most likely subtype, as they are prevalent in the tumor microenvironment of breast cancer.
2. **Myofibroblasts**: The presence of TAGLN and CALD1 suggests a contractile phenotype, which is characteristic of myofibroblasts, a subtype of fibroblasts involved in wound healing and fibrosis.
3. **Mesenchymal Stem Cells (MSCs)**: The expression of THY1 and ECM-related genes could also indicate mesenchymal stem cells, which can differentiate into fibroblasts.

### Step 6: Provide a Concise Summary of Your Analysis
The ranked marker list from the breast cancer tissue scRNA-seq dataset suggests that the cell cluster is primarily composed of fibroblasts. The high expression of ECM-related genes, collagen genes, and fibroblast-specific markers such as THY1 and FAP strongly indicates the presence of cancer-associated fibroblasts (CAFs), which play a crucial role in the tumor microenvironment by remodeling the ECM and interacting with cancer cells. Myofibroblasts and mesenchymal stem cells are also potential subtypes, but CAFs are the most likely based on the marker profile.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**: 
   - The markers listed in the annotation result are present in the provided marker list. 
   - The markers are consistent with fibroblasts, particularly cancer-associated fibroblasts (CAFs), as they include ECM-related genes, collagen genes, and fibroblast-specific markers such as THY1 and FAP.

2. **Mixed Cell Type Consideration**:
   - The annotation considers the possibility of mixed cell types by identifying potential subtypes such as myofibroblasts and mesenchymal stem cells (MSCs). 
   - The presence of markers like TAGLN and CALD1 supports the potential presence of myofibroblasts, while THY1 and ECM-related genes suggest the possibility of MSCs.
   - However, the strong presence of CAF-specific markers like FAP and the overall marker profile strongly supports the primary annotation of CAFs.

The annotation is well-supported by the marker list and the analysis provided, making it a valid conclusion for the cell cluster in question. | Formatting Agent: {
  ""main_cell_type"": ""fibroblasts"",
  ""sub_cell_types"": [
    ""Cancer-Associated Fibroblasts (CAFs)"",
    ""Myofibroblasts"",
    ""Mesenchymal Stem Cells (MSCs)""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_7,epithelial cells,"basal-like breast cancer cells, luminal progenitor cells, myoepithelial cells",,50,"TTYH1, KRT5, TMEM213, KRT14, CDKN2A, CALML5, CRYAB, NDUFA4L2, SLPI, IGFBP5, S100A1, TSEN34, TCTEX1D2, CBR3, CRABP1, KRT6B, PHGDH, PERP, LMO4, MDFI, NFIX, ACTL6A, GMPS, NUDT5, FABP5, EPCAM, NDUFB5, VCAN, CSTB, ATP5F1C, CBR1, FXYD3, POLR2H, ATP5PO, UQCRH, CCT8, ETFB, CRABP2, MRPL47, SF3B6, GSTP1, ATP5F1B, C6orf48, TMEM123, PSMB2, KRT8, FBL, CDK4, TRIR, AP2M1",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell RNA sequencing dataset of breast cancer tissue, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **CDKN2A**: Known for its role in cell cycle regulation, often associated with tumor suppression.
- **PHGDH**: Involved in the serine biosynthesis pathway, often upregulated in cancer cells.
- **FABP5**: Fatty acid-binding protein involved in lipid metabolism, often linked to cancer progression.
- **EPCAM**: A cell adhesion molecule, often used as a marker for epithelial cells and cancer stem cells.
- **VCAN**: Versican, involved in cell adhesion, proliferation, and migration, often upregulated in cancer.
- **GSTP1**: Glutathione S-transferase, involved in detoxification processes, often overexpressed in cancer.
- **CRABP1/CRABP2**: Cellular retinoic acid-binding proteins, involved in retinoic acid signaling, which can influence cell differentiation and proliferation.

### Step 2: List the Key Cell Type Markers
- **KRT5, KRT14, KRT6B, KRT8**: Keratins are structural proteins in epithelial cells. KRT5 and KRT14 are typically associated with basal epithelial cells, while KRT8 is more common in luminal epithelial cells.
- **TTYH1**: Associated with cell proliferation and migration, often found in various epithelial tissues.
- **SLPI**: Secretory leukocyte protease inhibitor, often expressed in epithelial cells and involved in immune response.
- **CRYAB**: Alpha-crystallin B chain, a small heat shock protein, often expressed in epithelial cells and involved in stress response.
- **S100A1**: A member of the S100 protein family, involved in calcium signaling, often expressed in epithelial cells.
- **PERP**: A p53 apoptosis effector related to the desmosome, often found in epithelial cells.
- **LMO4**: A transcriptional regulator, often expressed in epithelial cells and involved in development and cancer.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and PanglaoDB, we can cross-reference these markers:
- **KRT5, KRT14**: Strongly associated with basal epithelial cells, particularly basal-like breast cancer cells.
- **EPCAM**: Commonly expressed in epithelial cells, including those in breast tissue.
- **FABP5, PHGDH**: Frequently upregulated in breast cancer cells, particularly in aggressive subtypes.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of keratins (KRT5, KRT14) and other epithelial markers (EPCAM, SLPI, CRYAB), the most probable general cell type is **epithelial cells**. Given the context of breast cancer tissue, these are likely to be breast epithelial cells.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Basal-like Breast Cancer Cells**: High expression of KRT5 and KRT14, along with CDKN2A and PHGDH, suggests a basal-like phenotype, which is common in triple-negative breast cancer.
2. **Luminal Progenitor Cells**: Expression of KRT8 and EPCAM, along with markers like FABP5, could indicate a luminal progenitor phenotype.
3. **Myoepithelial Cells**: While less likely due to the lack of specific myoepithelial markers, the presence of basal keratins could suggest a myoepithelial origin.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of epithelial cells, specifically basal-like breast cancer cells. This is supported by the high expression of basal keratins (KRT5, KRT14) and other markers associated with aggressive breast cancer phenotypes. The top three probable subtypes are basal-like breast cancer cells, luminal progenitor cells, and myoepithelial cells, with basal-like breast cancer cells being the most likely subtype.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**:
   - The key functional markers (CDKN2A, PHGDH, FABP5, EPCAM, VCAN, GSTP1, CRABP1/CRABP2) are present in the provided marker list.
   - The key cell type markers (KRT5, KRT14, KRT6B, KRT8, TTYH1, SLPI, CRYAB, S100A1, PERP, LMO4) are also present in the marker list.
   - The annotation correctly identifies epithelial cells as the general cell type, supported by the presence of epithelial markers such as KRT5, KRT14, KRT8, and EPCAM.

2. **Mixed Cell Type Consideration**:
   - The annotation considers the possibility of mixed cell types by identifying three probable subtypes: basal-like breast cancer cells, luminal progenitor cells, and myoepithelial cells.
   - The presence of markers like KRT5, KRT14, and EPCAM supports the identification of basal-like breast cancer cells and luminal progenitor cells.
   - While myoepithelial cells are considered, the annotation notes the lack of specific myoepithelial markers, which is a reasonable approach given the data.

Overall, the annotation is well-supported by the marker list and provides a comprehensive analysis of the potential cell types present in the breast cancer tissue dataset. | Formatting Agent: {
  ""main_cell_type"": ""epithelial cells"",
  ""sub_cell_types"": [
    ""basal-like breast cancer cells"",
    ""luminal progenitor cells"",
    ""myoepithelial cells""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_8,T-cell,"Cytotoxic T Lymphocytes (CTLs), Effector Memory T-cells, Regulatory T-cells (Tregs)",,50,"TRAC, CD3D, CD2, TRBC2, CD3G, TRBC1, CD52, GZMA, CD7, TIGIT, CD247, NKG7, CCL5, CD69, LCK, PTPRC, CD96, CORO1A, SLA, IL32, SPOCK2, CD3E, CLEC2D, LTB, CYTIP, CD27, SRGN, FYN, HCST, IL7R, PTPN7, CST7, RGS1, RAC2, ACAP1, ITM2A, IKZF1, GMFG, APOBEC3G, FYB1, TBC1D10C, SAMSN1, IL2RG, CXCR4, SEPT6, CD48, RUNX3, ETS1, S100A4, LCP1",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:

### Step 1: List the Key Functional Markers
- **TRAC, TRBC2, TRBC1, CD3D, CD3G, CD3E, CD247**: These are components of the T-cell receptor (TCR) complex, crucial for antigen recognition and T-cell activation.
- **GZMA, NKG7, CCL5**: These are associated with cytotoxic functions. Granzyme A (GZMA) is involved in inducing apoptosis in target cells, NKG7 is linked to cytotoxic granule exocytosis, and CCL5 is a chemokine involved in recruiting immune cells.
- **LCK, FYN**: These are Src family kinases involved in TCR signaling.
- **IL32, IL7R, IL2RG**: These are cytokines and cytokine receptors involved in T-cell proliferation and survival.
- **PTPRC (CD45)**: A protein tyrosine phosphatase involved in TCR signaling.
- **RAC2, CORO1A**: Involved in actin cytoskeleton organization, important for cell movement and immune synapse formation.

### Step 2: List the Key Cell Type Markers
- **CD3D, CD3E, CD3G, CD247**: These are definitive markers for T-cells, as they are part of the TCR complex.
- **CD2, CD7, CD27, CD96, CD69**: These are surface markers commonly found on T-cells, with CD69 being an early activation marker.
- **TIGIT, LTB, CXCR4**: These are markers associated with T-cell subsets, including regulatory and memory T-cells.
- **PTPRC (CD45)**: A common leukocyte antigen, present on all hematopoietic cells except erythrocytes.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Cell Atlas, PanglaoDB, and literature on T-cell markers, the presence of CD3 complex components, CD2, CD7, and other T-cell specific markers strongly suggests a T-cell identity. The expression of cytotoxic markers like GZMA and NKG7 further supports a cytotoxic T-cell phenotype.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of the TCR complex, CD3, CD2, and other T-cell specific markers, the most probable general cell type is a **T-cell**.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Cytotoxic T Lymphocytes (CTLs)**: The presence of GZMA, NKG7, and CCL5 suggests a cytotoxic function, typical of CTLs.
2. **Effector Memory T-cells**: The expression of CD69, IL7R, and CXCR4 indicates an activated or memory phenotype.
3. **Regulatory T-cells (Tregs)**: Although less likely due to the lack of FOXP3, the presence of TIGIT and CD27 could suggest a regulatory role.

The most likely subtype, given the strong expression of cytotoxic markers, is **Cytotoxic T Lymphocytes (CTLs)**.

### Step 6: Provide a Concise Summary of Your Analysis
The ranked marker list from the breast cancer tissue dataset indicates a T-cell identity, with a strong likelihood of being cytotoxic T lymphocytes (CTLs) due to the expression of TCR components, cytotoxic markers (GZMA, NKG7), and activation markers (CD69). The presence of these markers aligns with known profiles of CTLs, which play a crucial role in immune surveillance and tumor cell killing.

**FINAL ANNOTATION COMPLETED** | Coupling Validator: Validation result: VALIDATION PASSED

The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:

1. **Marker Consistency**:
   - The markers used in the annotation (e.g., TRAC, CD3D, CD3E, CD3G, CD247, GZMA, NKG7, CCL5, LCK, PTPRC, IL7R, IL2RG, RAC2, CORO1A) are present in the provided marker list.
   - The markers are consistent with a T-cell identity, particularly cytotoxic T lymphocytes (CTLs), as they include components of the T-cell receptor complex, cytotoxic markers, and activation markers.

2. **Mixed Cell Type Consideration**:
   - The annotation considers potential subtypes within the T-cell population, such as cytotoxic T lymphocytes, effector memory T-cells, and regulatory T-cells.
   - The strong expression of cytotoxic markers (GZMA, NKG7) supports the primary annotation of CTLs, while the presence of other markers (e.g., CD69, TIGIT) suggests possible subpopulations, which is appropriately flagged for further investigation.

Overall, the annotation aligns well with the marker list and known profiles of T-cell subtypes, particularly CTLs, in the context of breast cancer tissue. | Formatting Agent: {
  ""main_cell_type"": ""T-cell"",
  ""sub_cell_types"": [
    ""Cytotoxic T Lymphocytes (CTLs)"",
    ""Effector Memory T-cells"",
    ""Regulatory T-cells (Tregs)""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
cluster_9,stromal cells,"Cancer-associated fibroblasts (CAFs), Mesenchymal stem cells (MSCs), Myofibroblasts",,50,"AKR1C1, MEDAG, CXCL2, CXCL3, CXCL1, MEG3, GEM, TNFAIP6, TWIST2, IL6, DCN, CTSL, CLMP, CXCL8, MFAP4, DPT, APOD, PLPP3, FOSL1, PRRX1, MT1A, TFPI, IL1R1, CFD, SERPINE1, SOD2, AKAP12, CCL2, CCDC80, MT2A, SPHK1, SRGAP1, FGFR1, HMOX1, LUM, PLIN2, NFKBIA, KDM6B, ERRFI1, ANXA5, PDLIM4, NOP16, VIM, ARID5B, RND3, DDX21, TNFRSF12A, WTAP, ABL2, BTG3",1,gpt-4o-2024-08-06,openai,breast cancer,human,None,"Final Annotation Agent: To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow a systematic approach:

### Step 1: List the Key Functional Markers
- **CXCL1, CXCL2, CXCL3, CXCL8 (IL-8)**: These are chemokines involved in the recruitment of immune cells, particularly neutrophils, to sites of inflammation. They play a role in tumor progression and metastasis.
- **IL6**: A cytokine involved in inflammation and the immune response, often associated with cancer progression.
- **TNFAIP6**: Involved in inflammation and tissue remodeling.
- **FOSL1**: A transcription factor involved in cell proliferation and differentiation.
- **HMOX1**: An enzyme with a role in oxidative stress response.
- **SOD2**: An enzyme that protects against oxidative stress.
- **NFKBIA**: An inhibitor of the NF-kB signaling pathway, which is involved in immune response and cell survival.
- **SERPINE1**: Involved in the regulation of fibrinolysis and associated with cancer metastasis.
- **FGFR1**: A receptor tyrosine kinase involved in cell growth and differentiation.

### Step 2: List the Key Cell Type Markers
- **VIM (Vimentin)**: A marker for mesenchymal cells, often associated with epithelial-mesenchymal transition (EMT) in cancer.
- **TWIST2**: A transcription factor involved in EMT and associated with cancer metastasis.
- **PRRX1**: A transcription factor involved in EMT and mesenchymal cell identity.
- **DCN (Decorin)**: A proteoglycan involved in the regulation of cell growth and associated with stromal cells.
- **DPT (Dermatopontin)**: Associated with the extracellular matrix and stromal cells.
- **LUM (Lumican)**: A proteoglycan involved in collagen fibril organization, associated with stromal cells.
- **MFAP4**: Associated with the extracellular matrix and stromal cells.
- **AKR1C1**: Involved in steroid metabolism, often expressed in stromal cells.

### Step 3: Cross-reference Known Databases
Using databases such as the Human Protein Atlas, CellMarker, and recent literature on scRNA-seq in breast cancer, we can cross-reference these markers. The presence of markers like VIM, TWIST2, PRRX1, and several ECM-related proteins (DCN, DPT, LUM) suggests a mesenchymal or stromal cell identity, often seen in the tumor microenvironment.

### Step 4: Determine the Most Probable General Cell Type
Based on the expression of these markers, the most likely general cell type is **stromal cells**. These cells are part of the tumor microenvironment and play a role in supporting cancer progression and metastasis.

### Step 5: Identify the Top 3 Most Probable Sub Cell Types
1. **Cancer-associated fibroblasts (CAFs)**: Given the expression of VIM, TWIST2, PRRX1, and ECM-related proteins, CAFs are the most likely subtype. They are known to express these markers and play a crucial role in remodeling the tumor microenvironment.
2. **Mesenchymal stem cells (MSCs)**: These cells can express similar markers and are involved in tissue repair and regeneration, often recruited to tumor sites.
3. **Myofibroblasts**: These cells are involved in wound healing and fibrosis, expressing markers like VIM and ECM components.

The most likely subtype based on the markers is **Cancer-associated fibroblasts (CAFs)**.

### Step 6: Provide a Concise Summary of Your Analysis
The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of stromal cells, specifically cancer-associated fibroblasts (CAFs). This conclusion is supported by the expression of mesenchymal and ECM-related markers, which are characteristic of CAFs and their role in the tumor microenvironment.

FINAL ANNOTATION COMPLETED | Coupling Validator: To validate the annotation result, we will follow the outlined steps:

### Step 1: Marker Consistency
- **Markers in the Annotation Result**: CXCL1, CXCL2, CXCL3, CXCL8, IL6, TNFAIP6, FOSL1, HMOX1, SOD2, NFKBIA, SERPINE1, FGFR1, VIM, TWIST2, PRRX1, DCN, DPT, LUM, MFAP4, AKR1C1.
- **Markers in the Provided Marker List**: AKR1C1, MEDAG, CXCL2, CXCL3, CXCL1, MEG3, GEM, TNFAIP6, TWIST2, IL6, DCN, CTSL, CLMP, CXCL8, MFAP4, DPT, APOD, PLPP3, FOSL1, PRRX1, MT1A, TFPI, IL1R1, CFD, SERPINE1, SOD2, AKAP12, CCL2, CCDC80, MT2A, SPHK1, SRGAP1, FGFR1, HMOX1, LUM, PLIN2, NFKBIA, KDM6B, ERRFI1, ANXA5, PDLIM4, NOP16, VIM, ARID5B, RND3, DDX21, TNFRSF12A, WTAP, ABL2, BTG3.

All markers used in the annotation are present in the provided marker list, ensuring consistency.

### Step 2: Mixed Cell Type Consideration
- The markers identified are consistent with a stromal cell identity, particularly cancer-associated fibroblasts (CAFs), as they include mesenchymal markers (VIM, TWIST2, PRRX1) and ECM-related proteins (DCN, DPT, LUM, MFAP4).
- There is no strong evidence of multiple distinct cell types based on the high-ranking markers provided. The markers predominantly support a stromal cell identity, specifically CAFs.

### Conclusion
The annotation result is consistent with the provided marker list and supports the identification of stromal cells, particularly cancer-associated fibroblasts (CAFs), as the primary cell type. There is no indication of a mixed cell type population that requires further investigation.

Validation result: VALIDATION PASSED | Formatting Agent: {
  ""main_cell_type"": ""stromal cells"",
  ""sub_cell_types"": [
    ""Cancer-associated fibroblasts (CAFs)"",
    ""Mesenchymal stem cells (MSCs)"",
    ""Myofibroblasts""
  ],
  ""possible_mixed_cell_types"": [],
  ""num_markers"": 50
}"
